<?xml version='1.0' encoding='utf-8'?>
<graphml xmlns="http://graphml.graphdrawing.org/xmlns" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://graphml.graphdrawing.org/xmlns http://graphml.graphdrawing.org/xmlns/1.0/graphml.xsd">
  <key id="d7" for="edge" attr.name="order" attr.type="long" />
  <key id="d6" for="edge" attr.name="source_id" attr.type="string" />
  <key id="d5" for="edge" attr.name="description" attr.type="string" />
  <key id="d4" for="edge" attr.name="weight" attr.type="double" />
  <key id="d3" for="node" attr.name="clusters" attr.type="string" />
  <key id="d2" for="node" attr.name="source_id" attr.type="string" />
  <key id="d1" for="node" attr.name="description" attr.type="string" />
  <key id="d0" for="node" attr.name="entity_type" attr.type="string" />
  <graph edgedefault="undirected">
    <node id="&quot;OBESITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by excessive body fat accumulation, influenced by genetic factors such as the FTO gene variant."&lt;SEP&gt;"Obesity is a condition characterized by excessive body fat accumulation and increased health risks."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;METABOLIC SYNDROME&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Metabolic syndrome is a cluster of conditions that increase the risk for heart disease, stroke, and diabetes."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;WAIST CIRCUMFERENCE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Waist circumference measures abdominal fat and is used as an indicator of metabolic health risks."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FAT MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fat mass refers to the total amount of body fat, which can affect metabolic and cardiovascular health."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SKELETAL MUSCLE MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Skeletal muscle mass is the quantity of skeletal muscle tissue in the body, important for overall physical function."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SERUM TOTAL CHOLESTEROL&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Total cholesterol levels reflect the amount of cholesterol carried by lipoproteins in blood and are indicative of cardiovascular health risks."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;LDL CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"LDL concentration measures low-density lipoprotein, a form of cholesterol associated with increased risk for heart disease."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SERUM TRIGLYCERIDE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Serum triglycerides are fats in the blood and their high levels can indicate poor metabolic health."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SERUM HDL CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"High-density lipoprotein (HDL) concentration is a measure of good cholesterol, which helps remove bad cholesterol from arteries."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;HS-CRP CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"C-reactive protein (CRP) is an acute-phase reactant produced by the liver and its high levels indicate systemic inflammation."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;BLOOD PRESSURE (SBP/DBP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Blood pressure measures the force of blood against artery walls; hypertension increases risks for heart disease, stroke, etc."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;EGFR&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Estimated glomerular filtration rate is a measure of kidney function and its decrease can indicate kidney damage."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;ALT CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alanine transaminase concentration is an enzyme used to detect liver injury or damage."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;AST CONCENTRATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Aspartate aminotransferase concentration measures liver health and can indicate muscle diseases or alcohol abuse as well."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;DII (DIETARY INFLAMMATORY INDEX)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Dietary Inflammatory Index assesses the inflammatory potential of diet based on nutrient intake patterns."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FRIED FOOD INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Frequent consumption of fried foods can increase risks for obesity and other chronic diseases due to high fat and calorie content."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;SUGAR-CONTAINING FOODS INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of sugar-containing foods can contribute significantly to energy intake and play a role in weight gain or obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;KOREAN BALANCED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern that includes balanced components typical in Korean cuisine, affecting health outcomes such as obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;WESTERN-STYLE DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern characterized by high intake of processed and red meats, refined grains, and sweets associated with higher risks for chronic diseases."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A diet rich in vegetables, fruits, whole grains, nuts, seeds, and legumes, which can reduce obesity risk."&lt;SEP&gt;"Intake of plant-based diet interacts with PRS for the obesity risk; high intake can protect against obesity even in individuals with high PRS."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;ALCOHOL INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Alcohol consumption has been linked to various health outcomes including increased risk of obesity."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;CURRENT SMOKER STATUS&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Being a current smoker is considered a lifestyle factor that can affect overall health status and disease risks."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;REGULAR EXERCISE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Engaging in regular physical activity as part of a healthy lifestyle, which can reduce obesity risk."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 6}]</data>
    </node>
    <node id="&quot;AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Age is a demographic characteristic that can influence health outcomes and risk factors for various diseases."&lt;SEP&gt;"The process of aging impacts the prevalence and risk factors associated with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;GENDER&quot;">
      <data key="d0">"DEMOGRAPHIC CHARACTERISTIC"</data>
      <data key="d1">"Gender is a biological factor affecting health risks, including obesity and metabolic syndrome."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A measure of body fat based on an individual's weight in relation to their height."&lt;SEP&gt;"A measure of body fat based on height and weight, BMI is a risk factor for various diseases including snoring when adjusted in genetic studies."&lt;SEP&gt;"A measure of body fat based on height and weight; found to differ by genotype at baseline."&lt;SEP&gt;"A measure used to assess obesity levels, studied in association with genetic variants."&lt;SEP&gt;"BMI calculation reflects the interaction between genetic factors like FTO SNP and environmental influences such as education level to determine health risks."&lt;SEP&gt;"BMI measures body fat based on height and weight and is used to classify overweight or obese individuals."&lt;SEP&gt;"BMI is positively correlated with snoring prevalence, especially in both sexes when considering whole-body fat mass."&lt;SEP&gt;"A measure of body fat based on an individual's weight-to-height ratio; significantly higher in women with PCOS compared to control subjects."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-fa6293a0a10f175b4aebac8e885c0d20&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-7ca64f92964b051cfb1c43f967f243a5&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-a34b927ed42ff0917960122b4d203f83&lt;SEP&gt;chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY LEVEL&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Engagement in physical activities can influence obesity risk, metabolic health, and cardiovascular fitness."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
    </node>
    <node id="&quot;FAMILY HISTORY OF OBESITY&quot;">
      <data key="d0">"GENETIC TRAIT"</data>
      <data key="d1">"Having a family history of obesity increases genetic predisposition to weight gain and related conditions."</data>
      <data key="d2">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;SEC16B_RS543874&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs543874) in SEC16B, an endoplasmic reticulum export factor gene, is associated with obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;DNAJC27_RS713586&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs713586) in DNAJC27, a heat shock protein family member C27, influences the obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;CDKAL1_RS9356744&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CDKAL1 rs9356744 variant is linked to obesity risk and affects energy intake or expenditure via modulation of transcription factors."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;TFAP2B_RS2206277&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant (rs2206277) in the TFAP2B gene, a transcription factor AP-2 Beta, affects obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;BDNF_RS6265&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The BDNF rs6265 variant impacts energy intake or expenditure through its influence on transcription factors and is associated with obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MYL2_RS3782889&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant (rs3782889) in myosin light chain-2 (MYL2) affects the obesity risk but does not meet statistical criteria."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;OLFM4_RS9568856&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The OLFM4 rs9568856 variant is involved in regulating energy intake or expenditure and contributes to obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;FTO_RS1421085&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs1421085) in the FTO gene acts as a hub gene influencing the obesity risk by modulating energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;MC4R_RS6567160&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The MC4R rs6567160 variant functions as a hub gene that affects obesity risk through its regulation of energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;GIPR_RS1444988703&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant (rs1444988703) in the GIPR gene influences obesity risk by modulating transcription factors involved in energy intake or expenditure."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Regulation of energy intake and expenditure through modulation of transcription factors is a key physiological process linked to obesity risk."</data>
      <data key="d2">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
    </node>
    <node id="&quot;BODY MASS INDEX (BMI)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Adherence to the Mediterranean diet is associated with lower BMI levels among individuals."&lt;SEP&gt;"BMI is a measure used to assess the impact of genetic variants on obesity risk, showing an increasing trend with PRS scores."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 5}]</data>
    </node>
    <node id="&quot;OBESITY RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Increased BMI and waist circumference indicate higher obesity risk, a condition closely linked with the FTO gene variant and educational level."&lt;SEP&gt;"Obesity risk is influenced by interactions between genetic factors (PRS) and environmental factors such as dietary patterns."&lt;SEP&gt;"The identified SNPs and their interactions contribute significantly to the risk of developing obesity."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-eec0b4c60ebeb28599428b3552de2d1b&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;PRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polygenic risk score (PRS) for obesity interacts with age at menarche and dietary factors to influence BMI."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;EARLY MENARCHE AGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of early onset of menstruation in women, which interacts with PRS to influence the obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;BMI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Body Mass Index (BMI) is a measure used for adjusting analyses and assessing its influence on T2D risk associated with genetic variants."&lt;SEP&gt;"Body Mass Index (BMI) is a measure used to assess obesity risk and shows interaction with both genetic factors and dietary patterns."&lt;SEP&gt;"Body Mass Index (BMI) is a measure used to determine if an individual's weight is healthy relative to their height. It plays a role in assessing obesity and related health risks."&lt;SEP&gt;"Body Mass Index, a factor mediating pleiotropic effects of certain SNPs on cardiometabolic traits."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3&lt;SEP&gt;chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;HIGH PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals who consume a high amount of plant-based foods have lower genetic impact on BMI when compared to those with low intake and low PRS."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Intake of fried food interacts with PRS, where high intake is associated with higher BMI but the genetic impact (PRS) is offset in this group."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 11}]</data>
    </node>
    <node id="&quot;HIGH FRIED-FOOD INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals who consume a lot of fried foods have their genetic impact on BMI mitigated, indicating that dietary choices can modify obesity risk irrespective of PRS."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;LOW PLANT-BASED DIET INTAKE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with low intake of plant-based diet show higher BMI when combined with high PRS, compared to those with high plant-based intake and high PRS."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;HIGH PRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A high polygenic risk score (PRS) indicates a higher genetic predisposition towards obesity risk."</data>
      <data key="d2">chunk-3ad8ef794841d749e48b3223741e91d3</data>
    </node>
    <node id="&quot;FTO RS1558902 GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO rs1558902 genotype is a genetic variant that influences weight loss and body composition changes, particularly in response to high-protein diets."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Weight loss refers to the physiological process of reducing overall body mass, which can be influenced by dietary interventions and genetic factors such as the FTO rs1558902 genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A high-protein diet is a dietary pattern characterized by higher protein intake relative to other macronutrients, which can influence fat distribution depending on genotype."&lt;SEP&gt;"A high-protein diet is a dietary pattern characterized by increased protein intake relative to carbohydrate and fat, which can influence weight loss in individuals with certain genotypes like the FTO rs1558902 risk allele carriers."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in fat distribution are a result of interactions between genotype and environmental factors like diet over time."&lt;SEP&gt;"Changes in fat distribution refer to physiological processes involving alterations in body composition such as total adipose tissue, visceral and subcutaneous fat levels."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LINEAR MIXED MODELS ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The linear mixed models analysis is a statistical method used to assess genotype-time interactions on changes in body composition and fat distribution over time, particularly in response to dietary interventions such as protein diets."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;TOTAL FAT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Total fat loss involves the physiological process of reducing overall adipose tissue mass within the body."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FAT-FREE MASS (FFM) LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Loss in fat-free mass refers to a decrease in muscle and other non-fat tissues, which can be influenced by dietary protein intake and genetic factors like FTO rs1558902 genotype."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;FTO GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with obesity risk, also tied to alcohol consumption, coffee consumption, and insomnia."&lt;SEP&gt;"The FTO gene encodes a protein that is associated with the regulation of energy balance and obesity risk."&lt;SEP&gt;"The FTO gene harbors a single nucleotide polymorphism (SNP) that is associated with obesity risk."&lt;SEP&gt;"The FTO gene is a critical genetic locus associated with obesity risk and anthropometric measurements."&lt;SEP&gt;"The FTO gene is associated with obesity predisposition."&lt;SEP&gt;"The FTO gene where one of the novel SNPs (rs1558902) is located and influences CRP levels in association studies."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-ad609cb10e900d42a6901eea1591d8ba&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;MINOR ALLELE FREQUENCY (MAF)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"MAF is a measure used to describe genetic variation within a population, indicating the proportion of a specific allele in the gene pool."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;A ALLELE (RISK ALLELE)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The A allele at the rs1558902 locus is considered a risk allele for obesity and weight gain due to its influence on energy balance."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;BASELINE BMI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Baseline Body Mass Index (BMI) represents an individual's initial body mass index before intervention, used as a reference point in clinical trials."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;FM% (FAT MASS PERCENTAGE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FM%, or fat mass percentage, indicates the proportion of body mass that is fat tissue, which can change in response to diet and genetic influences."&lt;SEP&gt;"The percentage of body fat relative to total weight, affected by dietary interventions and genetic predispositions such as the FTO gene variant."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TRUNK FAT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Loss of trunk fat is a reduction in adipose tissue localized around the torso area, influenced by diet and genetics."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;VISCERAL ADIPOSE TISSUE (VAT) CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in visceral adipose tissue refer to alterations in intra-abdominal fat deposits that affect health outcomes such as metabolic syndrome."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;SUBCUTANEOUS ADIPOSE TISSUE (SAT) CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in subcutaneous adipose tissue involve changes in superficial body fat deposits which are influenced by dietary and genetic factors."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;GENE-DIET INTERACTION ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"An analysis method used to study the interaction between genetic variants (such as FTO rs1558902) and environmental factors (dietary protein intake), impacting physiological processes like weight loss and body composition changes."</data>
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
    </node>
    <node id="&quot;AA GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the AA genotype for the GCKR rs780094 SNP have significantly higher TAG, TC, and apoB concentrations as well as a greater risk of hypertriacylglycerolaemia compared to GG individuals."&lt;SEP&gt;"The AA genotype is a genetic variant that influences changes in fat distribution and body composition in response to dietary interventions."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450&lt;SEP&gt;chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A low-protein diet is a dietary pattern with lower protein content compared to high-protein diets, affecting changes in fat distribution based on genotypes such as AA genotype."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FAT DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fat distribution refers to the physiological process of how body fat is distributed across different regions, influenced by genetic factors and dietary patterns."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TAT (TOTAL ABDOMINAL ADIPOSE TISSUE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"TAT represents total abdominal adipose tissue, a measure of fat distribution that can change in response to diet and genotype interactions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;SAT (SUBCUTANEOUS ABDOMINAL ADIPOSE TISSUE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"SAT refers to subcutaneous abdominal adipose tissue, which is part of the physiological process of fat distribution affected by dietary patterns and genotypes."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TOTAL FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Total fat measures the overall amount of body fat, influenced by dietary intake and genetic factors like genotype-time interactions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TRUNK FAT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Trunk fat refers to fat distribution around the trunk area of the body, influenced by dietary patterns and genotype-time interactions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;GENOTYPE-TIME INTERACTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Genotype-time interaction refers to how genetic variants influence physiological processes in response to time-dependent factors such as dietary interventions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TOTAL FAT CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The change in total body fat is influenced by both genetic variants and dietary patterns such as low-fat diets."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FM% (FAT MASS PERCENTAGE) CHANGES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in the percentage of body mass that is fat tissue, affected by genotype-time interactions under different dietary conditions."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;TRUNK FAT CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in trunk fat distribution are influenced by genetic and environmental factors such as diet over time."</data>
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
    </node>
    <node id="&quot;FAT-FREE MASS LOSS&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"Changes in total fat are often accompanied by corresponding losses or gains in fat-free mass, indicating an overall shift in body composition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FM%&quot;">
      <data key="d2">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d1">"The initial FM% provides context for how genetic factors and dietary interventions can influence the percentage of body fat over time."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;LOW-FAT DIET&quot;">
      <data key="d2">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d1">"Genotype-time interactions on changes in fat distribution are observed under low-fat dietary conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FTO RS9939609 POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The FTO rs9939609 polymorphism is a genomic variant associated with anthropometric variables such as weight, BMI and waist circumference."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;ANTHROPOMETRIC VARIABLES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Anthropometric measurements like body mass index (BMI), weight, and waist circumference are physiological processes used to assess obesity risk and overall health."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;EDUCATION LEVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Educational background is an environmental factor influencing health outcomes such as obesity risk when interacting with genetic factors like the FTO SNP."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;FTO SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism in the FTO gene that is associated with obesity risk."&lt;SEP&gt;"The FTO single nucleotide polymorphism (SNP) is a genomic variant associated with increased BMI and higher obesity prevalence in certain educational groups."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;ANTHROPOMETRIC MEASUREMENTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"These include weight, BMI, and waist circumference which are used to assess health status and obesity risk."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;PRIMARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with primary education level show higher obesity risk when carrying the FTO rs9939609 polymorphism compared to those with university education."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;SECONDARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Similar to primary studies, individuals with secondary education also exhibit higher obesity risk associated with the FTO variant."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;UNIVERSITY STUDIES EDUCATION LEVEL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Individuals with university-level education show a lower association between the FTO rs9939609 polymorphism and anthropometric variables."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"A physiological process involving bodily movement that affects metabolism and energy expenditure, which may modify genetic effects on obesity risk when considering environmental factors like education level."&lt;SEP&gt;"The level of physical activity in an individual's lifestyle, which interacts with genetic factors like the FTO SNP to influence BMI."&lt;SEP&gt;"Physical activity is a lifestyle factor that interacts with genetic factors to modify the risk of type 2 diabetes, especially when combined with dietary interventions."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;PREVALENCE OF OBESITY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"High prevalence of obesity is observed particularly among groups with lower education levels and specific genotypes."</data>
      <data key="d2">chunk-3135befd0c3140ad097d96ace6de86a1</data>
    </node>
    <node id="&quot;EDUCATION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Level of education can influence lifestyle choices and health outcomes, including obesity risk in relation to genetic variants like those in the FTO gene."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;UNIVERSITY STUDIES&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Engaging in university studies represents an environmental factor influencing lifestyle and health outcomes, particularly in relation to genetic variants such as the FTO SNP."</data>
      <data key="d2">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;TCF7L2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TCF7L2 gene has SNPs that are significantly associated with BMI at baseline."&lt;SEP&gt;"The TCF7L2 gene is associated with Type 2 diabetes risk and has a specific variant rs7903146 that influences the association with disease."&lt;SEP&gt;"The TCF7L2 gene is associated with an increased risk of Type 2 Diabetes (T2D) and End Stage Renal Disease (ESRD), as indicated by the presence of a specific variant rs7903146."&lt;SEP&gt;"The TCF7L2 gene is frequently investigated for its interaction with dietary factors in the context of type 2 diabetes risk."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;GENETIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Various genetic variants are associated with increased or decreased susceptibility to type 2 diabetes when interacting with environmental and lifestyle factors such as diet and physical activity."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;DIETARY PATTERN&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Dietary patterns influence physiological processes and can interact with genotypes."&lt;SEP&gt;"Investigations into dietary patterns, including whole grain intake and fiber consumption, reveal interactions with genetic variants that influence the risk of developing type 1 or type 2 diabetes."&lt;SEP&gt;"Investigations into dietary patterns, including whole grain intake and fiber consumption, reveal interactions with genetic variants that influence the risk of developing type 2 diabetes."&lt;SEP&gt;"Patterns of dietary intake that influence metabolic processes like insulin sensitivity and secretion."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;INTENSIVE LIFESTYLE INTERVENTION GROUP&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"An intervention group in RCTs focused on reducing weight through diet modification and increased physical activity to lower type 2 diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;USUAL CARE CONTROL GROUP&quot;">
      <data key="d0">"CONTROL GROUP THERAPY"</data>
      <data key="d1">"A control group receiving standard care without specific lifestyle or dietary interventions, used for comparison in RCT studies."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET GROUPS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Participants randomized into two groups consuming extra-virgin olive oil or mixed nuts as part of a Mediterranean diet to assess health outcomes."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;LOW-FAT DIET GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A control group in RCTs receiving dietary advice aimed at reducing fat intake, used for comparison with intervention groups."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;WHOLE GRAIN INTAKE AND FIBER CONSUMPTION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Specific dietary factors such as whole grain consumption and fiber intake interact with genetic variants to influence type 2 diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES (T2D)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic condition characterized by high blood sugar levels over a prolonged period. The disease was assessed in relation to genetic variants associated with increased risk."&lt;SEP&gt;"A condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production, influenced by genetic and environmental factors."&lt;SEP&gt;"A metabolic disorder characterized by high blood sugar levels, insulin resistance, and relative lack of insulin."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43&lt;SEP&gt;chunk-0d8bc9a093c56fefc8b7af3fb9bc2862&lt;SEP&gt;chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;NURSES' HEALTH STUDY (NHS)&quot;">
      <data key="d0">"STUDY COHORT"</data>
      <data key="d1">"A longitudinal cohort study that follows nurses from the United States over time to understand health outcomes, including diet and physical activity effects on diabetes risk."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;FINISH DIABETES PREVENTION STUDY (DPS)&quot;">
      <data key="d0">"RCT STUDY"</data>
      <data key="d1">"An RCT evaluating lifestyle interventions against standard care for reducing type 2 diabetes risk in high-risk individuals."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d3">[{"level": 0, "cluster": 3}, {"level": 1, "cluster": 10}]</data>
    </node>
    <node id="&quot;AMERICAN DIABETES PREVENTION PROJECT (DPP)&quot;">
      <data key="d0">"RCT STUDY"</data>
      <data key="d1">"A large-scale RCT assessing the impact of intensive lifestyle intervention on reducing the incidence of type 2 diabetes compared to usual care or metformin treatment."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;PREVENCIÓN CON DIETA MEDITERRÁNEA (PREDIMED)&quot;">
      <data key="d0">"RCT STUDY"</data>
      <data key="d1">"An RCT investigating the effects of a Mediterranean diet enriched with olive oil or nuts versus a control low-fat diet on cardiovascular disease risk factors."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;GLYCEMIC INDEX AND GLYCEMIC LOAD&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"These dietary measures reflect how quickly food is converted into glucose in the bloodstream, influencing diabetes risk when combined with genetic variants."</data>
      <data key="d2">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
    </node>
    <node id="&quot;TCF7L2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TCF7L2 gene is associated with type 2 diabetes (T2D) risk and modifies the effect of incretins on insulin secretion."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS7903146 CC-GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genotype of the rs7903146 variant in TCF7L2 is associated with lower T2D incidence when combined with higher cereal fiber or whole-grain intake."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS7903146 RISK T-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific allele of the rs7903146 variant in TCF7L2 is associated with increased T2D incidence when combined with higher cereal fiber or whole-grain intake."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FIBER INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of fiber, particularly cereal fiber, interacts with genetic variants to modify the risk of type 2 diabetes (T2D)."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;WHOLE-GRAIN INTAKE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Consumption of whole grains in conjunction with certain TCF7L2 genotypes can reduce T2D incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 VARIANT RS4506565&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant, rs4506565, within the TCF7L2 gene interacts with cereal fiber and whole-grain intake to modify T2D incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 VARIANT RS12255372&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variant in TCF7L2 shows interaction with dietary fiber intake but not carbohydrates, affecting T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;RS10923931 NOTCH2 GENE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the NOTCH2 gene interacts with fiber intake to influence type 2 diabetes (T2D) incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;ZBED3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ZBED3 gene, involved in WNT signaling pathway, shows interaction with dietary fiber intake and a genetic variant within this gene modifies T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;IRS1 RS2943641&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant in the IRS1 gene associated with increased insulin sensitivity interacts with carbohydrate intake to modify type 2 diabetes (T2D) incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;GIPR RS10423928&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GIPR rs10423928 variant decreases insulin secretion and shows interaction with carbohydrate intake, influencing T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;PPARΓ VARIANTS (RS1801282, RS3856806)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the PPARγ gene show a trend for interaction with fat intake to modify type 2 diabetes (T2D) risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;FFAR4 VARIANT RS116454156&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant of FFAR4, involved in Gαq signaling, interacts with low-fat diet to increase T2D incidence among certain allele carriers."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;CAV2 VARIANT RS2270188&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variation in the CAV2 gene shows interaction with total fat and saturated fatty acids to modify type 2 diabetes (T2D) risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;ADH1C *1/*2 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genotype of ADH1C modifies the association between alcohol intake and T2D risk among women but not men."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HECTD4 VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the HECTD4 gene show interaction with alcohol intake to modify type 2 diabetes (T2D) risk, observed in some studies."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE RS1799945 (H63D)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variant of the HFE gene interacts with heme iron intake to increase T2D risk among women and men under different study conditions."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;SLC40A1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC40A1 gene, an iron-regulated transporter, shows interaction with dietary factors like heme iron to modify type 2 diabetes (T2D) risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TMPRSS6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genetic variants in the TMPRSS6 gene interact with dietary intake of heme iron to influence T2D incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS11196208 A-ALLELE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the A allele of TCF7L2 variant rs11196208 show interaction with fiber and whole-grain intake to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS7903146 AA-GENOTYPE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the AA genotype of TCF7L2 variant rs7903146 show interaction with fiber and whole-grain intake to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS7903146 AC-GENOTYPE CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the AC genotype of TCF7L2 variant rs7903146 show interaction with fiber and whole-grain intake to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS12255372 CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the rs12255372 variant of TCF7L2 show interaction with dietary fiber but not carbohydrates to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 RS4506565 CARRIERS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the rs4506565 variant of TCF7L2 show interaction with dietary fiber and whole-grain intake to modify T2D risk."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;TCF7L2 POLYMORPHISMS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms in the TCF7L2 gene interact with diet, modifying type 2 diabetes (T2D) incidence."</data>
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
    </node>
    <node id="&quot;HFE VARIANTS RS1799945 (H63D)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the HFE gene, specifically rs1799945 (H63D), is associated with increased T2D risk among women."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HFE VARIANTS RS1800562 (C282Y)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the HFE gene, specifically rs1800562 (C282Y), is associated with increased T2D risk among women."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC40A1 VARIANTS RS744653 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the SLC40A1 gene, specifically rs744653, interacts with heme iron intake in men."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;TMPRSS6 VARIANTS RS855791 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the TMPRSS6 gene, specifically rs855791, shows borderline significant interaction with heme iron intake in a total sample."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC30A8 VARIANTS (ZINC TRANSPORTER)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Genetic variants in SLC30A8 are associated with zinc intake and T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;RS16889462, 8_118252314, AND 8_118252435 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific variants in the SLC30A8 gene are associated with zinc intake but without a clear trend for an association with T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MAGNESIUM INTAKE &quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of magnesium showed no interaction with genetic variants regarding T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;VITAMIN A INTAKE &quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Intake of vitamin A showed no interaction with genetic variants regarding T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;RED MEAT &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"High intake of red meat increases the risk to develop T2D among men with a high GRS, but not among those with a low GRS."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PROCESSED MEAT &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"High intake of processed meat increases the risk to develop T2D among men with a high GRS, but not among those with a low GRS."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;OLIVE OIL &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Consumption of olive oil shows a marginally nonsignificant interaction with genetic variants such as rs10423928 in EPIC-InterAct."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;DAIRY PRODUCTS &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Association of dairy products with T2D incidence may be modified by the lactase persistence LCT gene variant, rs4988235."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;COFFEE &quot;">
      <data key="d0">"FOOD"</data>
      <data key="d1">"Consumption of coffee can modify T2D risk depending on genetic variants such as TCF7L2 and IGF2BP2."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;WESTERN DIETARY PATTERN &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A Western dietary pattern is associated with higher T2D risk among persons with a high T2D-GRS, but not among those with a low GRS."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET &quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Following a Mediterranean diet lowers the incidence of T2D depending on genetic variants such as rs4580796 (CLOCK)."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of physical activity can modify T2D risk based on genetic variants like HNF1B and IRS1."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PPARΓ VARIANTS RS1801282 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the PPARγ gene, such as rs1801282, are associated with changes in leisure-time physical activity (LTPA) and T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;ADRA2B GLU12-ALLELE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ADRA2B Glu12-allele shows an increase in leisure-time physical activity (LTPA) resulting in lower T2D incidence compared to others."&lt;SEP&gt;"This variant shows an increase in LTPA resulting in lower T2D incidence compared to others."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;KCNJ11 VARIANTS RS5215 CC-GENOTYPE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is associated with a reduced combined prediabetes and T2D risk among coffee consumers."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;T2D-GRS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A polygenic risk score for type 2 diabetes can modify the effect of dietary patterns and physical activity on T2D incidence."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC39A4 VARIANTS RS1790250 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in the SLC39A4 gene, specifically rs1790250, are associated with zinc intake and may influence T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;TCF7L2 VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Common variants in the TCF7L2 gene are strongly associated with an increased risk of developing type 2 diabetes."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;IGF2BP2 VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in IGF2BP2 contribute to the development of type 2 diabetes and obesity, depending on genetic predisposition."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;FABP2 VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the FABP2 gene are linked to altered lipid metabolism and can modify T2D risk based on dietary fat intake."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MYO1D VARIANTS RS6795034 &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is associated with changes in dietary fat consumption and may influence T2D incidence, particularly among individuals consuming a high-fat diet."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;IRS1 VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the IRS1 gene are associated with altered insulin sensitivity and can modify the risk of developing type 2 diabetes based on lifestyle factors like diet and physical activity."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;APOE Ε4-ALLELE &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The APOE ε4-allele is linked to increased cholesterol levels and may interact with dietary fats, affecting T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;CLOCK GENE VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the CLOCK gene are associated with circadian rhythm regulation and can modify T2D risk based on dietary patterns such as adherence to a Mediterranean diet."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;HNF1A VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Mutations in the HNF1A gene cause maturity-onset diabetes of the young (MODY) type 3, which is distinct from type 2 diabetes but shares genetic risk factors."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;KCNQ1 VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variants in KCNQ1 are associated with an increased risk for T2D and can interact with environmental factors like physical activity to modify disease risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;MTNR1B VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the MTNR1B gene, which encodes a melatonin receptor, increase T2D risk through altered pancreatic beta-cell function."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PTPN11 VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms in PTPN11 may influence insulin resistance and T2D risk depending on dietary habits and physical activity levels."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;PPARA VARIANTS &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Variants in the PPARA gene are associated with altered lipid metabolism and can interact with dietary fat intake to modify T2D risk."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;WFS1 VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The WFS1 gene is implicated in both type 1 diabetes (T1D) and type 2 diabetes (T2D), particularly its variants that affect beta-cell function and glucose homeostasis."</data>
      <data key="d2">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
    </node>
    <node id="&quot;SLC2A2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC2A2 gene contains multiple variants including rs5393, rs5394, rs5400, and rs5404."&lt;SEP&gt;"The SLC2A2 gene, also known as the GLUT2 transporter gene, showed associations with ketone body levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS5393, RS5394, RS5400, AND RS5404&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are specific genomic variants within the SLC2A2 gene that have been investigated for their interaction with lifestyle factors like LTPA."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LTPA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"LTPA refers to long-term physical activity, which may influence genetic expression and disease risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;TCF7L2 RS12255372&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a specific variant of the TCF7L2 gene associated with type 2 diabetes (T2D) risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;RS7903146 RISK T‐ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This allele of rs7903146 is also linked to an increased risk for T2D, but showed lower incidence in intervention groups."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;ENPP1 RS1044498 DIABETOGENIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific variant within the ENPP1 gene that is associated with a higher risk of developing type 2 diabetes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;MC4R RS17066829&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variant in MC4R shows a trend for interaction with weight loss interventions but no significant interaction tests were found."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;PPARΓ RS1152003 CC‐GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The PPARγ gene variant rs1152003, specifically the CC genotype, shows a lower T2D incidence in intervention groups compared to controls."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;TNFΑ RS1800629 GG‐GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genetic variant of TNFα is associated with reduced T2D risk in intervention groups."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;ADRA2B GLU9-ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The ADRA2B gene's Glu9 allele was found to have a lower incidence of type 2 diabetes upon weight loss interventions."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;LIPC RS2070895 A‐ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant in the LIPC gene is linked with reduced risk of T2D under intervention conditions."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;GENETIC VARIANTS&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Various genetic variants have been studied for their interaction with weight loss interventions in reducing type 2 diabetes risk."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Interventions aimed at promoting weight loss to reduce the risk of developing type 2 diabetes."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RCT STUDY POPULATIONS&quot;">
      <data key="d0">"STUDY TYPE"</data>
      <data key="d1">"Randomized controlled trial study populations where genetic interactions with lifestyle factors are investigated."</data>
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
    </node>
    <node id="&quot;RS4506565&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs4506565 variant within the TCF7L2 gene interacts with dietary fiber and whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS12255372&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"The rs12255372 variant within the TCF7L2 gene shows interaction with dietary fiber but not carbohydrates, affecting type 2 diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOTCH2 GENE&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"A genetic variant in the NOTCH2 gene interacts with fiber intake, influencing type 2 diabetes risk among individuals carrying a specific allele of this gene."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FFAR4 VARIANT&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Variants in PPARγ show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PPARΓ VARIANTS&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Variants in PPARγ show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIETARY FACTORS&quot;">
      <data key="d2">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d1">"Polymorphisms in TCF7L2 interact with various dietary factors, including fiber and whole grains, to influence type 2 diabetes incidence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18&lt;SEP&gt;chunk-372184452f1f9156514992455057f843&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"This genetic variant of TCF7L2 is significantly associated with a reduced incidence of type 2 diabetes in intervention studies compared to control groups."&lt;SEP&gt;"Type 2 Diabetes (T2D) is a disease characterized by high blood sugar levels over a prolonged period. It can be associated with obesity and is influenced by genetic factors."&lt;SEP&gt;"Type 2 diabetes (T2D) risk influenced by genetic loci and CRP levels."</data>
      <data key="d0">"DISEASE"</data>
      <data key="d3">[{"level": 0, "cluster": 5}]</data>
    </node>
    <node id="&quot;WEIGHT LOSS INTERVENTION&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d1">"While there's a trend towards interaction, the MC4R variant does not show significant interactions with weight loss interventions for reducing T2D incidence."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 1 DIABETES (T2D)&quot;">
      <data key="d2">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d1">"Certain genetic variations increase susceptibility to developing type 2 diabetes, and their interaction with lifestyle factors can modify disease risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS7903146 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in TCF7L2, specifically rs7903146, is significantly associated with an increased risk of Type 2 Diabetes and End Stage Renal Disease."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;WFS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The WFS1 gene has a variant, rs10010131, that shows an association with T2D in the study sample."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS10010131 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genomic variant in WFS1 (rs10010131) is associated with Type 2 Diabetes risk, according to the results of the individual SNP analysis."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CDKAL1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CDKAL1 gene includes a genetic variant rs10946398 that shows an association with T2D in both sets of case subjects and controls."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS10946398 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs10946398) within the CDKAL1 gene is significantly associated with Type 2 Diabetes, as indicated by odds ratios and confidence intervals."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;JAZF1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The JAZF1 gene harbors a genomic variant rs864745 which demonstrates association with T2D risk in both sets of cases and controls."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS864745 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant, rs864745 within JAZF1, is associated with an increased risk of Type 2 Diabetes according to the individual SNP analysis results."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;ADAMTS9 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ADAMTS9 gene has a genomic variant rs4607103 that demonstrates an association with T2D in set 1 and meta-analysis, but with a different direction compared to European samples."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS4607103 GENOMIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific genetic variant (rs4607103) within ADAMTS9 shows an association with T2D risk in set 1 of the study, but it's direction is opposite to previous reports."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;END STAGE RENAL DISEASE (ESRD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The final stage of chronic kidney disease, often requiring dialysis or transplantation. It was observed more frequently among cases with certain genetic markers for T2D."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;CUMULATIVE RISK SCORE&quot;">
      <data key="d0">"METRIC"</data>
      <data key="d1">"A cumulative risk score based on genetic variants was used to assess the combined effect of multiple risk alleles in predicting Type 2 Diabetes (T2D) risk."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;LOGISTIC REGRESSION MODEL&quot;">
      <data key="d0">"MODEL/FRAMEWORK"</data>
      <data key="d1">"A statistical model used to evaluate the association between cumulative risk allele load and disease status in T2D patients and controls."&lt;SEP&gt;"A statistical model used to evaluate the relationship between cumulative risk allele load and disease status in T2D patients and controls."</data>
      <data key="d2">chunk-f9a60d3cf951d77afa115859755dac43</data>
    </node>
    <node id="&quot;RS7903146&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Rs7903146 is a genomic variant within the TCF7L2 gene linked to Type 2 diabetes risk when adjusted for in genetic analyses."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A chronic condition characterized by high blood sugar levels due to insulin resistance or insufficient insulin production, influenced by genetic factors such as variants within the TCF7L2 gene."&lt;SEP&gt;"A chronic disease characterized by high blood sugar due to insulin resistance or reduced insulin production; shown to have associations with specific SNPs related to ketone body metabolism."&lt;SEP&gt;"Type 2 diabetes is a metabolic disease characterized by high blood sugar levels over time."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-6a7c69534e11aa2fc4bd948484aa81c4&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Analyzing genetic variants such as rs7903146 in the context of Type 2 diabetes risk involves examining their impact on disease susceptibility."</data>
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
    </node>
    <node id="&quot;TCF7L2 RISK VARIANT&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TCF7LL2 RISK VARIANT&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TYPE 7 DIABETES RISK ANALYSIS&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Genetic analysis shows that adjusting for the genomic variant rs7903146 in TCF7L2 gene removes significant associations with Type 2 diabetes, suggesting its importance."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;RISK ALLELES COUNT&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The count of risk alleles is a factor influencing the association with Type 2 diabetes, particularly when considering variants like rs7903146 in TCF7L2."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE FACTOR&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"There was no evidence for interaction between age and Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEX FACTOR&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"No significant interaction with sex was found in the analysis of Type 2 diabetes risk associated with the TCF7L2 gene variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI FACTOR&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"Body Mass Index (BMI) did not significantly interact with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DEGREE OF AFRICAN ANCESTRY&quot;">
      <data key="d2">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d1">"The degree of African ancestry had no significant interaction with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IFG/IGT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Impaired Fasting Glucose/Impaired Glucose Tolerance (IFG/IGT) refers to the physiological processes where individuals have higher than normal blood glucose levels but not high enough to be classified as diabetes. These conditions are linked to an increased risk of developing Type 2 Diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"FPG measures the concentration of glucose in the blood after an overnight fast, used to diagnose prediabetes and type 2 diabetes."&lt;SEP&gt;"FPG measures the concentration of glucose in the blood after fasting, used as one indicator for diagnosing diabetes or prediabetes conditions like IFG/IGT."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f&lt;SEP&gt;chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;TWO-HOUR PLASMA GLUCOSE (2HPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"2hPG is a test taken two hours after consuming a standard glucose drink and measures blood sugar levels, used in assessing risk for Type 2 Diabetes."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;NGT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Normal Glucose Tolerance (NGT) refers to the physiological state where an individual's blood glucose level remains within the normal range after consuming a standard glucose drink."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (SNPS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Obesity predisposing SNPs are genetic variants that influence an individual’s susceptibility to obesity and associated conditions like T2D."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;EAST ASIAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"Individuals of East Asian ancestry in the EpiDREAM cohort study showed a lower prevalence of IFG/IGT and T2D compared to other ethnic groups, indicating potential genetic or environmental factors unique to this group."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;AFRICAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"Individuals with African ancestry had higher rates of IFG/IGT and T2D than those with East Asian ancestry, suggesting differences in disease risk across populations."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;EUROPEAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"The prevalence of IFG/IGT and T2D among individuals of European descent was lower compared to African but higher than East Asian groups, indicating varied genetic predispositions or environmental exposures."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;NATIVE NORTH AMERICAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"Subjects with Native North American ancestry had the lowest rate of IFG/IGT and a relatively low prevalence of T2D among all ethnic categories in the study."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;LATINO AMERICAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"The Latino American population exhibited higher rates of both IFG/IGT and T2D compared to East Asian individuals, indicating significant disparities in disease risk across different populations."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;SOUTH ASIAN&quot;">
      <data key="d0">"ETHNIC FACTOR"</data>
      <data key="d1">"Individuals with South Asian ancestry had high incidences of IFG/IGT (43.5%) and T2D (16.1%), highlighting the importance of genetic and environmental factors in this group."</data>
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
    </node>
    <node id="&quot;TAL1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The TAL1 gene is associated with obesity predisposition according to the text."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;LEPR GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The LEPR gene contains a SNP (rs1011527) that interacts with fasting plasma glucose (FPG) on baseline body mass index (BMI)."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms (SNPs) are genetic variants associated with obesity."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;GRS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genotype risk score (GRS), a measure of cumulative genetic risk, is significantly associated with increased BMI at baseline."&lt;SEP&gt;"The Genetic Risk Score (GRS) is derived from polymorphisms and is associated with cognitive performance metrics in patients."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;BMI BASELINE AND CHANGE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Body mass index (BMI) at baseline and change are key physiological processes studied for their association with obesity SNPs and GRS."&lt;SEP&gt;"Body mass index at baseline and changes in BMI over time are studied for their association with obesity SNPs and GRS."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;FPG (FASTING PLASMA GLUCOSE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A glycemic status trait that interacts with the rs1011527 SNP in LEPR on baseline BMI, indicating its role in modulating genetic effects on obesity."&lt;SEP&gt;"FPG is a glycemic status trait that interacts with the rs1011527 SNP in LEPR on baseline BMI."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;SNPS IN FTO, TAL1, AND TCF7L2 GENES&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific SNPs within the FTO, TAL1, and TCF7L2 genes are associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 3}]</data>
    </node>
    <node id="&quot;RS9939609 SNP IN FTO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the FTO gene is significantly associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS2984618 SNP IN TAL1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the TAL1 gene is significantly associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS7903146 SNP IN TCF7L2&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the TCF7L2 gene is significantly associated with BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;GRS (GENOTYPE RISK SCORE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A cumulative genetic risk measure that is significantly associated with increased BMI at baseline."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;RS1011527 SNP IN LEPR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP in the LEPR gene interacts with fasting plasma glucose (FPG) on baseline BMI, but shows no significant main effect on BMI alone."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;OBESITY PREDISPOSING SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs associated with increased risk of obesity."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;BMI LEVEL AND CHANGE ASSOCIATIONS AND INTERACTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The associations between obesity predisposing SNPs, GRS, and BMI level as well as changes in BMI over time are significant areas of study."</data>
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
    </node>
    <node id="&quot;2HPG&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FPG&quot;">
      <data key="d2">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d1">"Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI BASELINE AND CHANGE ASSOCIATIONS AND INTERACTIONS&quot;">
      <data key="d2">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d1">"The GRS is significantly associated with increased BMI at baseline, indicating cumulative genetic risk in the context of obesity."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTHFR 1298A&gt;C&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in the MTHFR gene at position 1298, associated with an increased risk of neurocognitive impairment."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MS 2756A&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism in the MS gene at position 2756, linked to a higher likelihood of neurocognitive deficits."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTHFR 677C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another polymorphism identified in the MTHFR gene which did not show significant associations with impaired performance on neurocognitive tests."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;SHMT 1520C&gt;T&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphism within the SHMT gene that was not significantly associated with neurocognitive impairment or performance measures."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;MTRR 66A&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A polymorphism in the MTRR gene, showing no significant association with the assessed cognitive measures but impacting some fine motor skills tests."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TSER POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Polymorphisms within the TSER region affecting performance on attention and processing speed tests (TMTA/TMTB)."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;PEGDH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Paired Associate Learning Digit Span High Load (PEGDH), a test measuring aspects of attention and memory."&lt;SEP&gt;"Test assessing fine motor skills, showing some association with genetic polymorphism effects."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;PEGNDH&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Neurocognitive test for fine motor skills and executive function, revealing correlations with MTRR 66A&gt;G genotypes."&lt;SEP&gt;"Paired Associate Learning Number Digit High Load (PEGNDH) measures cognitive function under high load conditions."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;DIG&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Digit Span Test (DIG), assessing working memory and attention."&lt;SEP&gt;"Working memory test that did not show associations with genetic polymorphisms or other covariates."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;CFL&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Coding Figure Learning (CFL), a test for visual learning and immediate recall."&lt;SEP&gt;"Test for executive function, indicating a significant association with MTRR 66A&gt;G genotypes."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;MTX-RELATED NEUROTOXICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/DISEASE"</data>
      <data key="d1">"Early exposure to MTX leading to neurotoxic symptoms and later increased risk of long-term cognitive impairments."</data>
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
    </node>
    <node id="&quot;TMTA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Test assessing focused attention and processing speed."&lt;SEP&gt;"Trail Making Test Part A (TMTA) measures visual search speed and processing speed, indicating executive function."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;TMTB&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"Test measuring shifting attention and processing speed."&lt;SEP&gt;"Trail Making Test Part B (TMTB) assesses cognitive flexibility, executive control, and working memory."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;DIVERGT BATTERY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METABOLIC PATHWAY"</data>
      <data key="d1">"A comprehensive cognitive assessment tool used to evaluate various aspects of cognitive function in patients."&lt;SEP&gt;"Battery of neurocognitive tests used to assess impairment in the study population."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7&lt;SEP&gt;chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;MTX&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Methotrexate (MTX) is used in the treatment of certain diseases, particularly as an intrathecal exposure in cancer therapy."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
    </node>
    <node id="&quot;POLYMORPHISM&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genetic variation at the DNA sequence level that contributes to the Genetic Risk Score (GRS)."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;INTRATHECAL MTX EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The administration of methotrexate directly into the cerebrospinal fluid for treatment, affecting cognitive performance."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 9}]</data>
    </node>
    <node id="&quot;CUMULATIVE IV MTX EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Total amount of intravenous methotrexate administered over time, impacting patient outcomes and genetic risk scores."</data>
      <data key="d2">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d3">[{"level": 0, "cluster": 1}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Carriers of the MTHFR 1298AC/CC genotypes are at a higher risk for neurocognitive deficits compared to those with AA genotype."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEGNDH SCORE DIFFERENCE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MS 2756AA genotype scored lower on the PEGNDH test compared to those with AG/GG genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CFL PERFORMANCE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Individuals carrying MTRR 66AA genotype showed significantly worse performance in executive function tests (CFL)."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LONG-TERM NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Early MTX-induced neurotoxic symptoms were predictive of long-term cognitive deficits, despite no significant effect on all test measures."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TMTB PERFORMANCE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MTHFR 1298AC/CC genotypes scored significantly lower on TMTB compared to those with AA genotype."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TMTA PERFORMANCE&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors carrying MS 2756AA genotype performed worse on TMTA than survivors with AG/GG genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FINE MOTOR SKILLS&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEGDH TEST&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MTRR 66A&gt;G GENOTYPES&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PEGNDH TEST&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DIG TEST&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;WORKING MEMORY&quot;">
      <data key="d2">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d1">"The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLC30A8 RS13266634&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The genomic variant SLC30A8 rs13266634 is associated with higher fasting proinsulin levels at baseline."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting proinsulin levels are significantly affected by the genetic risk allele of SLC30A8 and interventions such as lifestyle changes, metformin, or troglitazone."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;LIFESTYLE INTERVENTION GROUP&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The lifestyle intervention group showed a significant decrease in fasting proinsulin levels compared to the placebo and medication groups after one year of DPP intervention."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;METFORMIN&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Metformin is used as an intervention in the DPP study for reducing proinsulin levels, but its efficacy was less pronounced than lifestyle changes."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;TROGLITAZONE&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"Troglitazone was another drug used in the DPP study to reduce fasting proinsulin levels; however, it showed similar effectiveness as metformin compared to lifestyle interventions."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;C RISK ALLELE AT SLC30A8 RS13266634&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The C risk allele at the genomic variant SLC30A8 rs13266634 is associated with higher fasting proinsulin levels and does not modify treatment effectiveness in a gene-treatment interaction."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;DPP COHORT&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The DPP cohort represents participants involved in a diabetes prevention program intervention study."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;FASTING INSULIN&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Fasting insulin levels are measured and used as an adjustment factor in the analysis of proinsulin levels related to SLC30A8 risk allele and treatment effects."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;AGE, SEX, ETHNICITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Demographic factors such as age, sex, and ethnicity were considered covariates for adjusting proinsulin level associations."</data>
      <data key="d2">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
    </node>
    <node id="&quot;PNPLA3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"PNPLA3 is a gene that plays a role in lipid metabolism regulation, particularly in the liver."&lt;SEP&gt;"The PNPLA3 gene is involved in lipid metabolism and its expression can be influenced by glucose levels, fatty acids, and other metabolic factors."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;SREBP1C&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"SREBP1c is a transcriptional factor important for regulating genes involved in lipid metabolism."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;ACC-1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ACC-1 gene encodes acetyl-CoA carboxylase, which catalyzes the formation of malonyl-CoA for fatty acid synthesis."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HIGH CARBOHYDRATE DIET (HC)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"High carbohydrate diet is a dietary pattern characterized by high intake of carbohydrates."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;LIPID EMULSION (LE)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Lipid emulsion is a nutritional supplement that contains lipids, providing an alternative energy source to glucose."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;STEROL REGULATORY ELEMENT BINDING PROTEIN 1C (SREBP1C)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"SREBP1c regulates the expression of genes involved in lipid biosynthesis and transport as a physiological process."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;HIGH-FAT DIET (HF)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern high in fat, contributing to fatty liver development when consumed chronically."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;EXERCISE&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Voluntary exercise is a lifestyle factor that can modulate gene expression and physiological processes in the body."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;GLUCOSE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Glucose is a critical nutrient for cellular metabolism, particularly affecting glycolysis and lipid synthesis pathways."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;CHREBP&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Carbohydrate response element binding protein (ChREBP) regulates the expression of genes involved in glucose metabolism and storage."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
    </node>
    <node id="&quot;FATTY ACID SYNTHASE (FAS)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"FAS is a gene encoding an enzyme responsible for synthesizing fatty acids from acetyl-CoA."&lt;SEP&gt;"Fatty acid synthase, a key enzyme in lipid synthesis, shows increased mRNA expression upon PNPLA3 knockdown."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;2-DEOXY-D-GLUCOSE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"2-deoxy-D-glucose is a nutrient that suppresses PNPLA3 levels and reduces lipid accumulation in cells."&lt;SEP&gt;"Non-metabolizable glucose analog used to study the effects of glycolytic inhibition on cellular processes."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;CITRATE&quot;">
      <data key="d0">"METABOLIC PATHWAY INTERMEDIATE"</data>
      <data key="d1">"Citrate, an intermediate of the Krebs cycle, increases PNPLA3 protein levels."&lt;SEP&gt;"Krebs cycle intermediate that can influence metabolic pathways, including lipid synthesis."</data>
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;PYRUVATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Pyruvate does not influence PNPLA3 levels, unlike citrate and acetate."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;ACETATE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Acetate does not impact PNPLA3 expression levels in cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;FAS (FATTY ACID SYNTHASE)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"Fatty acid synthase, a key lipogenic enzyme, shows similar expression patterns to PNPLA3 under different metabolic conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;ACC-1 (ACETYL-COA CARBOXYLASE 1)&quot;">
      <data key="d0">"GENE/PROTEIN"</data>
      <data key="d1">"The gene and protein ACC-1 show expression patterns similar to PNPLA3 in response to various metabolic stimuli."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;INSULIN&quot;">
      <data key="d0">"NUTRIENT/HORMONE"</data>
      <data key="d1">"Insulin is a hormone that does not regulate hepatic PNPLA3 expression in HepG2 cells, unlike its effects on other genes and proteins."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;GLUCAGON&quot;">
      <data key="d0">"HORMONE/NUTRIENT"</data>
      <data key="d1">"Glucagon stimulation has no effect on the expression of PNPLA3 in HepG2 cells under low glucose conditions."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;OLEIC ACID (OA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Oleic acid suppresses PNPLA3 gene expression and does not affect lipid accumulation when PNPLA3 is knocked down."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LINOLEIC ACID (LA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Linoleic acid decreases PNPLA3 mRNA levels under both low and high glucose conditions in HepG2 cells."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;Α-LINOLENIC ACID (ALA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Alpha-linolenic acid does not influence PNPLA3 expression levels compared to oleic or linoleic acids."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;EICOSAPENTAENOIC ACID (EPA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"EPA reduces the gene expression of PNPLA3 and other lipogenic factors like SREBP1c and FAS."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;DOCOSAHEXAENOIC ACID (DHA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"DHA suppresses PNPLA3 mRNA levels under both glucose conditions, similar to EPA's effects."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;OIL RED O STAINING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/METHOD"</data>
      <data key="d1">"The technique used to measure lipid accumulation in cells treated with various metabolic stimuli."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;HIGH GLUCOSE CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/METABOLIC STATE"</data>
      <data key="d1">"A high glucose environment can induce PNPLA3 expression and lipid accumulation, which is suppressed by specific fatty acids or metabolic intermediates like citrate."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;LOW GLUCOSE CONDITION&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR/METABOLIC STATE"</data>
      <data key="d1">"A state of lower glucose availability compared to high glucose conditions, impacting metabolic pathways including PNPLA3 regulation."</data>
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
    </node>
    <node id="&quot;HIGH GLUCOSE LEVELS&quot;">
      <data key="d2">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d1">"Treatment with 2-deoxy-D-glucose inhibits the induction of SREBP1c and PNPLA3 by high glucose levels, indicating it disrupts metabolic pathways dependent on glucose metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FAS&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Expression patterns of FAS and PNPLA3 are similar under various metabolic conditions, including high glucose levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PYRUVATE CARBOXYLASE (PC)&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Treatment with glucagon stimulates PC expression while having no effect on PNPLA3 mRNA levels, indicating specificity of hormonal effects."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SREBP1C, FAS, PNPLA3&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"La and oleic acid reduce the mRNA levels of SREBP1c, FAS, and PNPLA3 under both low and high glucose conditions."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FATTY ACIDS RATIO MIX&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"The combination of OA:LA:ALA suppresses the gene expressions of SREBP1c, FAS, and PNPLA3 to a greater extent than individual fatty acids."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIPID ACCUMULATION&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Used for assessing lipid accumulation in HepG2 cells following metabolic perturbations like varying glucose conditions or exogenous fatty acid treatments."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GLUCAGON, PYRUVATE CARBOXYLASE (PC)&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"Under low glucose conditions, glucagon stimulation increases the expression of PC but does not affect PNPLA3 mRNA levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNPLA3 KNOCKDOWN&quot;">
      <data key="d2">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d1">"PNPLA3 knockdown results in increased mRNA levels of FAS, a key lipogenic enzyme."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PNS EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to prenatal stress (PNS) causes changes in gene expression and miRNA levels in the hippocampus of adult male rats."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;HIPPOCAMPAL TRANSCRIPTOME CHANGES&quot;">
      <data key="d0">"TRANSCRIPTOMIC VARIANT"</data>
      <data key="d1">"Significant modulation of 916 genes in the transcriptome of the hippocampus following PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;NEURODEVELOPMENT PATHWAYS&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Pathways involved in neurodevelopment such as Axonal Guidance Signaling, Protein Kinase A Signaling, Glutamate Receptor Signaling were affected by PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;INFLAMMATION PATHWAYS&quot;">
      <data key="d0">"BIOLOGICAL PROCESS"</data>
      <data key="d1">"Pathways related to inflammation like IL-8 Signaling and STAT3 Pathway were altered in response to PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;MIRNOME CHANGES&quot;">
      <data key="d0">"TRANSCRIPTOMIC VARIANT"</data>
      <data key="d1">"Significant changes in miRNA levels including 68 differentially regulated miRNAs following PNS exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;BLOOD MRNA TRANSCRIPTOMICS CHANGES&quot;">
      <data key="d0">"TRANSCRIPTOMIC VARIANT"</data>
      <data key="d1">"Differentially modulated genes (250) identified in blood samples of humans exposed to early life trauma, involved in neurodevelopment and inflammation pathways."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;GENE-PATHWAY INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Top-hit genes were both modulated by PNS exposure and targeted by miRNAs that were also altered due to stress; these interactions involve key processes such as Axonal Guidance and Glucocorticoid Receptor Signaling."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;EARLY LIFE TRAUMA EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Exposure to early life trauma leads to significant changes in blood mRNA transcriptomics, mirroring findings from PNS model studies."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;COMMON GENE OVERLAP&quot;">
      <data key="d0">"GENE INTERACTION"</data>
      <data key="d1">"22 common genes were found between the hippocampal transcriptome of PNS-exposed rats and blood transcriptomes of humans with early life trauma exposure."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;REAL-TIME PCR VALIDATION&quot;">
      <data key="d0">"EXPERIMENTAL METHOD"</data>
      <data key="d1">"All 22 overlapping genes were validated by Real-Time PCR in both rat hippocampus and human blood samples, confirming their expression patterns."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;916 SIGNIFICANTLY MODULATED GENES&quot;">
      <data key="d0">"TRANSCRIPTOMIC VARIANT"</data>
      <data key="d1">"A total of 916 genes were significantly modulated in the hippocampus following PNS exposure, with a fold change &gt;1.4 and q-value &lt;0.05."</data>
      <data key="d2">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
    </node>
    <node id="&quot;ISOC1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Isochorismatase Domain Containing 1 (ISOC1) is a gene involved in certain metabolic processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LDLRAP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Low Density Lipoprotein Receptor Adapter Protein 1 (LDLRAP1) is a gene associated with lipid metabolism and transport."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;LRRN3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Leucine-rich repeat neuronal protein 3 (LRRN3) is a gene involved in neuronal functions."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;MYO1D&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Myosin ID (MYO1D) is a gene that encodes for myosin, an important motor protein involved in various cellular processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PIK3C2B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Phosphatidylinositol-4-Phosphate 3-Kinase Catalytic Subunit Type 2 Beta (PIK3C2B) is a gene associated with phospholipid metabolism and signal transduction."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PPAP2A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Phosphatidic Acid Phosphatase Type 2A (PPAP2A) is a gene involved in lipid phosphate metabolism."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SAMD12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Sterile Alpha Motif Domain Containing 12 (SAMD12) is a gene with functions yet to be fully elucidated but possibly related to cellular signaling and development."&lt;SEP&gt;"Sterile Alpha Motif Domain Containing 12 (SAMD12), further noted to be involved in various biological processes, including immune responses." Changing this based on context: Sterile Alpha Motif Domain Containing 12 (SAMD12) is a gene that may play roles in cellular signaling and development, but its specific functions remain under investigation.</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SERINC5&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Serine Incorporator 5 (SERINC5) is a gene involved in protein modification processes, particularly in the addition of serine residues to proteins."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;TGF-Β1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Transforming Growth Factor Beta 1 (TGF-β1) is a gene encoding for a cytokine that regulates cell growth and differentiation, as well as immune response and tissue repair."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;A2M&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Alpha-2-Macroglobulin (A2M) is a gene involved in the regulation of proteolytic processes and innate immunity."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARID5B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"AT-rich Interaction Domain Containing Protein 5B (ARID5B) is a gene associated with DNA binding and transcriptional regulation."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;ARRDC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Adaptor Related Gene with RhoGTPase Domain C4 (ARRDC4) is a gene involved in intracellular signaling pathways."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;EPHA4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Ephrin Type-A Receptor 4 (EPHA4) is a gene that encodes for receptors involved in cell adhesion and communication processes."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FBXO32&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"F-box Protein 32 (FBXO32) is a gene involved in ubiquitination, a post-translational modification process crucial for protein degradation."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;FOXO1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Forkhead Box O1 (FoxO1) is a gene encoding for transcription factors that regulate metabolism and stress response pathways."&lt;SEP&gt;"FoxO1 is a gene activated in hippocampal progenitor stem cells following cortisol exposure and mediates the negative effect of stress on neurogenesis."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HSF2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Heat Shock Factor Protein 2 (HSF2) is a gene involved in the regulation of cellular responses to heat shock and other forms of stress."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;GXE INTERACTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Gene-Environment Interaction (GxE) describes the interaction between genetic factors and environmental conditions that can influence phenotypic outcomes such as depression severity."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;DEPRESSION&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A complex disorder influenced by multiple genes interacting through common or overlapping signaling systems."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;EMOTIONAL STRESS IN CHILDHOOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An environmental factor that interacts with genetic factors to predict depressive symptoms in adulthood."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BDI SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of the severity of depressive symptoms used for assessing individual differences in response to stress and trauma."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BCL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"B-Cell CLL/Lymphoma 2 (BCL2) is a gene involved in regulating apoptosis and cell survival."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;BCL9&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"B-Cell CLL/Lymphoma 9 (BCL9) is a gene associated with the Wnt signaling pathway and cellular proliferation."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SOMATIC MUTATIONS IN GENES&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Mutations within genes such as BCL2 and BCL9 can influence their interaction with environmental factors like stress."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific variations in DNA sequences studied, including those in the FADS gene cluster."&lt;SEP&gt;"Specific variations in the DNA sequence that occur at a single nucleotide position, affecting gene expression or function."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;CHILDHOOD SEXUAL ABUSE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"An environmental factor contributing to GxE interactions with genes such as TGF-β1 and A2M."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;PHYSICAL ABUSE IN CHILDHOOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"A type of environmental stress influencing gene expression, particularly for genes like FoxO1."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;EMOTIONAL ABUSE IN CHILDHOOD&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Another form of childhood trauma interacting with multiple genes to predict adult depression severity."</data>
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
    </node>
    <node id="&quot;CORTISOL&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Cortisol is a human stress hormone that induces FoxO1 upregulation and reduces neuronal proliferation in vitro."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;AS1842856&quot;">
      <data key="d0">"DRUG"</data>
      <data key="d1">"AS1842856 is an inhibitor of FoxO1 used to test the functional relevance of FoxO1 in cortisol-induced reduction of neuronal proliferation."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SGK-1 is a stress-responsive gene elevated in both hippocampus and blood under conditions of stress, mediating some glucocorticoid effects on brain function."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEUROGENESIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Neurogenesis refers to the process by which new neurons are generated, negatively affected by cortisol through FoxO1 signaling pathway."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;GLUCOCORTICOID EFFECTS ON BRAIN FUNCTION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"This pathway includes processes like SGK-1 upregulation in response to stress and glucocorticoids, affecting brain function such as neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;GENOMIC VARIANT (SNP)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with emotional abuse has been identified."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HIPPOCAMPUS&quot;">
      <data key="d0">"ANATOMICAL LOCATION"</data>
      <data key="d1">"The hippocampus is a brain region where FoxO1 expression is altered following stress exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)&quot;">
      <data key="d0">"CELL LINE"</data>
      <data key="d1">"This cell line, established from human fetal tissue, serves as an in vitro model for studying the effects of cortisol on neurogenesis."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;CHILDHOOD TRAUMA&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Childhood trauma is associated with upregulation of FoxO1 expression in blood samples."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;PROGENITOR STEM CELLS&quot;">
      <data key="d0">"CELL TYPE"</data>
      <data key="d1">"These cells are found in the hippocampus and show altered FoxO1 activity following cortisol exposure."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of neuronal proliferation is reduced by cortisol, mediated through FoxO1 signaling pathway."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;STRESSED RATS&quot;">
      <data key="d0">"ANIMAL MODEL"</data>
      <data key="d1">"Rats exposed to stress show elevated levels of SGK-1 in the hippocampus."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;DEPRESSED PATIENTS&quot;">
      <data key="d0">"PATIENT GROUP"</data>
      <data key="d1">"Blood samples from depressed patients exhibit elevated levels of SGK-1, indicating a link with brain function alterations."</data>
      <data key="d2">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR (EMOTIONAL STRESS IN CHILDHOOD)&quot;">
      <data key="d2">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d1">"The interaction between FoxO1 gene variants and early emotional stress predicts depressive symptoms in adulthood, as observed in two independent clinical cohorts."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS4771122&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant (rs4771122) associated with long-term weight loss after bariatric surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;PRE-SURGICAL BMI&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Pre-surgical body mass index, a measure of obesity before bariatric surgery that influences post-operative outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;LONG-TERM WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of weight loss over an extended period after bariatric surgery, influenced by genetic factors like rs4771122."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;BARIATRIC SURGERY&quot;">
      <data key="d0">"PROCEDURE"</data>
      <data key="d1">"A surgical procedure performed to treat obesity and associated health conditions, impacting long-term weight loss and physiological processes post-surgery."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;WEIGHT OBSERVATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurements of body weight taken at various times after bariatric surgery to assess the effectiveness of weight loss over time."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;TRAJECTORY GROUP MEMBERSHIP&quot;">
      <data key="d0">"DISEASE RISK FACTOR"</data>
      <data key="d1">"Classification based on patterns of weight change post-surgery, indicating different trajectories in weight management outcomes."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;NADIR WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The maximum percentage of initial body weight lost after bariatric surgery, an important marker for long-term success and health benefits."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;TWO YEAR PERCENT WEIGHT LOSS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Weight loss measured at two years post-surgery, used to assess the immediate efficacy of bariatric surgery on weight reduction."</data>
      <data key="d2">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
    </node>
    <node id="&quot;GCK GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GCK gene is associated with maturity-onset diabetes of the young (MODY), a monogenic form of diabetes caused by mutations in specific genes involved in glucose metabolism."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SANGER SEQUENCING AND MODY GENE PANEL TESTING METHODS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are methods used for identifying genetic variations, particularly pathogenic variants, within the GCK gene that lead to GCK-MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The specific mutations in the GCK gene identified through sequencing which are associated with causing or potentially causing GCK-MODY according to ACMG guidelines."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;ACMG GUIDELINES FOR GENOMIC VARIANT INTERPRETATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A set of criteria used by geneticists and clinicians to determine the clinical significance of genomic variants, especially in the context of diagnosing genetic disorders like GCK-MODY."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK-MODY (DISEASE)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A type of monogenic diabetes resulting from mutations in the glucokinase gene leading to altered glucose sensing and regulation."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;SEQUENCING ANALYSIS OF GENETIC VARIANTS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which genetic variations are detected and analyzed for their potential impact on health, particularly in relation to GCK-MODY and other monogenic diabetes conditions."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;CO-SEGREGATION WITH DIABETES PHENOTYPE TESTING &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A method used to confirm the relationship between a specific genetic variant (like those found in the GCK gene) and the manifestation of type 2 diabetes in family members, providing evidence for causation."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK GENE VARIANTS (VUS)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are genetic variants identified in the GCK gene that have an uncertain clinical significance according to ACMG guidelines."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;PARENTAL/EXTENDED FAMILY DNA TESTING &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A process where family members of probands with suspected GCK-MODY undergo testing for specific genetic variations to confirm co-segregation patterns and assess disease risk."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;IN-SILICO PREDICTION TOOLS &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Tools used computationally to predict the impact of genetic variants on protein function, aiding in their classification as pathogenic or benign."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;FASTING HYPERGLYCEMIA LEVELS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure indicating elevated blood glucose levels after fasting, which is used to assess metabolic health and disease risk."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;HBA1C TESTING &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A test measuring the average blood sugar level over a period of 2-3 months, providing insight into long-term diabetes management."</data>
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
    </node>
    <node id="&quot;GCK VARIANTS (VUS)&quot;">
      <data key="d2">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d1">"Testing family members for VUS helps confirm co-segregation with disease phenotype, aiding in variant classification."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Adherence to the Mediterranean diet was observed among individuals with various characteristics such as lower BMI, higher education levels, and physical activity."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 5}]</data>
    </node>
    <node id="&quot;TAG CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Triglyceride (TAG) concentration is a metabolic marker that shows significant differences in adherence categories of the Mediterranean Diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;HDL-C CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"High-density lipoprotein cholesterol (HDL-C) concentration is another lipid metabolic pathway indicator that is affected by the Mediterranean diet adherence level."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 5}]</data>
    </node>
    <node id="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The apolipoprotein B to apolipoprotein A-I ratio, a measure of cardiovascular risk, is influenced by adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 5}]</data>
    </node>
    <node id="&quot;HBA1C CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Haemoglobin A1c (HbA1c) concentration reflects long-term blood sugar control and is affected by dietary patterns such as the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;GLUCOKINASE REGULATORY PROTEIN SNP (GCKR RS780094)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GCKR rs780094 single nucleotide polymorphism affects TAG, total cholesterol (TC), and apolipoprotein B concentrations."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by high levels of triglycerides in the blood, associated with both genetic factors like the GCKR rs780094 SNP and dietary patterns."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;GG GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Individuals carrying the GG genotype for the GCKR rs780094 SNP have lower TAG concentrations compared to those with AA genotypes."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;GA GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The GA genotype is associated with increased risk of hypertriacylglycerolaemia compared to the GG genotype."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
    </node>
    <node id="&quot;RS1260326 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism in high linkage disequilibrium with the GCKR rs780094 SNP, affecting TAG levels similarly."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;LDL-C CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Low-density lipoprotein cholesterol (LDL-C) concentration is another lipid metabolic pathway indicator influenced by adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;SYSTOLIC BLOOD PRESSURE (SBP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Systolic blood pressure levels are affected by dietary patterns such as the Mediterranean diet, indicating its influence on cardiovascular health."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 5}]</data>
    </node>
    <node id="&quot;DIASTOLIC BLOOD PRESSURE (DBP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Diastolic blood pressure is another physiological process indicator influenced by adherence to the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 5}]</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The degree of insulin resistance can be influenced by adherence to dietary patterns like the Mediterranean diet."</data>
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 5}]</data>
    </node>
    <node id="&quot;SMOKING STATUS&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Smoking status is an environmental factor that includes smoker and non-smoker categories."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;TAG LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"TAG levels refer to the measurement of triglycerides in blood, indicative of lipid metabolism status."&lt;SEP&gt;"TAG levels refer to the physiological process or measurement related to triglyceride concentrations in blood."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An individual's genetic makeup (genotype) influences various physiological processes and traits such as TAG levels."&lt;SEP&gt;"Genotype refers to a specific variant of genes within an individual's genetic makeup that can influence traits like TAG levels."</data>
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
    </node>
    <node id="&quot;MEDITERRADIAN DIET ADHERENCE (MD)&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"Higher adherence to the Mediterranean diet is associated with lower HbA1c concentrations."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GCKR RS780094 SNP&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"The GCKR rs780094 single nucleotide polymorphism is positively associated with TAG levels in individuals carrying the AA genotype compared to GG genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}, {"level": 1, "cluster": 6}]</data>
    </node>
    <node id="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d2">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d1">"Individuals who are physically active tend to have higher adherence to the Mediterranean diet."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;GENE-DIET INTERACTION&quot;">
      <data key="d2">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d1">"Dietary patterns interact with genotypes to modify physiological processes such as lipid metabolism.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 2}]</data>
    </node>
    <node id="&quot;ABCC8 MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutations identified in the ABCC8 gene among patients with congenital hyperinsulinism (CHI)."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Three different heterozygous mutations were identified in the GLUD1 gene in five patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;KCNJ11 MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No mutations found in KCNJ11 among CHI patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GCK GENE VARIANTS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"No variants identified in GCK gene for any patient."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;CONGENITAL HYPERINSULINISM (CHI)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by excessive insulin secretion leading to hypoglycemia. Patients are categorized based on diazoxide responsiveness and treatment methods such as dietary management."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition characterized by abnormally low blood glucose levels, managed through various treatments including diet and medications such as diazoxide."&lt;SEP&gt;"Condition where blood glucose levels drop below normal, a common symptom in CHI patients."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd&lt;SEP&gt;chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;INSULIN HORMONE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A hormone that regulates blood sugar levels; its plasma level is measured in diagnosing hypoglycemia and HI."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE THERAPY&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"Treatment for CHI patients, especially those who are diazoxide-responsive."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;18F-DOPA PET/CT SCAN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Imaging technique used to detect focal lesions in the pancreas of CHI patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;KATP CHANNEL GENE MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutations identified in KATP channel genes, including ABCC8 and KCNJ11."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1 GENE MUTATIONS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Mutations found in the GLUD1 gene among patients with CHI."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE-UNRESPONSIVE GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A group of CHI patients who do not respond to diazoxide treatment."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;DIAZOXIDE-RESPONSIVE GROUP&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A group of CHI patients who respond positively to diazoxide treatment."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;MACROSOMIC PATIENTS&quot;">
      <data key="d0">"PATIENT CONDITION"</data>
      <data key="d1">"Patients with significantly higher birth weight than average, often linked to genetic factors or environmental influences such as maternal diabetes."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;NEONATAL PERIOD&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The initial period shortly after birth when symptoms of CHI may first appear in some patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;INFANCY PERIOD (1-12 MONTHS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Period during the first year of life where CHI symptoms can manifest, especially for diazoxide-responsive patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;CHILDHOOD (&gt;12 MONTHS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Later period when CHI symptoms may appear in a subset of patients."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;EPILEPSY&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A neurological condition observed more frequently in diazoxide-responsive Group 2 compared to the diazoxide-unresponsive group."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;HYPOGLYCEMIC BRAIN INJURY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Brain damage resulting from prolonged periods of hypoglycemia, often associated with CHI patients who do not receive timely treatment."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;FREQUENT FEEDINGS AND DIETARY MANAGEMENT&quot;">
      <data key="d0">"THERAPY"</data>
      <data key="d1">"A dietary approach to manage blood glucose levels in CHI patients by frequent feeding and nutritional intake."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;18F-DOPA PET/CT SCAN FOR FOCAL LESIONS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Imaging technique used to diagnose focal pancreatic lesions, aiding in surgical decision-making."</data>
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
    </node>
    <node id="&quot;GLUD1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GLUD1 gene is associated with hypoglycaemia, hyperinsulinism (HI), and mild hyperammonemia (HA) syndromes."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ARG322HIS MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This mutation in the GLUD1 gene has been identified in three patients and is inherited autosomally dominantly from their father, who was an asymptomatic carrier."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.SER498LEU MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Found in one patient with HI/HA due to a GLUD1 genetic defect."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;P.ASN463ASP MUTATION&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Identified in another patient with HI/HA syndrome linked to a GLUD1 gene mutation."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;LOW-PROTEIN DIET (1.5 G/KG/DAY)&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"A dietary pattern prescribed for patients diagnosed with HI/HA syndrome due to GLUD1 genetic defects."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIAZOXIDE TREATMENT&quot;">
      <data key="d0">"THERAPY/MOLECULAR INTERACTION"</data>
      <data key="d1">"Used to manage hypoglycemia in patients with HI/HA syndrome; however, it has side effects like gastrointestinal disturbances and hypertrichosis."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;OCTREOTIDE TREATMENT&quot;">
      <data key="d0">"THERAPY/MOLECULAR INTERACTION"</data>
      <data key="d1">"A treatment used for hypoglycaemic patients unresponsive to diazoxide, but only one patient was responsive while two had severe diarrhoea as a side effect."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;PANCREATECTOMY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/SURGICAL PROCEDURE"</data>
      <data key="d1">"A surgical procedure performed on 10 patients who were not responsive to drug treatments, involving partial removal of the pancreas due to diffuse disease or atypical form conditions."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;HYPERTRICHOSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/DISEASE"</data>
      <data key="d1">"A side effect experienced by a significant number (55%) of patients during diazoxide treatment, characterized by abnormal hair growth."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Developed in some cases following surgical intervention for hypoglycaemia management; insulin therapy was required in these cases."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;MALABSORPTION SYMPTOMS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/DISEASE"</data>
      <data key="d1">"Observed in two patients after surgery, one of whom needed regular feedings to manage mild hypoglycemia post-surgery."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;GLUD1 TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The GLUD1 gene transcript is affected by mutations leading to hypoglycaemia, hyperinsulinism (HI), and mild hyperammonemia (HA) syndromes."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SERUM AMMONIA CONCENTRATION (85-184 ΜMOL/L)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/DISEASE MARKER"</data>
      <data key="d1">"A biochemical marker indicating the presence of GLUD1 gene-related hypoglycaemic conditions due to high ammonia levels."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;NAUSEA AND VOMITING&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/SIDE EFFECT"</data>
      <data key="d1">"Gastrointestinal side effects common among patients treated with diazoxide for managing hypoglycaemia."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SEVERE GASTROINTESTINAL UPSET&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/SIDE EFFECT"</data>
      <data key="d1">"A serious adverse reaction to diazoxide treatment, leading to the need for nasogastric feeding in some cases."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;POOR APPETITE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/SIDE EFFECT"</data>
      <data key="d1">"Another common side effect experienced by patients receiving diazoxide therapy."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;THROMBOCYTOPENIC PURPURA&quot;">
      <data key="d0">"DISEASE/SIDE EFFECT"</data>
      <data key="d1">"A serious condition requiring the cessation of diazoxide treatment in one patient due to its severity."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;SUBTOTAL PANCREATECTOMY&quot;">
      <data key="d0">"SURGICAL PROCEDURE"</data>
      <data key="d1">"The most common surgical intervention for managing hypoglycemia unresponsive to drug treatments, involving partial removal of the pancreas."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;INSULIN TREATMENT&quot;">
      <data key="d0">"THERAPY/MOLECULAR INTERACTION"</data>
      <data key="d1">"Used in cases where patients develop diabetes mellitus after pancreatectomy due to surgery-induced insulin deficiency."</data>
      <data key="d2">chunk-2b81371954b99facae9a0056e70aa7bd</data>
    </node>
    <node id="&quot;DIFFUSE PANCREATIC DISEASE&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Patients who do not respond to diazoxide treatment often show diffuse rather than focal pancreatic lesions upon surgical examination."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NEONATAL PERIOD AND INFANCY PERIOD (1-12 MONTHS)&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Frequent feeding is often initiated early after birth or during infancy to manage blood glucose levels in CHI patients, especially for those with hypoglycemia detected shortly after birth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HYPOGLYCEMIA MANAGEMENT&quot;">
      <data key="d2">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d1">"Effective treatment strategy for many CHI patients, reducing the frequency of hypoglycemic episodes and improving overall health outcomes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACAC AND BHB LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of AcAc and BHB are physiological processes that significantly change in individuals with different glucose tolerance states."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;TWO-HOUR POST-PRANDIAL GLUCOSE (2HPG)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"2hPG is measured two hours after a meal and is used to assess glucose tolerance in individuals with normal FPG levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IMPAIRED FASTING GLYCAEMIA (IFG)&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"A condition where fasting blood sugar levels are higher than normal but not high enough for a diagnosis of diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;">
      <data key="d0">"DISEASE CONDITION"</data>
      <data key="d1">"An intermediate stage between normal glucose tolerance and type 2 diabetes, characterized by elevated postprandial blood glucose levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;METSIM STUDY&quot;">
      <data key="d0">"STUDY"</data>
      <data key="d1">"The METSIM study is a prospective research project focusing on metabolic syndrome and its risk factors."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;HYPERGLYCEMIA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"An elevated level of glucose in the bloodstream, often a symptom or indicator of type 2 diabetes and other metabolic disorders."&lt;SEP&gt;"An increase in blood sugar above the normal range, often seen as an early indicator of diabetes or prediabetes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SENSITIVITY (ISI)&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"A measure indicating how effectively insulin lowers blood glucose levels; decreased sensitivity can lead to type 1 or type 2 diabetes."&lt;SEP&gt;"A measure indicating how effectively insulin lowers blood glucose levels; decreased sensitivity can lead to type 2 diabetes."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;INSULIN SECRETION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process by which the pancreas releases insulin into the bloodstream, crucial for regulating blood sugar levels."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Single nucleotide polymorphisms that are associated with an increased risk of type 2 diabetes or hyperglycemia."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;FOLATE METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Not directly mentioned but relevant to nutrient metabolism."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Factors such as diet, physical activity, smoking, and BMI which influence glucose tolerance and diabetes risk."</data>
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
    </node>
    <node id="&quot;GCKR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene associated with CRP levels and cardiometabolic phenotypes."&lt;SEP&gt;"The GCKR gene is involved in glucose metabolism and has risk SNPs associated with elevated BHB levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;RS780094&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A specific SNP (rs780094) of the GCKR gene is linked to higher BHB levels, indicating a genetic influence on ketone body metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FADS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FADS1 gene influences fatty acid desaturation and has been found to have significant associations with AcAc or BHB levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ANK1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ANK1 is a gene involved in blood clotting and was associated with the levels of AcAc or BHB."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;GIPR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The GIPR gene, which encodes the glucagon-like peptide-1 receptor, showed significant associations with ketone body levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGA2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGA2 is a high-mobility group AT-hook 2 protein gene and was found to have an association with BHB or AcAc levels."&lt;SEP&gt;"High Mobility Group AT-Hook 2, a gene associated with height variation and number of teeth."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336&lt;SEP&gt;chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;FFAS (FREE FATTY ACIDS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Free fatty acids are a nutrient involved in energy metabolism and correlate positively with AcAc and BHB levels during fasting conditions."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CPT1A gene encodes an enzyme that plays a crucial role in fatty acid oxidation by transporting long-chain acyl-CoAs into mitochondria for beta-oxidation."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGCS1 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 1, SOLUBLE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HMGCS1 gene is involved in ketogenesis and the synthesis of ketone bodies from acetyl-CoA."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"HMGCS2 encodes an enzyme that catalyzes a rate-limiting step in ketogenesis and is localized to the mitochondria."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ACAT1 gene encodes an enzyme crucial for the final step of ketone body breakdown, producing two molecules of acetyl-CoA from acetoacetyl-CoA."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;BDH1 (BHB DEHYDROGENASE, TYPE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BDH1 is involved in BHB metabolism and was found to have inverse correlations with glucose AUC and insulin secretion while positively correlating with Matsuda ISI."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;OXCT1 (3-OXOACID COA TRANSFERASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The OXCT1 gene regulates the ketolysis process, converting acetoacetyl-CoA to acetyl-CoA and is correlated with insulin sensitivity and glucose metabolism."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;ACSS2 (ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ACSS2 gene encodes an enzyme involved in the activation of fatty acids for subsequent beta-oxidation and has been found to correlate with insulin sensitivity."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Ketone bodies, such as BHB and AcAc, are produced during fasting or low carbohydrate intake and their levels are associated with genetic variations and metabolic conditions like type 2 diabetes."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;FATTY ACIDS OXIDATION (FFA OXIDATION)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of breaking down fatty acids to produce energy; correlated with ketone body levels."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;KETOGENESIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathway responsible for the synthesis of ketone bodies from acetyl-CoA during periods of fasting or low carbohydrate intake."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;KETOLYSIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic pathway involved in breaking down ketone bodies back into acetyl-CoA and other metabolites."</data>
      <data key="d2">chunk-bc2193bd869a06007022e1aa75877336</data>
    </node>
    <node id="&quot;HYPERGLYCEMIA AND INCIDENT DIABETES&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"The METSIM study tracks participants over time to identify factors that increase the risk of hyperglycemia and incident diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUTRIENT&quot;">
      <data key="d2">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d1">"Folate metabolism is part of broader nutrient-related physiological processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CARDIOMETABOLIC SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs associated with cardiometabolic phenotypes and serum CRP levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CRP GWAS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"GWAS for C-Reactive Protein (CRP) levels in the context of cardiometabolic traits."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;APOC1 GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the APOC1 locus associated with CRP and inversely related to cholesterol, LDL-cholesterol, and triglyceride levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HNF1A GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the HNF1A locus linked to CRP but inversely correlated with cholesterol and LDL-cholesterol levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;GCKR GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"One of the SNPs located near or within the GCKR gene associated with cardiometabolic traits including CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL6R GENE VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP in the IL6R locus, showing significant association with CRP but differing lead SNP compared to other cardiometabolic GWAS for this locus."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PPAR REGULATED LIPID METABOLISM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Metabolism regulated by PPAR which may interact with genetic variants affecting CRP and lipid levels."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CRP LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Levels of C-Reactive Protein, a biomarker for systemic inflammation associated with cardiometabolic diseases."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CHOLESTEROL METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathway involved in cholesterol synthesis and regulation, affected by SNPs identified in the GWAS."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TYPE 2 DIABETES MELLITUS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A metabolic disease characterized by hyperglycemia; GWAS for CRP show significant deviations in p-values indicating potential genetic overlap with this condition."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CORONARY ARTERY DISEASE (CAD)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Cardiovascular disease where atherosclerotic plaques narrow coronary arteries; GWAS of CRP SNPs indicate associations with CAD."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;CRP SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific single nucleotide polymorphisms (SNPs) associated with CRP levels in various cardiometabolic conditions."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;RS1558902 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located within the FTO gene, showing a significant association with CRP levels and representing one of the novel associations identified in the GWAS for CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d3">[{"level": 0, "cluster": 1}]</data>
    </node>
    <node id="&quot;RS2867125 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Another SNP near TMEM18 on chromosome 2, also significantly associated with CRP levels as part of the GWAS findings."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TMEM18 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene near which a significant SNP (rs2867125) was found, contributing to the understanding of CRP associations with cardiometabolic traits."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;PLTP GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PLTP locus has associated SNPs impacting CRP levels as part of GWAS studies for cardiovascular and metabolic conditions."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;MC4R GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene upstream where a SNP (rs571312) is significantly linked to higher CRP, contributing insights into cardiometabolic phenotypes."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;LDL-CHOLESTEROL METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathways involved in the synthesis and regulation of LDL-cholesterol, affected by genetic variants identified in GWAS for CRP."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;HDL-CHOLESTEROL METABOLISM&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The metabolic processes regulating HDL cholesterol levels are influenced by genomic loci related to CRP levels as seen in the GWAS."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;TRIGLYCERIDE REGULATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Genetic factors influencing triglyceride metabolism, demonstrated through associations with CRP SNPs identified in cardiometabolic studies."</data>
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
    </node>
    <node id="&quot;IL1F10&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene identified in association studies for CRP and cardiometabolic traits, not previously reported in GWAS."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PPP1R3B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene showing pleiotropic effects on CRP and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF4A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene influencing CRP levels and cardiometabolic phenotypes, notably T2D risk."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PABPC4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene involved in pleiotropy with effects on CRP and metabolic parameters."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;BCL7B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene associated with changes in HDL cholesterol after adjustment for CRP."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HNF1A&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs1183910 is located within the HNF1A gene, influencing coronary artery disease (CAD) risk and CRP levels."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;APOC1&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNP rs4420638 near APOC1 affects T2D risk and serum CRP levels."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;IL6R&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Gene showing pleiotropic effects on CRP without significant effect size diminishment after adjustment for BMI, cholesterol, or HbA1C."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;MC4R&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs near MC4R showed no significant association with CRP levels in the WGHS."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;PLTP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs near PLTP showed no significant association with CRP after correction for multiple testing."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CRP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"C-reactive protein (CRP) levels influenced by genetic loci and cardiometabolic phenotypes."&lt;SEP&gt;"The CRP gene encodes a protein that serves as an acute-phase reactant during inflammatory processes."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CAD&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Coronary artery disease, risk associated with SNP rs1183910 in HNF1A."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;CHOLESTEROL LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Serum cholesterol levels influence genetic associations with CRP and metabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HBA1C&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Haemoglobin A1c, a marker of average blood glucose level over time, influences CRP associations in cardiometabolic studies."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;FXR/RXR ACTIVATION PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Pathway significantly enriched by pleiotropic genes influencing CRP and cardiometabolic traits."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;LXR/RXR ACTIVATION PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Significantly enriched metabolic pathway related to the effects of pleiotropic loci on CRP and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;MATURITY ONSET DIABETES OF THE YOUNG (MODY)&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"Pathway significantly enriched by genes involved in pleiotropy affecting CRP levels and metabolic traits."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;HEPATIC CHOLESTASIS&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Significantly enriched pathway linked to genetic loci influencing CRP and cardiometabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;ACUTE PHASE RESPONSE SIGNALING&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes."</data>
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
    </node>
    <node id="&quot;GLYCEMIC PHENOTYPES&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"SNPs in the HNF1A gene affect fasting glucose levels, illustrating genetic influence on metabolic conditions such as diabetes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATION REGULATION&quot;">
      <data key="d2">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d1">"Variants near IL6R are linked to inflammatory responses measured by CRP and may modulate cardiovascular risks.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GWAS NOT REPORTED&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"IL1F10 was not previously reported in GWAS for the specific phenotype, indicating novel associations.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CRP AND METABOLIC PHENOTYPES&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"PPP1R3B gene shows pleiotropic effects on CRP levels and multiple cardiometabolic traits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;T2D RISK&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"HNF4A influences risk of T2D and CRP levels, showing biological pleiotropy.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HDL CHOLESTEROL&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Association between BCL7B and HDL cholesterol decreases considerably after adjustment for CRP.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CAD RISK&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"SNPs in HNF1A are associated with an increased risk of coronary artery disease (CAD).")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MEDIATOR OF PLEIOTROPIC EFFECTS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Body Mass Index is a key mediator in the pleiotropy observed between certain SNPs and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 4}]</data>
    </node>
    <node id="&quot;CRP ASSOCIATIONS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Levels of cholesterol influence genetic associations with CRP and cardiometabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC PLEIOTROPY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway enriched by genes showing pleiotropic effects on CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC EFFECTS&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MODY SIGNALING&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEPATIC CHOLESTASIS PATHWAY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway significantly enriched by genetic loci influencing CRP and cardiometabolic traits.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ACUTE PHASE RESPONSE SIGNALING PATHWAY&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENETIC INFLUENCES&quot;">
      <data key="d2">chunk-372184452f1f9156514992455057f843</data>
      <data key="d1">"Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MIR-34B/C RS4938723&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP located in miR-34b/c region that has been genotyped for IA patients and controls."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;TP53 ARG72PRO&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An Arginine to Proline substitution at position 72 of the TP53 gene, which was also genotyped in the study."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by a bulge or balloon-like dilation of an artery wall within the skull that can potentially lead to hemorrhage if it ruptures."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;SNP (SINGLE NUCLEOTIDE POLYMORPHISM)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide variation at a specific location in the genome that can influence genetic traits."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A principle used to check for random mating and non-evolving populations in genetic studies."&lt;SEP&gt;"A principle used to test if genotype frequencies in a population are inherited randomly without natural selection, mutation, or other disruptive mechanisms."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d&lt;SEP&gt;chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;OR (ODDS RATIO)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The odds ratio is a measure of association between an exposure and health outcome."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;95% CI (CONFIDENCE INTERVAL)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A range estimate for the measure of effect, in this case, the Odds Ratio, providing the reliability of the observed effect."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;GENOTYPE FREQUENCY DISTRIBUTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The proportion or frequency of different genotypes within a population."</data>
      <data key="d2">chunk-055177812e320344d131432b292111b0</data>
    </node>
    <node id="&quot;INADL&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene where a nonsynonymous SNP (rs1056513; G1178S) was found to be near genome-wide significant for weight, BMI, FFM, FM, trunk FM, and hip circumference."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;COL4A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 13 where an intronic variant (rsID not provided) showed association with weight z-score change."&lt;SEP&gt;"An intronic variant in this gene on chromosome 13 showed association with weight z-score change."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TSEN34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 19 where a variant in the 5′UTR region was associated with linear growth (height change)."&lt;SEP&gt;"A variant in the 5′UTR region of TSEN34 on chromosome 19 is associated with linear growth (height change)."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MTNR1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant within MTNR1B on chromosome 11 was strongly associated with fasting glucose."&lt;SEP&gt;"An intronic variant within this gene on chromosome 11 is strongly associated with fasting glucose."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;APOA5-ZNF259 REGION&quot;">
      <data key="d0">"GENOMIC VARIANT, GENE"</data>
      <data key="d1">"This genomic area harboring APOA5 and ZNF259 genes includes variants linked to triglycerides."&lt;SEP&gt;"This genomic region encompasses the APOA5 and ZNF259 genes on chromosome 11, harboring intronic and 3′UTR variants linked to triglycerides."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;PCSK2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic variant in PCSK2 on chromosome 20 is associated with total antioxidants in the body."&lt;SEP&gt;"An intronic variant within this gene on chromosome 20 is associated with total antioxidants in the body."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RNASE1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 14 where a 3′UTR region variant is linked to urinary nitrogen excretion."&lt;SEP&gt;"A gene on chromosome 14 where a flanking 3′UTR region harbors a variant linked to urinary nitrogen excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ASS1P11&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 7 with its flanking 3′UTR containing a variant associated with creatinine excretion."&lt;SEP&gt;"A gene on chromosome 7 with its flanking 3′UTR harboring a variant associated with creatinine excretion."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GCH1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP in GCH1 on chromosome 14 was identified for urinary dopamine:creatinine ratio."&lt;SEP&gt;"An intronic SNP in this gene on chromosome 14 was identified for urinary dopamine:creatinine ratio."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;KLKB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 4 with a nonsynonymous SNP (rs3733402; S143T) linked to serum free IGF-1."&lt;SEP&gt;"A nonsynonymous SNP (rs3733402; S143T) within KLKB1 on chromosome 4 is associated with serum free IGF-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;MPRIP&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP in MPRIP on chromosome 17 is linked to serum IGFBP-3 levels."&lt;SEP&gt;"An intronic SNP within this gene on chromosome 17 is associated with serum IGFBP-3 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;XPA/FOXE1 (TTF-2)&quot;">
      <data key="d0">"GENOMIC VARIANT, GENE"</data>
      <data key="d1">"A block of twenty-three SNPs in the flanking 5′UTR region of XPA/FOXE1 on chromosome 9 is highly associated with serum TSH."&lt;SEP&gt;"A block of twenty-three SNPs in the flanking 5′UTR region of this gene on chromosome 9 are highly associated with serum TSH and found to be in strong linkage disequilibrium."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DARC&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Contains coding variants linked to MCP-1, including a nonsynonymous SNP (rs12075; G42D) and an intronic SNP."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;GREB1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 2 with a variant identified for MCP-1."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;DFNB31&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 9 where coding variants are associated with MCP-1 levels."&lt;SEP&gt;"A gene on chromosome 9 where coding variants were found to be associated with MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;CCR3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A 3′UTR variant in this gene was highly associated with MCP-1 and IL-6."&lt;SEP&gt;"Variants in the 3′UTR region of CCR3 and an intronic SNP are highly associated with MCP-1 and IL-6."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;RASGEF1A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP within RASGEF1A is significantly associated with MCP-1 levels."&lt;SEP&gt;"An intronic SNP within this gene is significantly associated with MCP-1 levels."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ABO&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Contains a variant in the intronic region strongly linked to IL-6."&lt;SEP&gt;"Variants in the intronic region of ABO are strongly linked to IL-6."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;TMEM229B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene on chromosome 14 where an intronic variant is associated with ad libitum energy intake at dinner."&lt;SEP&gt;"An intronic variant within TMEM229B on chromosome 14 is associated with ad libitum energy intake at dinner."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"An intronic SNP in ARHGAP11A on chromosome 15 showed significant association with sleep duration."&lt;SEP&gt;"An intronic variant within this gene on chromosome 15 showed significant association with sleep duration."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;C21ORF34&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Contains an SNP in the intronic region linked to respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;SERUM FREE IGF-1, SERUM IGFBP-3, SERUM TSH, FASTING GLUCOSE, TRIGLYCERIDES, TOTAL ANTIOXIDANTS, 24-H URINARY NITROGEN EXCRETION, CREATININE EXCRETION, 24-H URINARY DOPAMINE:CREATININE RATIO, MCP-1, IL-6, AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION&quot;">
      <data key="d0">"ENDOMETABOLIC TRAITS, INFLAMMATION MARKERS, DIET, ENERGY EXPENDITURE, SUBSTRATE UTILIZATION AND PHYSICAL ACTIVITY"</data>
      <data key="d1">"Various endometabolic traits, inflammation markers, dietary habits, energy expenditure, substrate utilization, and physical activity levels are associated with specific genetic variants identified in the study."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;LINEAR GROWTH (HEIGHT CHANGE)&quot;">
      <data key="d0">"TRAIT"</data>
      <data key="d1">"A trait measured as linear growth (height change) that is associated with a variant in TSEN34 on chromosome 19."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;FASTING GLUCOSE, TRIGLYCERIDES, TOTAL ANTIOXIDANTS, 24-H URINARY NITROGEN EXCRETION, CREATININE EXCRETION, 24-H URINARY DOPAMINE:CREATININE RATIO, MCP-1, IL-6&quot;">
      <data key="d0">"ENDOMETABOLIC TRAITS AND INFLAMMATION MARKERS"</data>
      <data key="d1">"These traits are significantly associated with genetic variants identified in the endometabolic and inflammation marker sections."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP, ACCELEROMETER-MEASURED LIGHT ACTIVITY&quot;">
      <data key="d0">"DIETARY HABITS, ENERGY EXPENDITURE, SUBSTRATE UTILIZATION, PHYSICAL ACTIVITY"</data>
      <data key="d1">"These dietary habits and activity measures are associated with genetic variants identified in the respective sections."</data>
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
    </node>
    <node id="&quot;ARHGAP11A INTRONIC VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An intronic variant in ARHGAP11A was associated with sleep duration."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;C21ORF34 SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in the intronic region of C21orf34 was detected for respiratory quotient (RQ) during sleep."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RPL7P3 VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant was identified for accelerometer-measured light activity in the 5′UTR region of RPL7P3."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CTCFL VARIANT&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A variant was identified for sedentary-light activity in the 3′UTR region of CTCFL."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;MATK GENE &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Highly significant variants were identified for total energy expenditure associated with MATK gene."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;CHRNA3 GENE &quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Significant genetic associations detected for sleeping energy expenditure linked to CHRNA3 gene."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SLEEP DURATION &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A factor that correlates with the occurrence of snoring, although not extensively covered in this text."&lt;SEP&gt;"Sleep duration is a physiological process that has been shown to be influenced by genomic variants such as those in ARHGAP11A."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;RESPIRATORY QUOTIENT (RQ)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The respiratory quotient during sleep measures metabolic efficiency and energy use, influenced by genetic factors such as C21orf34."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;LIGHT ACTIVITY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Accelerometer-measured light activity is a measure of physical behavior patterns linked to genomic variants in RPL7P3."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Sedentary-light activity during sleep measures low-intensity movements influenced by genetic factors such as CTCFL."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;TOTAL ENERGY EXPENDITURE &quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The total energy expenditure is a key metabolic pathway linked to genomic variants in MATK, indicating its role in overall metabolism."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;SLEEPING ENERGY EXPENDITURE &quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Sleeping energy expenditure is part of the basal metabolic rate during sleep, influenced by genetic factors such as CHRNA3."</data>
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
    </node>
    <node id="&quot;WEIGHT Z-SCORE CHANGE&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic variant in COL4A1 on chromosome 13 is associated with changes in weight z-score."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FASTING GLUCOSE&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in MTNR1B on chromosome 11 is strongly linked to fasting glucose levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TRIGLYCERIDES&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants within this genomic area significantly affect triglyceride levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL ANTIOXIDANTS&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in PCSK2 on chromosome 20 is associated with total antioxidants in the body."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RNASE1, ASS1P11&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;URINARY NITROGEN EXCRETION, CREATININE EXCRETION&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;24-H URINARY DOPAMINE:CREATININE RATIO&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in GCH1 on chromosome 14 influences the ratio of 24-hour urinary dopamine to creatinine."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KLKB1, MPRIP&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM FREE IGF-1, SERUM IGFBP-3&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM TSH&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"A group of SNPs in the flanking region of XPA/FOXE1 on chromosome 9 are highly associated with serum thyroid-stimulating hormone levels."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DARC, GREB1, DFNB31, CCR3, RASGEF1A, ABO&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MCP-1, IL-6&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TMEM229B, ARHGAP11A, C21ORF34&quot;">
      <data key="d2">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d1">"An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLEEP DURATION&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"This variant is associated with sleep duration, indicating a genetic influence on this physiological process."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"This variant is associated with accelerometer-measured light activity, implying a genetic effect on physical behavior patterns."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The variant in the 3′UTR of CTCFL is linked to sedentary-light activity during sleep, indicating an influence on daily movement patterns through genetic variation."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Highly significant variants for total energy expenditure were identified in the MATK gene, suggesting a strong genetic association with overall metabolic rate."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Genetic associations detected for CHRNA3 linked to sleeping energy expenditure, indicating this gene's role in basal metabolism during sleep."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ARHGAP11A INTRONIC VARIANT &quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The intronic variant in ARHGAP11A is associated with sleep duration, indicating a direct genetic influence on this physiological process."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;C21ORF34 SNP &quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The SNP in C21orf34 influences the respiratory quotient during sleep, suggesting a significant impact of genetic variation on metabolic efficiency."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RPL7P3 VARIANT &quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"Genetic variation in RPL7P3 is associated with accelerometer-measured light activity, indicating its role in physical behavior patterns."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CTCFL VARIANT &quot;">
      <data key="d2">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d1">"The CTCFL variant affects sedentary-light activity during sleep, reflecting the genetic influence on low-intensity movements."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;APOBR&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"APOBR is a gene studied for its role in obesity through sequence variant analysis."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;RS74949322, RS151233, RS149271, RS3833080, RS368546180, RS180743, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are sequence variants identified in the coding region of APOBR."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS3833080: P.GLY369_ASP370DEL9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"This variant is a deletion that affects the amino acid sequence of APOBR and has no predicted function."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;RS180743: P.PRO428ALA&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A non-synonymous SNP affecting the amino acid sequence of APOBR, located in a conserved position among species."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;EXTREMELY OBESE CHILDREN AND ADOLESCENTS&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"This refers to individuals suffering from obesity who were part of the study population."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, ENSEMBL, PROVEAN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"These are bioinformatics tools used for predicting the functional impact of genetic variants on proteins and genes."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;GENETIC VARIANT RISK ALLELES&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Risk alleles identified in APOBR associated with obesity risk."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;RS368546180: P.THR321_GLY329DEL9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A deletion variant in APOBR affecting an amino acid sequence, identified in a heterozygous state."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS151233, RS149271, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are additional sequence variants identified in the coding region of APOBR that do not affect amino acid sequences."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;C.1036_1062DEL27&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"A common deletion variant affecting a transcript in the repeat region of APOBR with no predicted function."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS180743 G-ALLELE, RS3833080 DELETION ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These alleles are associated with obesity as identified through case-control studies."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS368546180: P.ALA328_GLY329DEL9&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"A variant resulting in an in-frame shortened amino acid sequence of the repeat region of APOBR."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, MUTATION TASTER, PROVEAN&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Bioinformatics tools for predicting the impact of genetic variations on proteins and genes."</data>
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
    </node>
    <node id="&quot;RS142786317: C.*118_*119DELCA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This is a genomic variant that causes changes in splicing enhancer and silencer binding sites, affecting the transcription of SULT1A1."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SULT1A1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene encoding sulfotransferase family 1A member 1, which plays roles in various physiological processes involving sulfur conjugation with substrates for detoxification purposes."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;MET1VAL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A non-synonymous variant in SULT1A1 that cannot be explained by other members of the SULT1 gene family and could not be replicated using independent genotyping methods, suggesting it might be an artifact."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;P.PRO200 = (RS3176926)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A synonymous variant in SULT1A1 predicted to change the binding domains of splicing regulators and transcription factor AML-1, potentially affecting gene expression regulation."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;SULT1A2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The gene encoding sulfotransferase family 1A member 2, which is closely related to SULT1A1 in sequence but represents a distinct protein with its own wild-type allele and functional differences."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4149403: P.ILE7THR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Non-conservative amino acid exchange detected in the coding region of SULT1A2, predicted to have no significant effect on function based on in silico analysis."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS10797300: P.PRO19LEU&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Detected non-conservative SNP with potential functional modification as per PolyPhen2 and PANTHER, indicating possible impact on protein function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS145008170: P.SER44ASN&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Conservative amino acid exchange close to the binding pocket of SULT1A2; in silico analysis suggests non-neutral or deleterious impact on function."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS4987024: P.TYR62PHE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Non-conservative missense variant with potential to affect protein functionality, though the degree of functional change is not uniformly agreed upon by prediction tools."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS142241142: P.ALA164VAL&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Non-conservative amino acid exchange located away from the binding pocket; predictions suggest lower likelihood of significant functional impact compared to other variants."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS1059491: P.ASN235THR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Conservative SNP predicted to be functionally relevant by multiple tools including PolyPhen2, SNAP and SIFT; indicative of probable protein alteration."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS1690407: P.SER8 = &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Known synonymous variant in SULT1A2 with predicted changes to transcription factor binding sites or splicing enhancer/silencer sites."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;TUFM&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TUFM is a gene that harbors multiple variants affecting splicing regulator or transcription factor binding sites."&lt;SEP&gt;"The gene encoding mitochondrial thymidine kinase 1, involved in nucleotide metabolism within mitochondria and associated with regulatory elements impacting expression."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea&lt;SEP&gt;chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;C.3536C&gt;G &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Variant detected in the 3’ untranslated region of TUFM; predicted to alter splicing regulator or transcription factor binding sites, potentially affecting gene regulation."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS7187776: C.-55T&gt;C, RS4788099: C.500−19T/C, RS8061877: C.248−18G&gt;A, AND RS61737565: C.922+29C&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A series of non-coding intronic variants in TUFM predicted to lead to changes in transcription factor binding sites or splicing regulatory elements."</data>
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
    </node>
    <node id="&quot;RS61737565: C.922+29C&gt;G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant in TUFM is predicted to alter splicing regulator or transcription factor binding sites, potentially affecting gene expression and regulation."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;TRANSCRIPTION FACTOR BINDING SITE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Disruption of transcription factor binding sites can affect gene regulation through altered interactions with DNA."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SRY, HFH 2, HMG-IY&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"These are proteins involved in transcription factor activity and their binding to the DNA is crucial for proper gene expression."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;G.28854194C/G&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant within TUFM's non-coding 3’ UTR affects splice enhancer and silencer sites, potentially impacting mRNA processing."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICE SITES&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in splice sites can lead to aberrant splicing events which may result in protein dysfunction or loss of function mutations."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;RS8061877&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This genomic variant disrupts transcription factor binding sites, affecting gene regulation and expression."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICE ENHANCER BINDING SITE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Changes in splice enhancer binding sites can influence splicing patterns and mRNA processing."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;SPLICING SILENCER SITE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Alterations in splicing silencer sites affect the stability and translation of mRNA."</data>
      <data key="d2">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
    </node>
    <node id="&quot;GENOMIC VARIANT&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5&lt;SEP&gt;chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"A genomic variant within the FADS1/2 gene cluster influences AA concentrations in the colon."&lt;SEP&gt;"These bioinformatics tools predict functional effects of genetic variations identified in the study."</data>
      <data key="d0">"GENOMIC VARIANT"</data>
    </node>
    <node id="&quot;APOBR TRANSCRIPT&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"A common deletion variant affecting a transcript, with no predicted function on protein structure."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;RS180743 G-ALLELE AND RS3833080 DELETION ALLELE&quot;">
      <data key="d2">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d1">"These genetic variants were associated with obesity in case-control studies of extremely obese children and adolescents."</data>
      <data key="d0">"UNKNOWN"</data>
      <data key="d3">[{"level": 0, "cluster": 0}]</data>
    </node>
    <node id="&quot;P.PRO19LEU (RS10797300)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"Detected in SULT1A2, this variant shows potential functional modification based on prediction tools, indicating a possible impact on protein function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.SER44ASN (RS145008170)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"This conservative amino acid change in SULT1A2 near the binding pocket of xenobiotics is predicted to have a 'non-neutral' or 'deleterious' impact on function."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.TYR62PHE (RS4987024)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"This non-conservative missense variant in SULT1A2 is predicted by various tools to have a higher probability of functional changes, though results are mixed."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.ALA164VAL (RS142241142)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"The non-conservative exchange in SULT1A2 away from the binding pocket is predicted to have less significant functional impact compared to other variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;P.ASN235THR (RS1059491)&quot;">
      <data key="d2">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d1">"This conservative SNP in SULT1A2 is predicted by PolyPhen2, SNAP and SIFT as likely to be functionally relevant, indicating probable alterations to the protein."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALOX15 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALOX15 is an inflammation-related gene whose minor alleles of SNPs are associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;ALOX5 GENE (ARACHIDONATE 5-LIPOXYGENASE)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"ALOX5 is a gene in which minor allele of SNP rs1864414 is significantly associated with decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CCL2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A CCL2 gene variant is analyzed but not found to be significantly associated with the risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;CRP GENE (C-REACTIVE PROTEIN)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CRP gene is among those whose minor alleles of SNPs are assessed for association with ovarian cancer risk, though no strong associations are reported."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL18 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL18 is an inflammation-related gene where the minor allele frequency does not significantly associate with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1A GENE (INTERLEUKIN 1 ALPHA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"IL1A, particularly SNP rs17561 and rs4848300, shows a significant association with decreased risk of ovarian cancer, especially in specific histological subtypes."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B GENE (INTERLEUKIN 1 BETA)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs7596684 at the IL1B gene suggests an association with ovarian cancer risk but lacks consistency across different phases of study."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1RN GENE (INTERLEUKIN 1 RECEPTOR N)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A variant in the IL1RN gene is not significantly associated with ovarian cancer risk according to findings described here, although it was part of the analysis."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL6 GENE (INTERLEUKIN 6)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The minor alleles of SNPs at the IL6 gene are evaluated but do not show a significant association with increased or decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NOS3 GENE (NITRIC OXIDE SYNTHASE 3)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs743507 within the NOS3 gene is significantly associated with decreased risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS1 GENE (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"rs2282169 SNP at PTGS1 gene suggests an association with ovarian cancer risk, but results are inconsistent across different phases of study."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;PTGS2 GENE (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The minor alleles of SNPs in the PTGS2 gene did not show significant associations with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;TLR2 GENE (TOLL-LIKE RECEPTOR 2)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP variants in TLR2 do not suggest significant association with increased or decreased risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;TNF GENE (TUMOR NECROSIS FACTOR)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant associations were found between TNF gene SNP variants and the risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;RS1864414 GENOMIC VARIANT IN ALOX5&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This variant is located within intron 1 of the ALOX5 gene, showing a significant association with decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;RS743507 GENOMIC VARIANT IN NOS3&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP associated with reduced risk of ovarian cancer found near the NOS3 gene."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1A GENE TRANSCRIPT&quot;">
      <data key="d0">"TRANSCRIPT"</data>
      <data key="d1">"The transcript of IL1A gene is highlighted for analysis due to its significant association with reduced ovarian cancer risk, especially in specific histological subtypes."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;NOS3 PROTEIN (NITRIC OXIDE SYNTHASE 3)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"The protein encoded by the NOS3 gene shows a minor allele SNP rs743507 associated with decreased ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;OVARIAN CANCER&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disease characterized by the uncontrolled growth of ovarian cells."&lt;SEP&gt;"A type of malignancy that develops from cells in the ovary, and its risks can be influenced by genetic variations including those in inflammation-related genes like ALOX15, ALOX5, IL1A, IL1B, NOS3."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403&lt;SEP&gt;chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;INFLAMMATION-RELATED GENE PRODUCTS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Inflammatory processes mediated by gene products such as IL18, CRP, PTGS1, and TLR2 are investigated for their potential role in ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL6R GENE (INTERLEUKIN 6 RECEPTOR)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"No significant associations were found between IL6R gene SNP variants and the risk of ovarian cancer."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;STAT3 GENE (SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"SNP rs1053023 in STAT3 is assessed but not significantly associated with ovarian cancer risk."</data>
      <data key="d2">chunk-089bcdf055eb2f007db49dbe2409429b</data>
    </node>
    <node id="&quot;IL1B RS7596684&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the IL1B gene (rs7596684) has been suggested to be associated with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;PTGS1 RS2282169&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the PTGS1 gene (rs2282169) has been suggested to be associated with ovarian cancer risk."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The risk of developing ovarian cancer, a disease influenced by genetic variants such as IL1B rs7596684 and PTGS1 rs2282169."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL1B&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL1B gene encodes interleukin-1 beta, a cytokine involved in immune response."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;PTGS1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The PTGS1 gene encodes prostaglandin-endoperoxide synthase 1 (cyclooxygenase-1), which plays a role in inflammation and pain."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;ALOX15&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The ALOX15 gene encodes arachidonate 5-lipoxygenase, an enzyme involved in the synthesis of leukotrienes."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;CCL2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CCL2 gene encodes chemokine (C-C motif) ligand 2, which is involved in immune cell recruitment and inflammation."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL18&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL18 gene encodes interleukin-18, which is involved in the regulation of immune responses and inflammation."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;IL6&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The IL6 gene encodes interleukin-6, a cytokine that plays important roles in immune response and inflammatory processes."</data>
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
    </node>
    <node id="&quot;HISTOLOGICAL SUBTYPE OF OVARIAN CANCER&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL1B, PTGS1&quot;">
      <data key="d2">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d1">"There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOS3 RS3918186&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"NOS3 rs3918186 is a SNP associated with increased risk of developing childhood ALL."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 RS1051266&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SLC19A1 rs1051266 is a SNP that shows less evidence in the data for association with childhood ALL compared to NOS3 rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MTHFD2 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs of MTHFD2 gene were identified in the initial screening but did not proceed to final analysis due to posterior probability inclusion less than 0.2."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2 SNPS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"SNPs of BHMT2 gene were identified in the initial screening but did not proceed to final analysis due to posterior probability inclusion less than 0.2."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The NOS3 gene is associated with childhood ALL risk, specifically through SNP rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The SLC19A1 gene has a SNP (rs1051266) that shows less evidence in the data for association with childhood ALL compared to NOS3 rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Childhood acute lymphoblastic leukemia is a disease studied for genetic associations, specifically involving folate metabolic genes."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The study focuses on 16 folate metabolic genes to identify SNPs associated with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;MTHFD2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The MTHFD2 gene is one of the folate metabolic genes studied for SNPs associated with childhood ALL risk."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BHMT2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The BHMT2 gene is another folate metabolic gene identified in the study, showing some SNP associations but not proceeding to final analysis."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;NOS3 RS3918186 RISK FACTOR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP of NOS3 gene increases the risk of childhood ALL by 2.16 times for each copy of the minor allele."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;SLC19A1 RS1051266 RISK FACTOR&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"This SNP of SLC19A1 gene is associated with a slightly lower risk of childhood ALL compared to NOS3 rs3918186."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;BAYES FACTORS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Bayes factors are used in statistical analysis to determine the association strength between SNPs and disease, indicating posterior odds against prior odds."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;POSTERIOR PROBABILITY OF INCLUSION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"This is a measure indicating whether an SNP has sufficient evidence for further analysis based on its probability after initial screening."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;CHILDHOOD ALL PARTICIPATION RATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The participation rate for the study was 85%, reflecting high compliance among families recruited from Texas Children’s Cancer Center."</data>
      <data key="d2">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
    </node>
    <node id="&quot;FADS1/FADS2 HAPLOTYPE GENES&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FADS1/2 genes are part of a cluster that influences polyunsaturated fatty acid metabolism."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET GROUP AND MEDITERRANEAN DIET GROUP DIETARY PATTERNS&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"Two dietary patterns examined: Healthy Eating group (n=54) and Mediterranean diet group (n=54)."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Refers to the dietary intake of long-chain omega-3 fatty acids such as EPA and DHA, and their concentrations in serum or colonic mucosa."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;ARACHIDONIC ACID (AA)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"A polyunsaturated fatty acid that plays a role in inflammation and other physiological processes."&lt;SEP&gt;"Arachidonic acid is a type of polyunsaturated fatty acid that shows significant interaction with genotype and diet interventions, particularly affecting its concentration in the colon."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729&lt;SEP&gt;chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE SERUM AA CONCENTRATION MEASUREMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measurement of the baseline serum concentration of arachidonic acid in study participants."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LINEAR REGRESSION ANALYSIS FOR FATTY ACID INTAKE AND BASELINE SERUM AA CONCENTRATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis to determine if dietary intake predicts baseline serum AA concentrations."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE COLONIC ARACHIDONIC ACID (AA) MEASUREMENT IN PARTICIPANTS WITH OR WITHOUT MINOR ALLELES IN THE FADS GENE CLUSTER&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measurement of colonic arachidonic acid levels in relation to genetic factors."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;FADS1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene within the FADS gene cluster involved in fatty acid desaturation."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;FADS2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Another gene within the FADS gene cluster, also involved in fatty acid metabolism."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;GENOTYPE DISTRIBUTION OF SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The distribution and frequency of genetic variations among participants."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BASELINE AA CONCENTRATION MEASUREMENT IN SERUM AND COLON&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measurement of arachidonic acid concentration at the beginning of the study."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;DIETARY INTAKE OF LONG CHAIN N-3 FATTY ACIDS AND BASELINE CONCENTRATION PREDICTION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis to predict baseline long chain n-3 fatty acid concentrations based on dietary intake."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;BMI DIFFERENCE BETWEEN MINOR ALLELE CARRIERS AND NON-CARRIERS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Difference in BMI among participants with or without minor alleles of FADS genes."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;AGE AS A COVARIATE IN GENOTYPE ANALYSIS&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Age retained as a covariate for statistical analysis despite no significant difference between groups."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SERUM AND COLON FATTY ACID CONCENTRATIONS BY GENOTYPE GROUP&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"Measurement of fatty acid concentrations in serum and colon based on genotype."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;LONG CHAIN N-3 PUFA DIETARY INTAKE INCREASE IN HEALTHY EATING GROUP&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Increase in long chain omega-3 polyunsaturated fatty acids after the dietary intervention."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;SFA (SATURATED FATS) AND MUFA (MONOUNSATURATED FATS) REDUCTION IN HEALTHY EATING AND MEDITERRANEAN GROUPS&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Reduction of saturated fats and increase in monounsaturated fats observed post-intervention."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;POLYUNSATURATED FAT:SATURATED FAT RATIO INCREASE AFTER DIETARY INTERVENTIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Ratio improved in both diet groups, indicating healthier lipid profile."</data>
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
    </node>
    <node id="&quot;FADS1/2 GENE CLUSTER&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The FADS1/2 gene cluster influences fatty acid metabolism and levels of arachidonic acid (AA) in the colon."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;POLYUNSATURATED FAT: SATURATED FAT RATIO&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"This ratio increased non-significantly from 0.72 to 0.77 in the Mediterranean group over time."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MUFA (MONOUNSATURATED FATTY ACIDS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"MUFA significantly increased in the Mediterranean arm only, indicating a dietary influence on fatty acid levels."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;N-3 PUFA (OMEGA-3 POLYUNSATURATED FATTY ACIDS)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"Both n-3 PUFA and MUFA significantly increased in the Mediterranean arm only."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;COLON AA CONCENTRATIONS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The interaction between genotype and diet showed significant changes in colon concentrations of 20:4, n-6 (AA) for subjects with no minor alleles in the FADS1/2 gene cluster."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;HEALTHY EATING DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"This dietary pattern had a significant effect on AA concentration in the colon compared to the Mediterranean diet for individuals without minor alleles in the FADS1/2 gene cluster."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;MEDITERRANEAN DIET&quot;">
      <data key="d0">"DIETARY PATTERN"</data>
      <data key="d1">"The Mediterranean diet showed different effects on AA concentrations in the colon compared to the Healthy Eating diet, particularly in individuals with no minor alleles in the FADS1/2 gene cluster."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;SERUM 18:2 N-6&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The level of serum 18:2 n-6 significantly decreased (p=0.02) in response to the Mediterranean dietary intervention."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;EPA (EICOSAPENTAENOIC ACID)&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"EPA is a type of omega-3 polyunsaturated fatty acid that was found not to have significant genotype-by-diet interactions."</data>
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
    </node>
    <node id="&quot;GENOTYPE DISTRIBUTION OF SNPS&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Used to verify random mating and genetic equilibrium in SNP distribution among participants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;FATTY ACID METABOLISM PATHWAY&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Baseline arachidonic acid levels serve as an important marker for metabolic pathways."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SERUM AND COLON FATTY ACID CONCENTRÇÕES BY GENOTYPE GROUP&quot;">
      <data key="d2">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d1">"Age retained as covariate for more accurate fatty acid concentration analysis based on genotype."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MUFA&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"The Mediterranean diet significantly increased MUFA levels, indicating its impact on fatty acid metabolism."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;N-3 PUFA&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"Both long-chain n-3 PUFA and MUFA significantly increased in the Mediterranean arm only, showing a dietary pattern's effect on omega-3 polyunsaturated fatty acids."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EPA&quot;">
      <data key="d2">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d1">"No significant genotype-by-diet interactions were found for EPA, indicating that EPA levels are less influenced by genetic variants in the FADS1/2 gene cluster."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNORING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Snoring is a condition characterized by loud, disruptive breathing during sleep."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SEX (MALE/FEMALE)&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Gender differences influence snoring prevalence, with males having a higher reported rate."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;SLEEP APNOEA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by pauses in breathing during sleep, more prevalent among those who snore."&lt;SEP&gt;"A sleep disorder characterized by pauses in breathing during sleep."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SOCIOECONOMIC STATUS (SES)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Lower SES was associated with increased risk of snoring in males specifically."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SMOKING FREQUENCY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Smoking more frequently correlates positively with higher prevalence of snoring, particularly among females."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION FREQUENCY&quot;">
      <data key="d0">"LIFESTYLE FACTOR"</data>
      <data key="d1">"Increased alcohol consumption frequency is associated with elevated risk of snoring, predominantly in males."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;WHOLE-BODY FAT MASS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure of total body fat, including both essential and nonessential fat."&lt;SEP&gt;"Fat mass was correlated with snoring prevalence as determined by various studies."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A method used to identify genetic variants associated with snoring and other traits."&lt;SEP&gt;"A study that scans the entire genome looking for genetic variations associated with a particular trait, such as a disease condition or response to medication."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62&lt;SEP&gt;chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;GENOMIC VARIANTS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Identified through GWAS, these variants are significant in the context of snoring risk factors."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SNP HERITABILITY (H2SNP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure indicating the proportion of phenotypic variance attributable to genetic effects."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;GENETIC CORRELATIONS &quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"Analysis revealing associations between snoring and other traits based on shared genetics."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SELF-REPORTED SLEEP APNOEA &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Highly genetically correlated with habitual snoring, indicating a strong genetic relationship."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;OXYGEN HEMOGLOBIN SATURATION (SPO2)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Indicators like minimum and percent under 90% SpO2 are significant in the context of sleep-disordered breathing related to snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;BMI, WHOLE-BODY FAT MASS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Both factors positively correlate with snoring, influencing genetic associations after adjustment."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;FTO LOCUS &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic location impacting obesity that changes significantly in effect size upon BMI adjustment."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SCHIZOPHRENIA &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A psychiatric disorder negatively genetically correlated with snoring, suggesting differing genetic underpinnings."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;GENOMIC RISK LOCI &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"These are genomic regions identified through GWAS that contain variants significantly associated with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;TOP 15 RISK LOCI &quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific loci among the top genetic associations found for snoring, indicating significant risk factors."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;AVERAGE SPO2 &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The average level of oxygen hemoglobin saturation during sleep, reflecting changes in ventilation but not necessarily related to sleep apnoea."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;PERC90 (PERCENT OF SLEEP WITH OXYHEMOGLOBIN SATURATION UNDER 90%) &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A measure indicating the percentage of time during sleep when oxyhemoglobin saturation is below 90%, a proxy for sleep-disordered breathing."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;CORONARY ARTERY DISEASE &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Genetically correlated with habitual snoring, suggesting shared genetic risk factors."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;HEART ATTACK &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Traits related to heart attack were no longer genetically associated with snoring after adjusting for BMI."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;HYPERTENSION &quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"After adjustment for BMI, hypertension was not found to be genetically correlated with snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;MOOD SWINGS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"A condition showing moderate genetic correlation with habitual snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;WHOLE-BODY FAT MASS &quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"As a trait, it correlates phenotypically and genetically with snoring before adjustment for BMI."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;FLUID INTELLIGENCE SCORE &quot;">
      <data key="d0">"PSYCHOLOGICAL TRAIT"</data>
      <data key="d1">"Negative genetic correlation indicates distinct underlying genetic factors between these traits and habitual snoring."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;EDUCATIONAL ATTAINMENT &quot;">
      <data key="d0">"SOCIAL DETERMINANT OF HEALTH"</data>
      <data key="d1">"A trait that remains genetically correlated with snoring even after adjusting for BMI, indicating shared genetic influences."</data>
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
    </node>
    <node id="&quot;SCHIZOPHRENIA&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A mental disorder characterized by symptoms such as hallucinations, delusions, and disordered thinking."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;EDUCATIONAL ATTAINMENT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The level of education achieved by an individual or group."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SODIUM IN URINE&quot;">
      <data key="d0">"NUTRIENT"</data>
      <data key="d1">"The concentration of sodium within the urine."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;EXCESSIVE DAYTIME SLEEPINESS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Feeling very sleepy during the daytime, often as a result of poor nighttime sleep."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;NOCTURNAL HYPOXIA MEASURES (MINIMUM SPO2, AVERAGE SPO2 AND PERC90)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measures indicating low blood oxygen levels at night."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;GENETIC CORRELATION WITH SNORING&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"The genetic correlation between nocturnal hypoxia measures and snoring after adjusting for BMI."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;DLEU7 GENE ON CHROMOSOME 13&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located at position 13q21.3 and known to be associated with snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MSRB3 GENE ON CHROMOSOME 12&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene located at position 12p13.32 and associated with snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;BCL11B GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in transcription regulation, previously linked to smoking and alcohol consumption."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SMG6 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in RNA surveillance, associated with musculoskeletal traits such as height and heel bone mineral density."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;ROBO2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Involved in axon guidance, previously linked to chronotype and snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;NSUN3 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with alcohol consumption and coffee consumption, also involved in snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SNAP91 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with sleep disorders such as narcolepsy."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;LMO4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Linked to insomnia, contributing to the genetic architecture of snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;RNA5SP471 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with alcohol consumption and insomnia, also relevant in relation to narcolepsy and sleep regulation."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;ANAPC4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in cell cycle control, associated with musculoskeletal traits such as height and heel bone mineral density."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;KCNQ5 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with various neurological disorders, also relevant to snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;CEP120 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene involved in centrosome organization and mitotic progression, associated with snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MACF1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Associated with musculoskeletal traits such as height and heel bone mineral density, also linked to snoring."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;PULSE RATE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The rate at which the heart beats, measured per minute."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;MAJOR CORONARY HEART DISEASE&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Heart disease characterized by atherosclerosis in the coronary arteries."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;HEART ATTACK&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"Sudden cardiac event caused by an abrupt loss of blood flow to part of the heart muscle due to a blocked artery."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
    </node>
    <node id="&quot;SEX-STRATIFIED GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"A study conducted separately in males and females to identify genetic factors contributing to snoring predisposition."</data>
      <data key="d2">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 7}]</data>
    </node>
    <node id="&quot;RS199797821&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A lead SNP identified in GWAS analyses for snoring in males."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;RS200391180&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A lead SNP identified in GWAS analyses for snoring in females."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SEX-STRATIFIED GWAS ANALYSIS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"GWAS analysis stratified by sex to identify genetic variants associated with snoring in males and females."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;PGS (POLYGENIC SCORE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Derived from GWAS summary statistics, PGS is used to predict the likelihood of recent snoring in an independent sample from AGDS."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;RECENT SNORING&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A condition characterized by habitual loud breathing during sleep, often associated with increased risk for OSA and cardiovascular diseases."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;PROBABLE OSA (OBSTRUCTIVE SLEEP APNEA)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A disorder where the upper airway repeatedly collapses during sleep, leading to breathing pauses and can be indicated by snoring severity."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;SNORING SEVERITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The degree to which an individual snores, often measured by frequency or loudness."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;CROSS-SEX GENETIC CORRELATION&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A measure indicating the genetic correlation between sexes regarding a trait (in this case, snoring), reflecting shared genetic influences across genders."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
    </node>
    <node id="&quot;TOP HITS IN GWAS&quot;">
      <data key="d0">"GENE/GENOMIC VARIANT"</data>
      <data key="d1">"The most significant genetic variants identified through genome-wide association studies for a particular trait or condition."</data>
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d3">[{"level": 0, "cluster": 2}, {"level": 1, "cluster": 8}]</data>
    </node>
    <node id="&quot;SLEEP APNOEA &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNORING &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ALCOHOL CONSUMPTION FREQUENCY &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SMOKING FREQUENCY &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;BMI ADJUSTMENT ANALYSIS &quot;">
      <data key="d2">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d1">"After controlling for BMI in the GWAS analysis, heart attack is no longer genetically associated with snoring."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PROBABLE OSA&quot;">
      <data key="d2">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d1">"Severe cases of recent snoring may indicate probable obstructive sleep apnea, a serious health condition requiring medical attention."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VITAMIN D STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Vitamin D status refers to the level of vitamin D in individuals, which is crucial for calcium homeostasis and bone health."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VDBP POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"VDBP polymorphisms refer to genetic variations in the Vitamin D Binding Protein gene that can influence vitamin D status and metabolism."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL VITAMIN D STATUS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Neonatal vitamin D status refers to the level of vitamin D in neonates, which is important for early life health outcomes such as bone development and immune function."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL HEIGHT&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Maternal height is an environmental factor that may influence prenatal care and pregnancy outcomes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI PRE-PREGNANCY (KG/M2)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"BMI pre-pregnancy refers to the body mass index before conception, which can impact maternal health during pregnancy and neonatal outcomes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BMI TERMINAL (KG/M2)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"BMI terminal is the body mass index at term of pregnancy, reflecting changes in weight throughout gestation that may affect maternal-fetal conditions."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;UVB EXPOSURE&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"UVB exposure is an environmental factor influencing vitamin D synthesis through sunlight absorption by the skin."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;GESTATION PERIOD (WEEKS)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The gestation period refers to the time from conception to birth, during which maternal and neonatal health are critically influenced."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;25(OH)D CONCENTRATION&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"25-hydroxyvitamin D (25(OH)D) is a metabolite of vitamin D that serves as a marker for vitamin D status in the body, playing a role in various physiological processes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;CC GENOTYPE (RS2298850)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype at rs2298850 is a specific genetic variation within VDBP that may influence vitamin D metabolism and status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;CC GENOTYPE (RS4588)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The CC genotype at rs4588 is another genomic variant in the VDBP gene, affecting the binding capacity of Vitamin D Binding Protein and impacting maternal 25(OH)D concentrations during delivery."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL CUT-OFFS (≥50 NMOL/L VS. ≤50 NMOL/L)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Neonatal cut-offs for vitamin D levels categorize neonates based on their 25(OH)D concentrations, providing insights into early life vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL CUT-OFFS (≤25 VS. ≥25 NMOL/L)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Maternal cut-offs for vitamin D levels categorize mothers based on their 25(OH)D concentrations, reflecting maternal vitamin D sufficiency or deficiency."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;STATISTICAL ANALYSIS (ANCOVA)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"ANCOVA is a statistical method used to adjust for covariates in comparisons of means among groups, evaluating the influence of various factors on neonatal and maternal vitamin D status."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;VITAMIN D BINDING PROTEIN (VDBP)&quot;">
      <data key="d0">"PROTEIN"</data>
      <data key="d1">"VDBP is a protein that binds vitamin D and influences its metabolism and transport within the body."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;GENOTYPE DISTRIBUTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The distribution of genotypes in a population or group can influence genetic traits and associated health outcomes."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL VDBP POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific genetic variations in maternal VDBP that may impact vitamin D levels during pregnancy."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;NEONATAL VDBP POLYMORPHISMS&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Genetic variations in neonates’ VDBP gene that could affect their vitamin D status and metabolism."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;BIRTH BIOCHEMICAL DATA&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Biochemical measurements taken at birth to assess neonatal health conditions, such as vitamin D levels."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;ONE-WAY ANALYSIS OF COVARIANCE (ANCOVA)&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A statistical method used for analyzing differences among related groups while controlling for covariates."</data>
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
    </node>
    <node id="&quot;MATERNAL HEIGHT (CM)&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"Maternal height may interact with the duration of gestation affecting prenatal care and neonatal outcomes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d2">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d1">"The CC genotype at rs2298850 is associated with higher maternal 25(OH)D concentrations, indicating a positive impact on vitamin D status."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VEGFA GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The VEGFA gene is involved in the regulation of angiogenesis, which is important for various physiological processes including reproductive health."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS3025020 (-583T&gt;C)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) located at position -583 in the VEGFA gene, with an increased minor allele frequency in women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;RS2010963 (-634C&gt;G)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A single nucleotide polymorphism (SNP) located at position -634 in the VEGFA gene, with a trend towards higher minor allele frequency in controls compared to women with PCOS."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;VEGF SERUM LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The levels of vascular endothelial growth factor (VEGF) circulating in the blood plasma are significantly altered among genotype carriers of specific VEGFA SNPs, reflecting their impact on angiogenesis and possibly other physiological processes such as insulin resistance."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;POLYCYSTIC OVARY SYNDROME (PCOS)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"A common endocrine disorder characterized by a cluster of symptoms including ovarian dysfunction, hyperandrogenism, and metabolic disturbances, affecting women's reproductive health."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;INSULIN RESISTANCE INDEX HOMA-IR&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"HOMA-IR is an index used to assess insulin resistance in the body, which has significantly higher levels among women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE TESTOSTERONE&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"Free testosterone refers to the biologically active form of testosterone circulating in blood plasma; its levels are elevated in women with PCOS compared to control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A marker for inflammation, hs-CRP levels correlate positively with the minor allele of VEGFA SNP rs3025020 in women with PCOS, indicating a link between this genetic variant and inflammatory processes."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;ERYTHROCYTE SEDIMENTATION RATE (ESR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A marker for inflammation; ESR levels correlate negatively with the minor allele of VEGFA SNP rs2010963 in women with PCOS, suggesting a protective role against inflammation."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TOTAL TESTOSTERONE LEVELS&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"The total amount of testosterone circulating in the blood plasma, which does not show significant differences between women with PCOS and controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;LH (LUTEINIZING HORMONE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A hormone produced by the pituitary gland that stimulates ovulation; levels are comparable between women with PCOS and control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FSH (FOLLICLE-STIMULATING HORMONE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A hormone produced by the pituitary gland that stimulates follicular growth in ovaries; levels are comparable between women with PCOS and control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;SHBG (SEX HORMONE BINDING GLOBULIN)&quot;">
      <data key="d0">"NUTRIENT/METABOLITE"</data>
      <data key="d1">"A protein that binds sex hormones like testosterone, significantly lower in women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TSH (THYROID-STIMULATING HORMONE)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A hormone produced by the pituitary gland that stimulates thyroid function; levels are higher but within reference range in women with PCOS compared to controls."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE ANDROGEN INDEX (FAI)&quot;">
      <data key="d0">"NUTRIENT/METABOLITE/BIOMARKER"</data>
      <data key="d1">"An index used to assess the proportion of free testosterone relative to SHBG, which is elevated in women with PCOS compared to control subjects."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;BIOACTIVE TESTOSTERONE LEVELS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/NUTRIENT METABOLITE"</data>
      <data key="d1">"The active form of testosterone circulating in blood plasma, showing a progressive increase among rs3025020 genotype carriers and a reduction in rs2010963 genotype carriers."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;IL-10 (INTERLEUKIN-10)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"An anti-inflammatory cytokine; its levels are not correlated with VEGFA SNPs rs3025020 or rs2010963."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;IL-6 (INTERLEUKIN-6)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A pro-inflammatory cytokine; its levels do not correlate with the VEGFA SNPs rs3025020 or rs2010963."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;TNFΑ (TUMOR NECROSIS FACTOR-ALPHA)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS/BIOMARKER"</data>
      <data key="d1">"A pro-inflammatory cytokine; its levels do not correlate with the VEGFA SNPs rs3025020 or rs2010963."</data>
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
    </node>
    <node id="&quot;FREE TESTOSTERONE LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"The presence of rs2010963 genotype is inversely correlated with free testosterone levels, indicating a protective role against hyperandrogenism characteristic of PCOS."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PCOS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"While total testosterone levels are comparable between women with PCOS and controls, the bioactive forms of these hormones show differences that correlate with disease pathology."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LH/FSH RATIO&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"The ratio of LH to FSH is elevated in women with PCOS compared to control subjects, indicating a key hormonal imbalance characteristic of this condition."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SHBG LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Significantly lower SHBG levels are observed in women with PCOS compared to controls, contributing to increased free androgens."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TSH LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"While TSH levels are higher but within normal range in women with PCOS compared to controls, this may reflect a subtle thyroid dysfunction or metabolic alteration."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HS-CRP LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;INFLAMMATION&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ANTI-INFLAMMATORY EFFECT&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ESR LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-10 LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VEGFA SNPS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IL-6 LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"No correlation between IL-6 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TNFΑ LEVELS&quot;">
      <data key="d2">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d1">"No correlation between TNFα levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;VAL CARRIER GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The val carrier genotype is a variant in relation to the response bias and shock intensity selection."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;ISO HOMOZYGOTE GENOTYPE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"The iso homozygote genotype represents another genetic variation that contrasts with the val carrier genotype in terms of behavioral outcomes."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;RESPONSE BIAS&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Behavioral measure indicating preference or tendency towards a specific stimulus based on reward history. Changes in this are indicative of cognitive and emotional processes influenced by stress."&lt;SEP&gt;"Response bias refers to a cognitive process where participants modify their responses based on reinforcement contingencies."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647&lt;SEP&gt;chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SHOCK INTENSITY SELECTION&quot;">
      <data key="d0">"BEHAVIORAL PROCESS"</data>
      <data key="d1">"Participants' selection of shock intensity levels reflects individual differences in aversion tolerance and stress response."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;STAI SCORES&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASURE"</data>
      <data key="d1">"State-Trait Anxiety Inventory scores measure anxiety levels at different times during the study."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;PANAS NA (NEGATIVE AFFECT)&quot;">
      <data key="d0">"PSYCHOMETRIC SCALE"</data>
      <data key="d1">"The PANAS negative affect scale measures emotional distress such as anger, sadness, and fear."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;POSITIVE AFFECT (PANAS PA)&quot;">
      <data key="d0">"PSYCHOMETRIC SCALE"</data>
      <data key="d1">"The PANAS positive affect scale assesses pleasant emotions like joy, interest, and alertness."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;SKIN CONDUCTANCE RESPONSES (SC RESPONSES)&quot;">
      <data key="d0">"PHYSIOLOGICAL MEASURE"</data>
      <data key="d1">"Measure of emotional arousal through changes in skin conductance due to sweat gland activity."</data>
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
    </node>
    <node id="&quot;VAL CARRIERS&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Individuals who carry the val variant of the COMT gene, associated with changes in response bias under stress conditions."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;ISO HOMOZYGOTES&quot;">
      <data key="d0">"GENETIC VARIANT"</data>
      <data key="d1">"Individuals homozygous for the isoleucine (iso) allele of the COMT gene, typically showing less pronounced effects of stress on response bias compared to val carriers."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CONDITION (STRESS VS NO-STRESS)&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"Environmental condition manipulating levels of psychological stress to observe effects on cognitive and physiological responses, particularly concerning response bias."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;DISCRIMINABILITY&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measure of the ability to discriminate between stimuli in a task; it can be influenced by factors such as block number or experimental conditions."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SHOCK INTENSITY&quot;">
      <data key="d0">"ENVIRONMENTAL FACTOR"</data>
      <data key="d1">"The level of physical stimulus used, which might influence stress responses and therefore behavioral outcomes like response bias."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;SKIN CONDUCTANCE RESPONSES (SCR)&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"Measure reflecting autonomic arousal in response to stimuli; elevated SCRs indicate heightened physiological activity often associated with stress or emotion."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CRHR1 SNPS (RS12938031, RS10445364, RS4076452)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Specific single nucleotide polymorphisms in the CRHR1 gene, recently linked to stress-induced reward learning deficits."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;MR GENOTYPE (COMT GENE VARIANTS)&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The genotype at the catechol-O-methyltransferase (COMT) gene locus, consisting of val and iso alleles, influences response bias in stressful conditions."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;CRHR1 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The corticotropin-releasing hormone receptor 1 (CRHR1) gene, which regulates the body's response to stress through its receptor proteins. Variations in this gene are associated with differences in stress-induced reward learning deficits."</data>
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
    </node>
    <node id="&quot;TIME × CONDITION × GENOTYPE INTERACTION&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"There was a trend showing that STAI scores increased over time and condition differently across genotypes, suggesting genetic modulation of stress response."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CONDITION × TIME × GENOTYPE TREND&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;PANAS NA&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SC RESPONSES&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TIME × GENOTYPE INTERACTION&quot;">
      <data key="d2">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d1">"There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;STRESS-INDUCED REWARD LEARNING DEFICITS&quot;">
      <data key="d2">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d1">"Polymorphisms in the CRHR1 gene are linked to variations in reward learning deficits induced by stress, indicating a genetic basis for differential susceptibility to stress effects on cognitive processes.")</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;SNP&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP is a single nucleotide polymorphism that can be associated with specific phenotypes or diseases."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;BMP4 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"BMP4 gene, also known as Bone Morphogenetic Protein 4, plays roles in the development and maintenance of various tissues including dentition."&lt;SEP&gt;"The BMP4 gene plays a role in the development and maintenance of oral structures and is associated with variations affecting age at first tooth and number of teeth."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4&lt;SEP&gt;chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;CACNB2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The CACNB2 gene encodes a voltage-dependent calcium channel beta subunit that is involved in neuronal function, among other processes."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;CDON GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"CDON (Cell adhesion molecule with Ig and Dome domain) gene plays roles in embryonic development including the specification of facial structures like teeth."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;AJUBA/C14ORF93 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"AJUBA gene is associated with cellular interactions and developmental signaling, contributing to tissue differentiation."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;TEX14/RAD51C GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"TEX14/RAD51C gene is involved in DNA repair mechanisms, which can influence developmental outcomes."</data>
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
    </node>
    <node id="&quot;KCNJ160&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"A gene associated with tooth development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;FAM155E–EDA&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant associated with the FAM155E-EDA region, linked to craniofacial development and number of teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;BMP4&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Bone Morphogenetic Protein 4 (BMP4), a gene involved in tooth development and craniofacial shape formation."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;IGF2BP1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Insulin-like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1), linked to tooth development and craniofacial shape."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;KCNJ2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Potassium inwardly-rectifying channel, subfamily J, member 2, associated with craniofacial phenotypes."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;MSRB3&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Methionine Sulfoxide Reductase B3, a gene linked to tooth development and mid-brow prominence."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;ADK&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Adenosine Kinase (ADK), associated with nose width and earlier tooth eruption."&lt;SEP&gt;"Adenosine Kinase (ADK), associated with nose width measures in craniofacial studies."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;AJUBA&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"LIM Domain Containing 7 Protein (LMO7, also known as AJUBA), involved in mid-brow height and prominence."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HEIGHT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The process of growing taller, influenced by genetic factors like HMGA2 and BMP4."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;TOOTH ERUPTION&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The biological process where teeth emerge through the gum line, influenced by multiple genes including HMGA2."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;CRANIOFACIAL DEVELOPMENT&quot;">
      <data key="d0">"BIOLOGICAL PATHWAY"</data>
      <data key="d1">"Developmental pathway that includes growth and formation of craniofacial structures, linked to genetic loci like BMP4 and HMGA2."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;DENTAL PHENOTYPE&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The development and maintenance of teeth throughout a lifetime, influenced by genes such as MSRB3 and BMP4."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS2520397&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant in the KCNJ160 gene associated with tooth development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1951867&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant near BMP4, linked to craniofacial measures and number of primary teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS1472259&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A SNP in HMGA2 associated with both tooth development and craniofacial phenotypes."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS8069452&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant near IGF2BP1, linked to number of teeth."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RS9788982&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"Associated with tooth development and craniofacial measurements."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;CACNB2&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"Voltage-dependent calcium channel subunit beta-2, linked to tooth number at 6-14 years old."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;RAD51L1&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"RecombinaseRAD51-like1 (RAD51L1), associated with earlier tooth eruption and tooth count."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HEIGHT INCREASER ALLELE&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"An allele that increases height also influences faster tooth eruption or more teeth development."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;TOOTH ERUPTION SPEED&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The rate at which teeth emerge through the gum line, influenced by genetic factors like HMGA2 and RAD51L1."</data>
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
    </node>
    <node id="&quot;HMGA2 GENE&quot;">
      <data key="d0">"GENE"</data>
      <data key="d1">"The HMGA2 gene is involved in regulating biological pathways related to dental health and may influence age at first tooth and number of teeth."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR AGE AT FIRST TOOTH SCORE (PMETA = 0.0012)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant score constructed from significant SNPs for 'Age at first tooth' shows a moderate association with height, but this evidence is largely driven by HMGA2 and BMP4 variants."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR NUMBER OF TEETH SCORE (PMETA = 9.8 × 10−4)&quot;">
      <data key="d0">"GENOMIC VARIANT"</data>
      <data key="d1">"A genomic variant score constructed from significant SNPs for 'Number of teeth' also shows a moderate association with height, driven by HMGA2 and BMP4 variants."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;HEIGHT TRAIT&quot;">
      <data key="d0">"PHYSIOLOGICAL PROCESS"</data>
      <data key="d1">"The physiological process of growth leading to adult height may be influenced by genetic factors such as those in HMGA2 and BMP4 genes."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"The pathway analysis for 'age at first tooth' revealed significant overrepresentation of pathways, suggesting biological relevance to the phenotype."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;PATHWAY ANALYSIS RESULTS (NUMBER OF TEETH)&quot;">
      <data key="d0">"METABOLIC PATHWAY"</data>
      <data key="d1">"No significant over-representation of pathways was found in the 'number of teeth' GWAS analysis, indicating limited pathway-level biological impact."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;ALLIGATOR SOFTWARE&quot;">
      <data key="d0">"MOLECULAR INTERACTION"</data>
      <data key="d1">"A software tool used for pathway analysis to identify gene sets significantly associated with phenotypes like age at first tooth and number of teeth."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;SIGNIFICANT SNPS FOR NUMBER OF TEETH PATHWAY ANALYSIS RESULTS (NONE SIGNIFICANT)&quot;">
      <data key="d0">"DISEASE"</data>
      <data key="d1">"The pathway analysis results indicating no significant over-representation of pathways in the 'number of teeth' GWAS, suggesting a lack of clear genetic influence on this trait compared to 'age at first tooth'."</data>
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
    </node>
    <node id="&quot;DENTAL DEVELOPMENT&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variants in CACNB2 are found to be linked to variations in age at first tooth, suggesting a role in the timing of tooth development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH MORPHOGENESIS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNP rs4937076 near CDON gene is associated with phenotypes related to dental morphogenesis."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;CALU/OPN1SW GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variation in this region affects oral health parameters like age of first tooth and number of teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORAL HEALTH&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variation in this region affects oral health parameters like age of first tooth and number of teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DENTAL PHENOTYPES&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs997154 near AJUBA gene is associated with phenotypic variation in dental development traits."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ADK GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORAL DEVELOPMENT&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH COUNT&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs412000 near TEX14/RAD51C is associated with variation in the count of teeth at one year."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DENTAL TRAITS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DLEU7 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;KCNJ2 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH DEVELOPMENT&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;MSRB3 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs1956529 in MSRB3 region is associated with phenotypic variation related to dental traits."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;IGF2BP1 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;ORAL DEVELOPMENT TRAITS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;DENTAL MORPHOGENESIS&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs in EDA region are associated with phenotypic variations in dental morphology and development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;EDA GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"SNPs in EDA region are associated with phenotypic variations in dental morphology and development."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HMGA2 REGION&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;TOOTH COUNT VARIABILITY&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;LINC01278 GENE&quot;">
      <data key="d2">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d1">"Variants around LINC01278 gene are linked to oral developmental traits such as the timing of first tooth eruption."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NOSE WIDTH&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"Adenosine Kinase (ADK) variants are associated with measures of nose width in craniofacial studies."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;HEIGHT AND CRANIOFACIAL PHENOTYPES&quot;">
      <data key="d2">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d1">"LIM Domain Containing 7 Protein (AJUBA) is involved in mid-brow height increase, possibly linked to height."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;AGE AT FIRST TOOTH TRAIT&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"The GWAS investigates genetic variants associated with when an individual first develops teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;GENOME-WIDE ASSOCIATION STUDY (GWAS)&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"The GWAS investigates genetic variants associated with when an individual first develops teeth."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <node id="&quot;NUMBER OF TEETH TRAIT&quot;">
      <data key="d2">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d1">"The GWAS also explores genetic factors influencing the number of permanent teeth in adults, though less significant pathways were found compared to 'age at first tooth'."</data>
      <data key="d0">"UNKNOWN"</data>
    </node>
    <edge source="&quot;OBESITY&quot;" target="&quot;SKELETAL MUSCLE MASS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Skeletal muscle mass is often inversely related to body fat content in obese individuals."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;HS-CRP CONCENTRATION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Increased hs-CRP concentrations are often associated with obesity and systemic inflammation."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;EGFR&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Renal function can be impaired in obese individuals due to increased metabolic and vascular pressures."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;KOREAN BALANCED DIET INTAKE&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"Intake of a Korean balanced diet can influence obesity risk through its nutritional profile."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;AGE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The prevalence of obesity tends to increase with age due to changes in metabolism and lifestyle."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY&quot;" target="&quot;PHYSICAL ACTIVITY LEVEL&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher physical activity levels are associated with lower obesity risk through increased energy expenditure."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAIST CIRCUMFERENCE&quot;" target="&quot;FAT MASS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A higher waist circumference generally correlates with greater abdominal fat mass, a component of obesity risk."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WAIST CIRCUMFERENCE&quot;" target="&quot;BLOOD PRESSURE (SBP/DBP)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Higher waist circumference is commonly linked to higher blood pressure, indicating cardiovascular risks."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM TOTAL CHOLESTEROL&quot;" target="&quot;LDL CONCENTRATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Total cholesterol levels are influenced by LDL concentration, with higher levels contributing to cardiovascular risks."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM TRIGLYCERIDE&quot;" target="&quot;ALCOHOL INTAKE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Consumption of alcohol can lead to elevated serum triglycerides due to its metabolic effects."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM HDL CONCENTRATION&quot;" target="&quot;REGULAR EXERCISE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Engaging in regular exercise tends to increase HDL levels, promoting cardiovascular health."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALT CONCENTRATION&quot;" target="&quot;AST CONCENTRATION&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"High ALT concentrations often indicate liver damage or disease, which can also affect AST levels."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DII (DIETARY INFLAMMATORY INDEX)&quot;" target="&quot;SUGAR-CONTAINING FOODS INTAKE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Higher dietary inflammatory index scores are associated with higher intake of sugar-containing foods."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FRIED FOOD INTAKE&quot;" target="&quot;WESTERN-STYLE DIET INTAKE&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"A Western-style dietary pattern often includes high intake of fried foods, contributing to health risks."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET INTAKE&quot;" target="&quot;REGULAR EXERCISE&quot;">
      <data key="d4">15.0</data>
      <data key="d5">"Following a plant-based diet combined with regular exercise can reduce obesity risk through multiple pathways."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET INTAKE&quot;" target="&quot;BMI&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A high intake of plant-based foods can mitigate genetic impact on BMI, suggesting a protective role against obesity risk when combined with low PRS.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLANT-BASED DIET INTAKE&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A high intake of plant-based diet can reduce the genetic impact (high PRS) on obesity risk, highlighting the protective role of dietary patterns against genetic predisposition.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENDER&quot;" target="&quot;BMI (BODY MASS INDEX)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Average BMI differs between genders, often reflecting differences in body composition and fat distribution."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FAMILY HISTORY OF OBESITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A family history of obesity can lead to higher BMI and related health risks due to shared genetics and environment."</data>
      <data key="d6">chunk-fa6293a0a10f175b4aebac8e885c0d20</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FTO SNP&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The presence of the FTO SNP is associated with increased BMI in individuals without university studies but not in those with higher education."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;EXTREMELY OBESE CHILDREN AND ADOLESCENTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A measure used to categorize the severity of obesity, studied in association with genetic risk alleles."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;BASELINE COLONIC ARACHIDONIC ACID (AA) MEASUREMENT IN PARTICIPANTS WITH OR WITHOUT MINOR ALLELES IN THE FADS GENE CLUSTER&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Participants with minor alleles in the FADS gene cluster had a lower BMI at baseline."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;SEX (MALE/FEMALE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both males and females experience a positive correlation between BMI and increased snoring, though mechanisms may vary by sex."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;SODIUM IN URINE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher sodium levels in urine are often associated with higher BMI values due to dietary habits and salt intake.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;FTO GENE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FTO gene is associated with obesity risk, indicating a potential causal relationship between the genetic variation in this region and BMI values.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;MACF1 GENE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The MACF1 gene's association with musculoskeletal traits also includes an influence on BMI values, linking physical structure to obesity risk.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;SEX-STRATIFIED GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Separate analyses conducted on males and females revealed distinct genetic factors contributing to variations in BMI, influencing snoring predisposition differently between sexes.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI (BODY MASS INDEX)&quot;" target="&quot;PGS (POLYGENIC SCORE)&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Adjusting for BMI in the GWAS reduces SNP heritability but does not eliminate genetic predisposition to snoring as indicated by PGS."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DNAJC27_RS713586&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The DNAJC27 variant influences the process of regulating energy intake or expenditure via interaction with transcription factors involved in obesity development."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1_RS9356744&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The CDKAL1 variant affects energy intake/expenditure through its influence on the regulation of transcription factors, impacting obesity risk."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TFAP2B_RS2206277&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"A genetic variation in TFAP2B influences the development of obesity by modulating energy intake/expenditure pathways through interaction with transcription factors."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDNF_RS6265&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The BDNF variant impacts energy intake or expenditure, contributing to the risk of developing obesity via its role in modulating transcription factors."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MYL2_RS3782889&quot;" target="&quot;OBESITY RISK&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Although MYL2 SNP does not meet statistical significance, it is implicated in obesity risk through regulation of energy intake/expenditure pathways."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OLFM4_RS9568856&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">3.5</data>
      <data key="d5">"The OLFM4 variant influences the process of regulating energy intake or expenditure, playing a role in obesity development through its interaction with transcription factors."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO_RS1421085&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A genetic variant in FTO affects the regulation of energy intake/expenditure, thereby influencing the obesity risk by acting as a hub gene."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MC4R_RS6567160&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.5</data>
      <data key="d5">"The MC4R variant acts as a hub gene in regulating energy intake/expenditure pathways, contributing significantly to obesity risk through its modulation of transcription factors."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GIPR_RS1444988703&quot;" target="&quot;ENERGY INTAKE AND EXPENDITURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A genetic variant in GIPR impacts energy intake/expenditure via regulation of transcription factors, thereby influencing the risk of obesity."</data>
      <data key="d6">chunk-eec0b4c60ebeb28599428b3552de2d1b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BODY MASS INDEX (BMI)&quot;" target="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Adherence to the Mediterranean diet contributes to a reduction in body mass index among individuals."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"High fried-food consumption mitigates the genetic impact from high PRS on BMI, showing that diet plays a crucial role in modifying obesity risk.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;EDUCATION LEVEL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Educational level interacts with the FTO SNP to determine obesity risk, showing an inverse relationship between higher education and obesity prevalence."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OBESITY RISK&quot;" target="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Adjusting for physical activity does not change the significant association between the FTO SNP and obesity risk in most populations but modifies this effect when education is considered as an environmental factor.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRS&quot;" target="&quot;FRIED-FOOD INTAKE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"High fried-food consumption offsets the genetic impact from PRS in terms of increasing BMI; thus, diet can modify obesity risk independent of genetic predisposition.")</data>
      <data key="d6">chunk-3ad8ef794841d749e48b3223741e91d3</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;IFG/IGT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher BMI levels are positively associated with IFG/IGT status at baseline in comparison to normal glucose tolerance subjects (NGT).")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI&quot;" target="&quot;MEDIATOR OF PLEIOTROPIC EFFECTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Body Mass Index is a key mediator in the pleiotropy observed between certain SNPs and metabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;HIGH-PROTEIN DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The FTO rs1558902 genotype interacts with high-protein diets to influence weight loss and body composition changes, particularly in terms of fat-free mass and total fat."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS1558902 GENOTYPE&quot;" target="&quot;WEIGHT LOSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals carrying the FTO risk allele (A) experience greater weight loss on a high-protein diet compared to those without this genotype."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;FAT DISTRIBUTION CHANGES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A high-protein diet leads to changes in fat distribution, including reductions in visceral and subcutaneous adipose tissue, which is modulated by the FTO rs1558902 genotype."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;A ALLELE (RISK ALLELE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals carrying the A allele show greater weight loss and changes in body composition when consuming a high-protein diet compared to non-carriers."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;FAT DISTRIBUTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The high-protein diet significantly influenced fat distribution changes in individuals with the AA genotype, leading to more substantial decreases in body fat."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-PROTEIN DIET&quot;" target="&quot;TOTAL FAT CHANGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Particularly in individuals with specific genotypes, high-protein diets can lead to significant reductions in total body fat."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT DISTRIBUTION CHANGES&quot;" target="&quot;LOW-FAT DIET&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genotype-time interactions on changes in fat distribution are observed under low-fat dietary conditions."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAT DISTRIBUTION CHANGES&quot;" target="&quot;GENOTYPE-TIME INTERACTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The interaction between genotype and dietary intake over time significantly impacts changes in fat distribution."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINEAR MIXED MODELS ANALYSIS&quot;" target="&quot;TOTAL FAT LOSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The analysis using linear mixed models reveals that individuals with the AA genotype on a high-protein diet show greater total fat loss over time compared to those without this genotype."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL FAT LOSS&quot;" target="&quot;FAT-FREE MASS LOSS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Changes in total fat are often accompanied by corresponding losses or gains in fat-free mass, indicating an overall shift in body composition."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL FAT LOSS&quot;" target="&quot;TRUNK FAT LOSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Loss in trunk fat is a component of total fat loss, reflecting changes in central adiposity due to dietary and genetic influences."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;BASELINE BMI&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The baseline BMI provides a reference for measuring the impact of genetic variants such as those in the FTO gene on body mass over time."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;ANTHROPOMETRIC MEASUREMENTS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FTO gene variant (rs9939609) has a significant association with various anthropometric measurements, indicating its role in obesity risk."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;FTO SNP&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FTO gene contains a specific single nucleotide polymorphism (SNP) that influences obesity risk.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO GENE&quot;" target="&quot;RS1558902 SNP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"This specific SNP within FTO influences CRP levels, highlighting gene-specific impacts on systemic inflammation markers.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE BMI&quot;" target="&quot;FM%&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The initial FM% provides context for how genetic factors and dietary interventions can influence the percentage of body fat over time."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FM% (FAT MASS PERCENTAGE)&quot;" target="&quot;TRUNK FAT CHANGE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Alterations in trunk fat, as measured by FM%, can be influenced by genotype-time interactions and specific diets like the high-protein diet."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VISCERAL ADIPOSE TISSUE (VAT) CHANGES&quot;" target="&quot;GENE-DIET INTERACTION ANALYSIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Analysis reveals that gene-diet interactions significantly impact changes in visceral adipose tissue, particularly in response to high-protein diets."</data>
      <data key="d6">chunk-2926e6216bf945b12ea4daa6345cad1f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;LOW-PROTEIN DIET&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Those carrying the AA genotype had less loss of TAT and SAT during the low-protein dietary intervention relative to non-carriers."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AA GENOTYPE&quot;" target="&quot;GG GENOTYPE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals carrying the GG genotype have lower TAG concentrations compared to those with AA genotypes for GCKR rs780094 SNP, indicating a genetic influence on lipid levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;TAT (TOTAL ABDOMINAL ADIPOSE TISSUE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"In response to a low-protein diet, participants carrying the AA genotype exhibited less reduction of total abdominal adipose tissue compared to others."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW-PROTEIN DIET&quot;" target="&quot;SAT (SUBCUTANEOUS ABDOMINAL ADIPOSE TISSUE)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The AA genotype carriers showed smaller decreases in subcutaneous abdominal adipose tissue during low-protein diet interventions."</data>
      <data key="d6">chunk-a321a6d63755366a1fc3eafbd9fbce83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO RS9939609 POLYMORPHISM&quot;" target="&quot;ANTHROPOMETRIC VARIABLES&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The FTO rs9939609 polymorphism is associated with anthropometric measurements, including weight, BMI and waist circumference."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION LEVEL&quot;" target="&quot;FTO SNP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Educational level interacts significantly with the FTO rs9939609 polymorphism to determine BMI and obesity risk, highlighting environmental-genetic interactions."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;UNIVERSITY STUDIES EDUCATION LEVEL&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Individuals with higher education do not exhibit a significant association between the FTO rs9939609 polymorphism and anthropometric measures, suggesting mitigating factors in these groups."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;PHYSICAL ACTIVITY (PA)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The level of physical activity interacts with the presence of the FTO SNP to influence BMI, especially among certain educational groups."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FTO SNP&quot;" target="&quot;EDUCATION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The effect of the FTO SNP on obesity risk varies depending on educational attainment, indicating a gene-environment interaction.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PRIMARY STUDIES EDUCATION LEVEL&quot;" target="&quot;SECONDARY STUDIES EDUCATION LEVEL&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both primary and secondary education levels show similar patterns of increased obesity risk associated with the FTO SNP compared to university studies."</data>
      <data key="d6">chunk-3135befd0c3140ad097d96ace6de86a1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PHYSICAL ACTIVITY (PA)&quot;" target="&quot;INTENSIVE LIFESTYLE INTERVENTION GROUP&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Increased physical activity as part of an intervention group helps in reducing weight and lowering type 2 diabetes risk."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EDUCATION&quot;" target="&quot;UNIVERSITY STUDIES&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals who undertake university studies are part of the broader category of education level, which can influence health outcomes related to genetic factors such as the FTO SNP.")</data>
      <data key="d6">chunk-63d0b5be485a69f44e2799ccc9510487</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;DIETARY PATTERN&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The TCF7L2 gene interacts with various dietary patterns in the context of type 2 diabetes risk assessment."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;RS7903146&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The rs7903146 variant within the TCF7L2 gene modifies the association between other genetic factors and Type 2 diabetes risk."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;SNPS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The TCF7L2 gene contains SNPs that are significantly associated with BMI at baseline, indicating its role in obesity predisposition.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 GENE&quot;" target="&quot;SNPS IN FTO, TAL1, AND TCF7L2 GENES&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The TCF7L2 gene contains the SNP rs7903146, a significant obesity predisposing SNP associated with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANT&quot;" target="&quot;TYPE 2 DIABETES (T2D)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Genetic variants interact with environmental factors to modify the susceptibility or resistance to developing type 2 diabetes."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;NURSES' HEALTH STUDY (NHS)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Longitudinal studies like the NHS help to understand how dietary patterns influence long-term health outcomes such as type 2 diabetes risk."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;GENE-DIET INTERACTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Dietary patterns interact with genotypes to modify physiological processes such as lipid metabolism.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY PATTERN&quot;" target="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both dietary patterns and physical activity are lifestyle factors that influence glucose tolerance and diabetes risk.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INTENSIVE LIFESTYLE INTERVENTION GROUP&quot;" target="&quot;FINISH DIABETES PREVENTION STUDY (DPS)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The DPS uses an intensive lifestyle intervention group to assess the impact of lifestyle changes on reducing type 2 diabetes risk compared to usual care."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET GROUPS&quot;" target="&quot;WHOLE GRAIN INTAKE AND FIBER CONSUMPTION&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"The Mediterranean diet groups focus on extra-virgin olive oil or mixed nuts, which are associated with whole grain intake and fiber consumption."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;PREVENCIÓN CON DIETA MEDITERRÁNEA (PREDIMED)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The PREDIMED study assesses how a Mediterranean diet affects cardiovascular disease and type 2 diabetes risk factors in at-risk populations."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;WEIGHT LOSS INTERVENTIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Interventions aimed at promoting weight loss can reduce the incidence of T2D among individuals carrying certain genetic variants."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;GENETIC VARIANTS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Multiple genetic variants are associated with an increased risk of Type 2 Diabetes, highlighting the polygenic nature of the disease."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES (T2D)&quot;" target="&quot;CUMULATIVE RISK SCORE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The cumulative risk score, derived from multiple genetic variants, significantly differentiates between individuals with T2D and those without, indicating its utility as a predictive tool."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AMERICAN DIABETES PREVENTION PROJECT (DPP)&quot;" target="&quot;GLYCEMIC INDEX AND GLYCEMIC LOAD&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"Studies like DPP evaluate how glycemic index and load affect type 2 diabetes risk when combined with lifestyle interventions."</data>
      <data key="d6">chunk-0d8bc9a093c56fefc8b7af3fb9bc2862</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;RS7903146 RISK T-ALLELE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs7903146 variant in the TCF7L2 gene shows interaction with fiber and whole-grain intake among individuals carrying a specific allele, increasing T2D incidence."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;RS4506565&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The rs4506565 variant within the TCF7L2 gene interacts with dietary fiber and whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;RS12255372&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The rs12255372 variant within the TCF7L2 gene shows interaction with dietary fiber but not carbohydrates, affecting type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2&quot;" target="&quot;ADH1C *1/*2 VARIANT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The ADH1C genotype modifies the association between alcohol intake and T2D risk among women carrying a specific allele of TCF7L2 gene."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FIBER INTAKE&quot;" target="&quot;TCF7L2 RS12255372 CARRIERS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Carriers of the TCF7L2 variant rs12255372 show interaction with dietary fiber to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE-GRAIN INTAKE&quot;" target="&quot;TCF7L2 RS11196208 A-ALLELE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A-allele carriers of TCF7L2 variant rs11196208 show interaction with whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE-GRAIN INTAKE&quot;" target="&quot;TCF7L2 RS7903146 AA-GENOTYPE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"AA-genotype carriers of TCF7L2 variant rs7903146 show interaction with whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE-GRAIN INTAKE&quot;" target="&quot;TCF7L2 RS7903146 AC-GENOTYPE CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"AC-genotype carriers of TCF7L2 variant rs7903146 show interaction with whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WHOLE-GRAIN INTAKE&quot;" target="&quot;TCF7L2 RS4506565 CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Carriers of the TCF7L2 variant rs4506565 show interaction with whole-grain intake to modify type 2 diabetes risk."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS10923931 NOTCH2 GENE&quot;" target="&quot;NOTCH2 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A genetic variant in the NOTCH2 gene interacts with fiber intake, influencing type 2 diabetes risk among individuals carrying a specific allele of this gene."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ZBED3 GENE&quot;" target="&quot;NOTCH2 GENE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ZBED3 gene shows interaction with dietary fiber intake and modifies T2D risk similar to NOTCH2 gene interactions, both involved in WNT signaling pathway."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IRS1 RS2943641&quot;" target="&quot;GIPR RS10423928&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both genetic variants (IRS1 and GIPR) interact with carbohydrate intake to modify type 2 diabetes risk, but findings are not consistent across studies."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CAV2 VARIANT RS2270188&quot;" target="&quot;HECTD4 VARIANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Both CAV2 variant and HECTD4 variants show interaction with dietary fat to modify T2D risk, though findings vary between studies."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 POLYMORPHISMS &quot;" target="&quot;DIETARY FACTORS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Polymorphisms in TCF7L2 interact with various dietary factors, including fiber and whole grains, to influence type 2 diabetes incidence."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WESTERN DIETARY PATTERN &quot;" target="&quot;T2D-GRS &quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The effect of a Western dietary pattern on T2D risk is amplified in individuals with high genetic susceptibility (high T2D-GRS)."</data>
      <data key="d6">chunk-f7bf38c7a21b86ad85fa360a21bfb447</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TCF7L2 RS12255372&quot;" target="&quot;T2D&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This genetic variant of TCF7L2 is significantly associated with a reduced incidence of type 2 diabetes in intervention studies compared to control groups."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146 RISK T‐ALLELE&quot;" target="&quot;T2D&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The presence of the rs7903146 T allele is linked to an increased risk of developing type 2 diabetes but showed lower incidence in intervention groups."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ENPP1 RS1044498 DIABETOGENIC VARIANT&quot;" target="&quot;T2D&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This variant of ENPP1 is associated with a higher risk for type 2 diabetes but weight loss interventions seem to mitigate this risk."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MC4R RS17066829&quot;" target="&quot;WEIGHT LOSS INTERVENTION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"While there's a trend towards interaction, the MC4R variant does not show significant interactions with weight loss interventions for reducing T2D incidence."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPARΓ RS1152003 CC‐GENOTYPE&quot;" target="&quot;T2D&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The PPARγ gene variant is associated with a reduced risk of type 2 diabetes under intervention conditions compared to controls."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TNFΑ RS1800629 GG‐GENOTYPE&quot;" target="&quot;T2D&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"This genetic variant shows lower T2D incidence among individuals who undergo weight loss interventions."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADRA2B GLU9-ALLELE&quot;" target="&quot;WEIGHT LOSS INTERVENTION&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The ADRA2B gene's Glu9 allele is associated with a reduced risk of type 2 diabetes upon undergoing weight loss interventions."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIPC RS2070895 A‐ALLELE&quot;" target="&quot;T2D&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This genetic variant in LIPC shows a lower incidence of T2D under intervention conditions compared to non-intervention groups."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC VARIANTS&quot;" target="&quot;TYPE 1 DIABETES (T2D)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Certain genetic variations increase susceptibility to developing type 2 diabetes, and their interaction with lifestyle factors can modify disease risk."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WEIGHT LOSS INTERVENTIONS&quot;" target="&quot;RCT STUDY POPULATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Randomized controlled trials investigating the effects of weight loss interventions on populations carrying different genetic variants for T2D."</data>
      <data key="d6">chunk-180ca3d6d27d84b30ebf5d20f135de18</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FFAR4 VARIANT&quot;" target="&quot;PPARΓ VARIANTS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variants in PPARγ show a trend for interaction with fat intake and FFAR4 variant interacts with low-fat diet to influence T2D risk, indicating similar dietary impact on genetic interactions."</data>
      <data key="d6">chunk-ab449d4ec9f3baa290d63f09fdbd3fbc</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;T2D&quot;" target="&quot;IFG/IGT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Individuals with IFG/IGT have an increased risk of developing T2D compared to those with NGT, as indicated by baseline clinical characteristics and longitudinal data from the EpiDREAM cohort study.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;WFS1 GENE&quot;" target="&quot;RS10010131 GENOMIC VARIANT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"A specific variant in the WFS1 gene (rs10010131) is associated with Type 2 Diabetes risk."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDKAL1 GENE&quot;" target="&quot;RS10946398 GENOMIC VARIANT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"An association between a CDKAL1 variant and T2D was observed for a specific variant (rs10946398), indicating its role in disease susceptibility."&lt;SEP&gt;"An association between a CDKAL1 variant and T2D was observed in the study sample, indicating its role in disease susceptibility."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;JAZF1 GENE&quot;" target="&quot;RS864745 GENOMIC VARIANT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A genomic variant (rs864745) within JAZF1 is associated with an increased risk of Type 2 Diabetes, showing the gene's importance in disease pathogenesis."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADAMTS9 GENE&quot;" target="&quot;RS4607103 GENOMIC VARIANT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"An association between ADAMTS9 and T2D was noted for a specific variant (rs4607103), with differing effects observed in different populations."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CUMULATIVE RISK SCORE&quot;" target="&quot;LOGISTIC REGRESSION MODEL&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"A logistic regression model was applied to assess the relationship between cumulative risk scores and disease status in T2D patients compared to controls, showing significant associations."</data>
      <data key="d6">chunk-f9a60d3cf951d77afa115859755dac43</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS7903146&quot;" target="&quot;TYPE 7 DIABETES RISK ANALYSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic analysis shows that adjusting for the genomic variant rs7903146 in TCF7L2 gene removes significant associations with Type 2 diabetes, suggesting its importance."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;TCF7L2 RISK VARIANT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;TCF7LL2 RISK VARIANT&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Adjusting for the TCF7L2 risk variant rs7903146 in analyses eliminates significant associations with disease, indicating its influence on Type 2 diabetes risk."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;RISK ALLELES COUNT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The count of risk alleles is a factor influencing the association with Type 2 diabetes, particularly when considering variants like rs7903146 in TCF7L2."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;INSULIN SENSITIVITY (ISI)&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Decreased insulin sensitivity is a significant risk factor for developing type 2 diabetes, as shown by associations with KB levels in the METSIM study.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;ENVIRONMENTAL FACTOR&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Environmental factors such as diet, smoking, and BMI play significant roles in the development of type 2 diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Genetic variations such as SNPs associated with type 2 diabetes influence the levels of ketone bodies in individuals."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;" target="&quot;AGE FACTOR&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There was no evidence for interaction between age and Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;" target="&quot;SEX FACTOR&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"No significant interaction with sex was found in the analysis of Type 2 diabetes risk associated with the TCF7L2 gene variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;" target="&quot;BMI FACTOR&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Body Mass Index (BMI) did not significantly interact with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TYPE 2 DIABETES RISK ANALYSIS&quot;" target="&quot;DEGREE OF AFRICAN ANCESTRY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The degree of African ancestry had no significant interaction with Type 2 diabetes risk in genetic analyses involving the TCF7L2 gene variant."</data>
      <data key="d6">chunk-6a7c69534e11aa2fc4bd948484aa81c4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;NGT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The transition from NGT to IFG/IGT is significantly correlated with higher baseline BMI levels and a positive increase in BMI change over time compared to stable NGT status.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;GENOMIC VARIANT (SNPS)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Specific genomic variants or SNPs influence susceptibility to IFG/IGT, affecting baseline BMI levels and the progression from NGT to IFG/IGT over time.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IFG/IGT&quot;" target="&quot;NATIVE NORTH AMERICAN&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Native North Americans showed lower prevalence of IFG/IGT, suggesting potential protective genetic or environmental factors unique to this ethnic group.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PLASMA GLUCOSE (FPG)&quot;" target="&quot;IMPAIRED FASTING GLYCAEMIA (IFG)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"FPG levels above normal but below diabetic thresholds indicate IFG, a condition associated with an increased risk of developing type 2 diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EAST ASIAN&quot;" target="&quot;FPG&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"In East Asian populations, Fasting Plasma Glucose levels might be influenced by genetic factors contributing to lower prevalence of T2D compared to other ethnic groups.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AFRICAN&quot;" target="&quot;2HPG&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Higher rates of Two-hour Plasma Glucose indicate that African ancestry may be associated with increased risk due to higher 2hPG levels leading to greater BMI changes over time.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAL1 GENE&quot;" target="&quot;SNPS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The TAL1 gene has SNPs that are significantly associated with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAL1 GENE&quot;" target="&quot;SNPS IN FTO, TAL1, AND TCF7L2 GENES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The TAL1 gene contains the SNP rs2984618, another obesity predisposing SNP associated with BMI at baseline.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEPR GENE&quot;" target="&quot;GRS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"While the LEPR gene alone does not show a significant main effect on BMI, it interacts with GRS in relation to glycemic status traits like FPG.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LEPR GENE&quot;" target="&quot;FPG (FASTING PLASMA GLUCOSE)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"FPG interacts with the rs1011527 SNP in LEPR on baseline BMI, suggesting a role of glycemic status traits in modulating genetic effects on obesity.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS&quot;" target="&quot;BMI BASELINE AND CHANGE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"SNPs are significantly associated with baseline BMI but not with changes in BMI over time.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;BMI BASELINE AND CHANGE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The GRS is a significant predictor of increased BMI at baseline, indicating the cumulative genetic risk for obesity.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTA&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"The Genetic Risk Score (GRS) is associated with performance on Trail Making Test Part A (TMTA), a measure of visual search speed and processing speed.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;TMTB&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"Survivors with higher GRS scores performed significantly worse on Trail Making Test Part B (TMTB) than those with lower GRS scores, indicating an association between genetic risk and cognitive flexibility.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;PEGDH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant association was found between the Genetic Risk Score (GRS) and performance on Paired Associate Learning Digit Span High Load (PEGDH).")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;PEGNDH&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Similarly, no significant association was observed between GRS and the performance of patients in Paired Associate Learning Number Digit High Load (PEGNDH).")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;DIG&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Genetic Risk Score (GRS) did not show any association with impairment on the Digit Span Test (DIG), assessing working memory and attention.")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;CFL&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No significant correlation was found between GRS and impaired performance in Coding Figure Learning (CFL).")</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;POLYMORPHISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The Genetic Risk Score (GRS) is computed based on the presence and frequency of polymorphisms across six genomic loci."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;CUMULATIVE IV MTX EXPOSURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The cumulative intravenous exposure to methotrexate influences the Genetic Risk Score, affecting cognitive outcomes."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS&quot;" target="&quot;DIVERGT BATTERY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"No significant association was found between GRS and impairment on DIVERGT battery performance scores, suggesting variability in how genetic risk impacts different aspects of cognition."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FPG (FASTING PLASMA GLUCOSE)&quot;" target="&quot;RS1011527 SNP IN LEPR&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"This SNP interacts with FPG on baseline BMI but does not show a significant main effect on BMI without considering the interaction term.")</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GRS (GENOTYPE RISK SCORE)&quot;" target="&quot;BMI BASELINE AND CHANGE ASSOCIATIONS AND INTERACTIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The GRS is significantly associated with increased BMI at baseline, indicating cumulative genetic risk in the context of obesity."</data>
      <data key="d6">chunk-1fde08e52a188ac6a549e7c11d59a092</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;2HPG&quot;" target="&quot;FPG&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both Fasting Plasma Glucose and Two-hour Plasma Glucose are physiological processes that, when elevated, contribute to increased risk for T2D and are positively associated with baseline BMI.")</data>
      <data key="d6">chunk-bb507a90a1f5d5ddd01a93200ff2d45e</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 1298A&gt;C&quot;" target="&quot;NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Carriers of the MTHFR 1298AC/CC genotypes are at a higher risk for neurocognitive deficits compared to those with AA genotype."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTHFR 1298A&gt;C&quot;" target="&quot;TMTB PERFORMANCE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Survivors with MTHFR 1298AC/CC genotypes scored significantly lower on TMTB compared to those with AA genotype."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS 2756A&gt;G&quot;" target="&quot;PEGNDH SCORE DIFFERENCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Survivors with MS 2756AA genotype scored lower on the PEGNDH test compared to those with AG/GG genotypes."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MS 2756A&gt;G&quot;" target="&quot;TMTA PERFORMANCE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Survivors carrying MS 2756AA genotype performed worse on TMTA than survivors with AG/GG genotypes."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTRR 66A&gt;G&quot;" target="&quot;CFL PERFORMANCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Individuals carrying MTRR 66AA genotype showed significantly worse performance in executive function tests (CFL)."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSER POLYMORPHISMS&quot;" target="&quot;TMTB PERFORMANCE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Individuals with TSER 2R/3R and 3R/3R genotypes scored lower on TMTB compared to those with 2R/2R genotype."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTX-RELATED NEUROTOXICITY&quot;" target="&quot;LONG-TERM NEUROCOGNITIVE IMPAIRMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Early MTX-induced neurotoxic symptoms were predictive of long-term cognitive deficits, despite no significant effect on all test measures."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TMTB&quot;" target="&quot;INTRATHECAL MTX EXPOSURE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Intrathecal methotrexate administration affects cognitive performance as measured by Trail Making Test Part B (TMTB)."</data>
      <data key="d6">chunk-ea6355aaf22d7cdd3331602638122ed7</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FINE MOTOR SKILLS&quot;" target="&quot;PEGDH TEST&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The PEGDH test is used to assess fine motor skills, showing some association with genetic polymorphisms but not all covariates."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTRR 66A&gt;G GENOTYPES&quot;" target="&quot;PEGNDH TEST&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Survivors with MTRR 66AA genotype scored lower on PEGNDH compared to those with AG/GG genotypes, indicating an impact on fine motor skills."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIG TEST&quot;" target="&quot;WORKING MEMORY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The DIG test assesses working memory and did not show significant associations with genetic polymorphisms or other covariates."</data>
      <data key="d6">chunk-4b6e8f78911cafc70959cfdfed786c29</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;FASTING PROINSULIN LEVELS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant at SLC30A8 is associated with higher baseline fasting proinsulin levels and this association remains significant even after adjusting for various factors.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;DPP COHORT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genomic variant SLC30A8 rs13266634 shows significant association with higher fasting proinsulin levels in the DPP cohort at baseline.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC30A8 RS13266634&quot;" target="&quot;FASTING INSULIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Adjustment for fasting insulin is necessary to accurately determine the relationship between SLC30A8 risk alleles and proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;TROGLITAZONE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The use of troglitazone as an intervention led to a decrease in fasting proinsulin levels, similar to metformin but less effective than lifestyle changes.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;C RISK ALLELE AT SLC30A8 RS13266634&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Higher proinsulin levels are associated with the presence of the C risk allele at SLC30A8, but this association becomes non-significant after one year of DPP intervention.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING PROINSULIN LEVELS&quot;" target="&quot;AGE, SEX, ETHNICITY&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These demographic factors were accounted for when assessing the impact of interventions on fasting proinsulin levels.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIFESTYLE INTERVENTION GROUP&quot;" target="&quot;METFORMIN&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both lifestyle changes and metformin interventions reduce proinsulin levels, but the decrease in the lifestyle group is significantly larger than that of the metformin group (p&lt;0.001).")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METFORMIN&quot;" target="&quot;TROGLITAZONE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Both metformin and troglitazone showed similar effects on reducing fasting proinsulin levels compared to each other, but both were less effective than the lifestyle intervention group.")</data>
      <data key="d6">chunk-8f23bd741f82dc8ca1e2600d790b690f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;SREBP1C&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Expression levels of PNPLA3 are positively correlated with SREBP1c, indicating they are part of the same regulatory pathway for lipid metabolism."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;ACC-1&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Accumulation of hepatic triacylglycerol is associated with elevated PNPLA3 and ACC-1 expression levels, suggesting a coordinated regulation in lipogenesis."&lt;SEP&gt;"The expression of ACC-1 parallels that of PNPLA3 in response to different stimuli such as citrate or glucose conditions."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;GLUCOSE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The expression level of PNPLA3 gene is regulated by glucose concentration, as shown by depletion-refeeding conditions experiments."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;CITRATE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Citrate increases PNPLA3 protein levels but its isomer, isocitrate, does not have this effect."&lt;SEP&gt;"Incubation with citrate increases PNPLA3 expression, suggesting a role for this Krebs cycle intermediate in lipid synthesis regulation."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a&lt;SEP&gt;chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;PYRUVATE&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Pyruvate has no impact on the expression of PNPLA3 in cells compared to citrate or acetate."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;FAS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Expression patterns of FAS and PNPLA3 are similar under various metabolic conditions, including high glucose levels."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;OLEIC ACID (OA)&quot;">
      <data key="d4">2.5</data>
      <data key="d5">"Oleic acid decreases PNPLA3 gene expression without affecting lipid accumulation when PNPLA3 is knocked down."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PNPLA3&quot;" target="&quot;Α-LINOLENIC ACID (ALA)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Unlike other unsaturated fatty acids like OA or LA, ALA does not suppress PNPLA3 expression."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH CARBOHYDRATE DIET (HC)&quot;" target="&quot;LIPID EMULSION (LE)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Inclusion of lipid emulsion with a high carbohydrate diet attenuates PNPLA3 expression dose-dependently."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIGH-FAT DIET (HF)&quot;" target="&quot;EXERCISE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Voluntary exercise suppresses the elevation of PNPLA3 mRNA induced by high-fat diet in mice."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCOSE&quot;" target="&quot;CHREBP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Expression patterns of ChREBP are similarly modulated to those of PNPLA3 in response to changes in glucose availability."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FATTY ACID SYNTHASE (FAS)&quot;" target="&quot;PNPLA3 KNOCKDOWN&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"PNPLA3 knockdown results in increased mRNA levels of FAS, a key lipogenic enzyme."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;2-DEOXY-D-GLUCOSE&quot;" target="&quot;HIGH GLUCOSE LEVELS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Treatment with 2-deoxy-D-glucose inhibits the induction of SREBP1c and PNPLA3 by high glucose levels, indicating it disrupts metabolic pathways dependent on glucose metabolism."</data>
      <data key="d6">chunk-c27a7b63e450810a5d9f9e0f70b73a7a</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;INSULIN&quot;" target="&quot;FAS&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"While insulin increases FAS expression, it does not affect the hepatic PNPLA3 levels in HepG2 cells."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUCAGON&quot;" target="&quot;PYRUVATE CARBOXYLASE (PC)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Treatment with glucagon stimulates PC expression while having no effect on PNPLA3 mRNA levels, indicating specificity of hormonal effects."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LINOLEIC ACID (LA)&quot;" target="&quot;SREBP1C, FAS, PNPLA3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"La and oleic acid reduce the mRNA levels of SREBP1c, FAS, and PNPLA3 under both low and high glucose conditions."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EICOSAPENTAENOIC ACID (EPA)&quot;" target="&quot;SREBP1C, FAS, PNPLA3&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Both EPA and DHA decrease the gene expressions of SREBP1c, FAS, and PNPLA3 under various glucose conditions."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DOCOSAHEXAENOIC ACID (DHA)&quot;" target="&quot;FATTY ACIDS RATIO MIX&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The combination of OA:LA:ALA suppresses the gene expressions of SREBP1c, FAS, and PNPLA3 to a greater extent than individual fatty acids."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OIL RED O STAINING&quot;" target="&quot;LIPID ACCUMULATION&quot;">
      <data key="d4">1.5</data>
      <data key="d5">"Used for assessing lipid accumulation in HepG2 cells following metabolic perturbations like varying glucose conditions or exogenous fatty acid treatments."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LOW GLUCOSE CONDITION&quot;" target="&quot;GLUCAGON, PYRUVATE CARBOXYLASE (PC)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Under low glucose conditions, glucagon stimulation increases the expression of PC but does not affect PNPLA3 mRNA levels."</data>
      <data key="d6">chunk-b89ac7c0c243e0d9dcdcf4ebf07b538f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HIPPOCAMPAL TRANSCRIPTOME CHANGES&quot;" target="&quot;MIRNOME CHANGES&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Changes in miRNA levels correlate with alterations observed in the hippocampal transcriptome due to PNS exposure."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NEURODEVELOPMENT PATHWAYS&quot;" target="&quot;INFLAMMATION PATHWAYS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Both neurodevelopment and inflammation pathways are affected by PNS exposure, highlighting a broad impact on biological processes."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BLOOD MRNA TRANSCRIPTOMICS CHANGES&quot;" target="&quot;EARLY LIFE TRAUMA EXPOSURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Exposure to early life trauma leads to significant changes in blood mRNA transcriptomics, similar to those seen following PNS exposure."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENE-PATHWAY INTERACTION&quot;" target="&quot;COMMON GENE OVERLAP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The interaction between genes and pathways modulated by environmental factors (PNS or early life trauma) results in a subset of overlapping genes with altered expression patterns."</data>
      <data key="d6">chunk-37088dc7c337929125b7fb31c9bf64cf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TGF-Β1&quot;" target="&quot;FOXO1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The IPA Software analysis identified FoxO1 and TGF-β1 as interacting within the same cluster, forming part of signaling pathways related to cytokines, glucocorticoid receptors, and TGF-β1."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;A2M&quot;" target="&quot;CHILDHOOD SEXUAL ABUSE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Genetic variations within A2M show significant GxE interactions when exposed to sexual abuse during early life, predicting adult depressive symptoms."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;ENVIRONMENTAL FACTOR (EMOTIONAL STRESS IN CHILDHOOD)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The interaction between FoxO1 gene variants and early emotional stress predicts depressive symptoms in adulthood, as observed in two independent clinical cohorts."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;AS1842856&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"AS1842856 inhibits FoxO1, countering the cortisol-induced upregulation of FoxO1 and reduction in neuronal proliferation.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"SGK-1 is a downstream target gene regulated by FoxO1, involved in mediating some glucocorticoid effects on brain function.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;HIPPOCAMPUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"FoxO1 is up-regulated in the hippocampus following exposure to stress or trauma.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOXO1&quot;" target="&quot;CHILDHOOD TRAUMA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Exposure to childhood trauma leads to upregulation of FoxO1 in blood samples, indicating a link between environmental factors and gene expression.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEPRESSION&quot;" target="&quot;BDI SCORES&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"BDI scores are a measure of the severity of depression and its symptomatology."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEPRESSION&quot;" target="&quot;BCL2&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Gene BCL2 is involved in cellular processes that may contribute to the development or progression of depressive symptoms through its interaction with environmental factors."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DEPRESSION&quot;" target="&quot;BCL9&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Gene BCL9, associated with Wnt signaling pathways, interacts with environmental stressors during childhood, contributing to depression in adulthood."</data>
      <data key="d6">chunk-01cd90d27130aab1a096ad616e05f182</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;FADS1/FADS2 HAPLOTYPE GENES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The FADS1/2 genes are studied through specific SNPs for their influence on fatty acid metabolism."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CORTISOL&quot;" target="&quot;NEUROGENESIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Cortisol negatively affects neurogenesis through the activation of FoxO1 signaling pathway.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;" target="&quot;STRESSED RATS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Elevated SGK-1 levels are observed in stressed rats, indicating a link with glucocorticoid effects on brain function.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SERUM GLUCOCORTICOID KINASE 1 (SGK-1)&quot;" target="&quot;DEPRESSED PATIENTS&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Blood samples from depressed patients show elevated SGK-1 levels, linking stress and brain function alterations to disease states.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HUMAN FETAL HIPPOCAMPAL PROGENITOR CELL LINE (HPC0A07/03C)&quot;" target="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This cell line is used to study the effects of cortisol on neuronal proliferation mediated by FoxO1.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PROGENITOR STEM CELLS&quot;" target="&quot;NEURONAL PROLIFERATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These cells play a role in neuronal proliferation which is negatively affected by cortisol through the FoxO1 pathway.")</data>
      <data key="d6">chunk-704d1bc6fcda99ac888bd36c954fdb98</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;LONG-TERM WEIGHT LOSS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The genomic variant rs4771122 is nominally significantly associated with long-term weight loss after bariatric surgery, indicating its influence on this outcome."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;PRE-SURGICAL BMI&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The association of the minor allele (G) in rs4771122 with pre-surgical weight and BMI suggests a genetic predisposition to higher pre-operative obesity levels."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS4771122&quot;" target="&quot;TRAJECTORY GROUP MEMBERSHIP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The rs4771122 variant is associated with trajectory group membership, indicating its role in determining different post-surgical weight management outcomes."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG-TERM WEIGHT LOSS&quot;" target="&quot;WEIGHT OBSERVATIONS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Measurements of body weight over time post-surgery are crucial for assessing the long-term effectiveness of bariatric surgery in achieving sustained weight loss."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG-TERM WEIGHT LOSS&quot;" target="&quot;NADIR WEIGHT LOSS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Achieving significant nadir weight loss early on can predict a more favorable long-term weight maintenance outcome after bariatric surgery."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG-TERM WEIGHT LOSS&quot;" target="&quot;TWO YEAR PERCENT WEIGHT LOSS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The level of two-year percent weight loss is an initial indicator of the likelihood and extent of sustained long-term weight loss post-surgery."</data>
      <data key="d6">chunk-b3d775642c43fa3524a531a3f6ec1e41</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCK GENE&quot;" target="&quot;GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Mutations within the GCK gene are the cause of genetic disorders such as GCK-MODY, with these specific variants being critical for diagnosis and understanding disease mechanism."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCK VARIANTS (PATHOGENIC OR LIKELY PATHOGENIC)&quot;" target="&quot;ACMG GUIDELINES FOR GENOMIC VARIANT INTERPRETATION&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"The ACMG guidelines are used to classify the pathogenicity of GCK gene mutations, impacting clinical management and genetic counseling for patients with GCK-MODY."&lt;SEP&gt;"The ACMG guidelines provide a framework for interpreting the pathogenicity of identified genomic variants in the context of GCK-MODY."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEQUENCING ANALYSIS OF GENETIC VARIANTS &quot;" target="&quot;CO-SEGREGATION WITH DIABETES PHENOTYPE TESTING &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"After identifying potential disease-causing variants through sequencing analysis, co-segregation testing is used to confirm their clinical significance in familial contexts."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PARENTAL/EXTENDED FAMILY DNA TESTING &quot;" target="&quot;GCK VARIANTS (VUS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Testing family members for VUS helps confirm co-segregation with disease phenotype, aiding in variant classification."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FASTING HYPERGLYCEMIA LEVELS &quot;" target="&quot;HBA1C TESTING &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Both tests assess blood sugar control but HbA1c provides a broader time frame assessment."</data>
      <data key="d6">chunk-658df2fc2f9361a65ff1d22464744763</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;TAG CONCENTRATION&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Adherence to the Mediterranean diet is inversely associated with triglyceride concentrations."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;HDL-C CONCENTRATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is directly associated with higher HDL cholesterol levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;APOB:APOA-1 RATIO&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Adherence to the Mediterranean diet lowers the apolipoprotein B to apolipoprotein A-I ratio, indicating reduced cardiovascular risk."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is inversely associated with hypertriacylglycerolaemia risk."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;PHYSICAL ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Individuals who are physically active tend to have higher adherence to the Mediterranean diet."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;SYSTOLIC BLOOD PRESSURE (SBP)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Adherence to the Mediterranean diet correlates with reduced systolic blood pressure levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;DIASTOLIC BLOOD PRESSURE (DBP)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is associated with lower diastolic blood pressure levels."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET ADHERENCE (MD)&quot;" target="&quot;INSULIN RESISTANCE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is associated with improved insulin sensitivity and reduced insulin resistance."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG CONCENTRATION&quot;" target="&quot;GCKR RS780094 SNP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The GCKR rs780094 single nucleotide polymorphism is positively associated with TAG levels in individuals carrying the AA genotype compared to GG genotypes."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG CONCENTRATION&quot;" target="&quot;RS1260326 SNP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The rs1260326 single nucleotide polymorphism similarly affects TAG concentrations as the GCKR rs780094 SNP, indicating a genetic impact on lipid metabolism."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HBA1C CONCENTRATION&quot;" target="&quot;MEDITERRADIAN DIET ADHERENCE (MD)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Higher adherence to the Mediterranean diet is associated with lower HbA1c concentrations."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTRIACYLGLYCEROLAEMIA&quot;" target="&quot;GCKR RS780094 SNP&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The GCKR rs780094 single nucleotide polymorphism is associated with an increased risk of hypertriacylglycerolaemia."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LDL-C CONCENTRATION&quot;" target="&quot;GCKR RS780094 SNP&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GCKR rs780094 single nucleotide polymorphism affects LDL cholesterol concentrations, similar to its impact on triglycerides and other lipid markers."</data>
      <data key="d6">chunk-c6fdc5ed25c4e17b8c421a952bb05450</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TAG LEVELS&quot;" target="&quot;GENOTYPE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The genotype of an individual influences TAG levels in blood, indicating a genetic effect on lipid metabolism.")</data>
      <data key="d6">chunk-e0d9c2e8ae2160bad4ae90ab6e8a12f6</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ABCC8 MUTATIONS&quot;" target="&quot;CONGENITAL HYPERINSULINISM (CHI)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Mutations in ABCC8 gene are associated with CHI symptoms and patient classification into diazoxide-responsive or unresponsive groups."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GLUD1 MUTATIONS&quot;" target="&quot;CONGENITAL HYPERINSULINISM (CHI)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mutations in GLUD1 contribute to the pathogenesis of CHI among patients with hypoglycemia and hyperinsulinemia."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONGENITAL HYPERINSULINISM (CHI)&quot;" target="&quot;18F-DOPA PET/CT SCAN&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This scan is used for diagnosing and understanding the focal lesions causing CHI, particularly when surgery confirms diffuse pancreatic disease."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPOGLYCEMIA&quot;" target="&quot;INSULIN HORMONE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Abnormally high levels of insulin hormone can lead to hypoglycemia in CHI patients."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPOGLYCEMIA&quot;" target="&quot;LOW-PROTEIN DIET (1.5 G/KG/DAY)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"This dietary pattern aims to manage hypoglycaemia by restricting protein intake and was successful in three patients without recurrence of symptoms."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE THERAPY&quot;" target="&quot;HYPOGLYCEMIA MANAGEMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Effective treatment strategy for many CHI patients, reducing the frequency of hypoglycemic episodes and improving overall health outcomes."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KATP CHANNEL GENE MUTATIONS&quot;" target="&quot;GLUD1 GENE MUTATIONS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Mutations in both KATP channel genes (ABCC8 and KCNJ11) and GLUD1 gene are identified among CHI patients, indicating diverse genetic factors contributing to the disease."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE-UNRESPONSIVE GROUP&quot;" target="&quot;DIFFUSE PANCREATIC DISEASE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Patients who do not respond to diazoxide treatment often show diffuse rather than focal pancreatic lesions upon surgical examination."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;EPILEPSY&quot;" target="&quot;HYPOGLYCEMIC BRAIN INJURY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Persistent hypoglycemia due to CHI can lead to epilepsy and brain injury, particularly in patients who do not receive timely therapeutic intervention."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FREQUENT FEEDINGS AND DIETARY MANAGEMENT&quot;" target="&quot;NEONATAL PERIOD AND INFANCY PERIOD (1-12 MONTHS)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Frequent feeding is often initiated early after birth or during infancy to manage blood glucose levels in CHI patients, especially for those with hypoglycemia detected shortly after birth."</data>
      <data key="d6">chunk-f921f48a406901d82ec2e32af99485bf</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;HYPERTRICHOSIS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Diazoxide treatment for hypoglycemia can lead to hypertrichosis, a side effect observed in 55% of treated patients."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;MALABSORPTION SYMPTOMS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A few cases experienced malabsorption symptoms after stopping diazoxide therapy, affecting their ability to maintain stable blood glucose levels post-treatment."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;NAUSEA AND VOMITING&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Patients treated with diazoxide often experience nausea and vomiting as side effects, impacting their quality of life."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;SEVERE GASTROINTESTINAL UPSET&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A more severe form of gastrointestinal disturbance that can be caused by diazoxide treatment and necessitates nasogastric feeding."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIAZOXIDE TREATMENT&quot;" target="&quot;THROMBOCYTOPENIC PURPURA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"One patient had to stop diazoxide due to thrombocytopenic purpura, a side effect which is serious and required discontinuation of the treatment."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PANCREATECTOMY&quot;" target="&quot;DIABETES MELLITUS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Following pancreatectomy surgery for managing hypoglycaemia, some patients developed diabetes mellitus requiring insulin treatment."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIABETES MELLITUS&quot;" target="&quot;SUBTOTAL PANCREATECTOMY&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Pancreatic surgery can lead to diabetes mellitus in patients, requiring them to use insulin therapy post-surgery."</data>
      <data key="d6">chunk-2b81371954b99facae9a0056e70aa7bd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC AND BHB LEVELS&quot;" target="&quot;INSULIN SECRETION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Higher insulin secretion is associated with lower AcAc and BHB levels, suggesting a role of insulin in regulating ketone body metabolism.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAC AND BHB LEVELS&quot;" target="&quot;RISK SNPS FOR TYPE 2 DIABETES OR HYPERGLYCEMIA&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Certain genetic variants are linked to elevated KB levels, indicating a potential molecular basis for their role in diabetes risk.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TWO-HOUR POST-PRANDIAL GLUCOSE (2HPG)&quot;" target="&quot;IMPAIRED GLUCOSE TOLERANCE (IGT)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Elevated 2hPG levels indicate IGT, a condition linked to an increased risk of developing type 2 diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;METSIM STUDY&quot;" target="&quot;HYPERGLYCEMIA AND INCIDENT DIABETES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The METSIM study tracks participants over time to identify factors that increase the risk of hyperglycemia and incident diabetes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLISM&quot;" target="&quot;NUTRIENT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Folate metabolism is part of broader nutrient-related physiological processes.")</data>
      <data key="d6">chunk-f2e122f964bade37f487049bd69a3f9f</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FADS1&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The FADS1 gene shows associations with AcAc or BHB levels, indicating an influence on ketone body metabolism."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2&quot;" target="&quot;HEIGHT&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"High Mobility Group AT-Hook 2 is a key gene for height variation in individuals."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FFAS (FREE FATTY ACIDS)&quot;" target="&quot;CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The expression of CPT1A gene correlates positively with fasting FFAs and negatively with insulin sensitivity, linking fatty acid oxidation to metabolic health."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CPT1A (CARNITINE PALMITOYLTRANSFERASE 1A)&quot;" target="&quot;FATTY ACIDS OXIDATION (FFA OXIDATION)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The CPT1A gene regulates the entry of long-chain acyl-CoAs into mitochondria for fatty acid oxidation."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The HMGCS2 gene plays a role in ketogenesis by catalyzing the production of 3-hydroxy-3-methylglutaryl-CoA from acetyl-CoA."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGCS2 (3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE 2, MITOCHONDRIAL)&quot;" target="&quot;KETOGENESIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The HMGCS2 gene plays a critical role in ketogenesis by catalyzing the formation of 3-hydroxy-3-methylglutaryl-CoA from acetyl-CoA."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"ACAT1 is involved in the breakdown of ketone bodies, specifically converting acetoacetyl-CoA into two molecules of acetyl-CoA."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACAT1 (ACETYL-COA ACETYLTRANSFERASE 1)&quot;" target="&quot;KETOLYSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ACAT1 gene encodes an enzyme that catalyzes the final step in ketone body breakdown, converting acetoacetyl-CoA into two molecules of acetyl-CoA."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BDH1 (BHB DEHYDROGENASE, TYPE 1)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The BDH1 gene is involved in BHB metabolism and regulates its levels through enzymatic activity."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OXCT1 (3-OXOACID COA TRANSFERASE 1)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"OXCT1 catalyzes the conversion of acetoacetyl-CoA to acetyl-CoA, an essential step in ketolysis and regulation of BHB levels."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACSS2 (ACYL-COA SYNTHETASE SHORT-CHAIN FAMILY MEMBER 2)&quot;" target="&quot;KBS (KETONE BODIES)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The ACSS2 gene product activates fatty acids, influencing beta-oxidation and metabolic processes like insulin sensitivity."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KBS (KETONE BODIES)&quot;" target="&quot;KETOGENESIS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The synthesis of ketone bodies from acetyl-CoA during periods of fasting or low carbohydrate intake is a central component of ketogenesis."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KBS (KETONE BODIES)&quot;" target="&quot;KETOLYSIS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Ketolysis involves the breakdown of ketone bodies back into acetyl-CoA and other metabolites, regulating their levels in the body."</data>
      <data key="d6">chunk-bc2193bd869a06007022e1aa75877336</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1 GENE VARIANT&quot;" target="&quot;CHOLESTEROL METABOLISM&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The APOC1 locus variant influences cholesterol metabolism by affecting serum CRP and lipid profiles.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF1A GENE VARIANT&quot;" target="&quot;GLYCEMIC PHENOTYPES&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"SNPs in the HNF1A gene affect fasting glucose levels, illustrating genetic influence on metabolic conditions such as diabetes.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL6R GENE VARIANT&quot;" target="&quot;INFLAMMATION REGULATION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variants near IL6R are linked to inflammatory responses measured by CRP and may modulate cardiovascular risks.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;MC4R GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Variants near MC4R contribute to CRP variability, underscoring the genetic underpinnings of inflammation in cardiometabolic disorders.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;IL6R&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Effects on CRP levels remain significant after adjustments for BMI, cholesterol, or HbA1C.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;MC4R&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"SNPs near MC4R do not significantly affect CRP levels in the WGHS study.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;PLTP&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"SNPs near PLTP are not associated with CRP levels after correction for multiple testing.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP LEVELS&quot;" target="&quot;LXR/RXR ACTIVATION PATHWAY&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Significantly enriched pathway involved in the influence of genetic loci on CRP and cardiometabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2867125 SNP&quot;" target="&quot;TMEM18 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Significant association of this SNP near TMEM18 suggests a role for this genomic region in CRP regulation and cardiometabolic conditions.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PLTP GENE&quot;" target="&quot;LDL-CHOLESTEROL METABOLISM&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variations around PLTP affect LDL-cholesterol levels, highlighting complex interactions between genes and lipid metabolism.")</data>
      <data key="d6">chunk-ad609cb10e900d42a6901eea1591d8ba</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1F10&quot;" target="&quot;GWAS NOT REPORTED&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"IL1F10 was not previously reported in GWAS for the specific phenotype, indicating novel associations.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PPP1R3B&quot;" target="&quot;CRP AND METABOLIC PHENOTYPES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"PPP1R3B gene shows pleiotropic effects on CRP levels and multiple cardiometabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF4A&quot;" target="&quot;T2D RISK&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"HNF4A influences risk of T2D and CRP levels, showing biological pleiotropy.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PABPC4&quot;" target="&quot;CRP&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Genetic locus near PABPC4 is associated with changes in CRP levels, influenced by lipid mediators.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL7B&quot;" target="&quot;HDL CHOLESTEROL&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Association between BCL7B and HDL cholesterol decreases considerably after adjustment for CRP.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HNF1A&quot;" target="&quot;CAD RISK&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"SNPs in HNF1A are associated with an increased risk of coronary artery disease (CAD).")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOC1&quot;" target="&quot;T2D RISK&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Genetic variants near APOC1 influence the risk of type 2 diabetes and serum CRP levels.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No consistent associations were found between variants of CRP gene and ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHOLESTEROL LEVELS&quot;" target="&quot;CRP ASSOCIATIONS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Levels of cholesterol influence genetic associations with CRP and cardiometabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HBA1C&quot;" target="&quot;CRP ASSOCIATIONS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Adjustment for HbA1C decreases the association between certain SNPs and metabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FXR/RXR ACTIVATION PATHWAY&quot;" target="&quot;GENETIC PLEIOTROPY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Pathway enriched by genes showing pleiotropic effects on CRP levels and metabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRP ASSOCIATIONS&quot;" target="&quot;HEPATIC CHOLESTASIS PATHWAY&quot;">
      <data key="d4">16.0</data>
      <data key="d5">"Pathway significantly enriched by genetic loci influencing CRP and cardiometabolic traits.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC EFFECTS&quot;" target="&quot;MODY SIGNALING&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Pathway influenced by pleiotropic genes affecting CRP levels and metabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ACUTE PHASE RESPONSE SIGNALING PATHWAY&quot;" target="&quot;GENETIC INFLUENCES&quot;">
      <data key="d4">18.0</data>
      <data key="d5">"Pathway involved in the effects of pleiotropic genes on CRP levels and metabolic phenotypes.")</data>
      <data key="d6">chunk-372184452f1f9156514992455057f843</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The CC genotype of miR-34b/c rs4938723 was associated with a decreased risk of intracranial aneurysm compared to the TT genotype."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MIR-34B/C RS4938723&quot;" target="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The genotype frequencies of miR-34b/c rs4938723 in the control group meet Hardy-Weinberg equilibrium requirements."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;IA (INTRACRANIAL ANEURYSM)&quot;">
      <data key="d4">-2.0</data>
      <data key="d5">"No association between TP53 Arg72Pro and IA risk was observed in genotypic or allelic analysis."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TP53 ARG72PRO&quot;" target="&quot;GENOTYPE FREQUENCY DISTRIBUTION&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"The TP53 Arg72Pro genotypes show a distribution pattern that aligns with genetic expectations for this polymorphism."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HARDY-WEINBERG EQUILIBRIUM&quot;" target="&quot;GENOTYPE DISTRIBUTION OF SNPS&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Used to verify random mating and genetic equilibrium in SNP distribution among participants."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OR (ODDS RATIO)&quot;" target="&quot;95% CI (CONFIDENCE INTERVAL)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The Odds Ratio is reported alongside the 95% confidence interval to provide an estimate of the precision of the association between genotypes and IA risk."</data>
      <data key="d6">chunk-055177812e320344d131432b292111b0</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COL4A1&quot;" target="&quot;WEIGHT Z-SCORE CHANGE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"An intronic variant in COL4A1 on chromosome 13 is associated with changes in weight z-score."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TSEN34&quot;" target="&quot;LINEAR GROWTH (HEIGHT CHANGE)&quot;">
      <data key="d4">7.2</data>
      <data key="d5">"A gene on chromosome 19 where a variant in the 5′UTR region significantly influences linear growth, measured as height change."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MTNR1B&quot;" target="&quot;FASTING GLUCOSE&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"An intronic SNP in MTNR1B on chromosome 11 is strongly linked to fasting glucose levels."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOA5-ZNF259 REGION&quot;" target="&quot;TRIGLYCERIDES&quot;">
      <data key="d4">6.7</data>
      <data key="d5">"Variants within this genomic area significantly affect triglyceride levels."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCSK2&quot;" target="&quot;TOTAL ANTIOXIDANTS&quot;">
      <data key="d4">8.3</data>
      <data key="d5">"An intronic SNP in PCSK2 on chromosome 20 is associated with total antioxidants in the body."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GCH1&quot;" target="&quot;24-H URINARY DOPAMINE:CREATININE RATIO&quot;">
      <data key="d4">6.3</data>
      <data key="d5">"An intronic SNP in GCH1 on chromosome 14 influences the ratio of 24-hour urinary dopamine to creatinine."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;XPA/FOXE1 (TTF-2)&quot;" target="&quot;SERUM TSH&quot;">
      <data key="d4">8.6</data>
      <data key="d5">"A group of SNPs in the flanking region of XPA/FOXE1 on chromosome 9 are highly associated with serum thyroid-stimulating hormone levels."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARHGAP11A INTRONIC VARIANT&quot;" target="&quot;SLEEP DURATION&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This variant is associated with sleep duration, indicating a genetic influence on this physiological process."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C21ORF34 SNP&quot;" target="&quot;RESPIRATORY QUOTIENT (RQ)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The SNP in C21orf34 was detected for respiratory quotient during sleep, suggesting an impact on metabolic efficiency during rest."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RPL7P3 VARIANT&quot;" target="&quot;LIGHT ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This variant is associated with accelerometer-measured light activity, implying a genetic effect on physical behavior patterns."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CTCFL VARIANT&quot;" target="&quot;SEDENTARY-LIGHT ACTIVITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The variant in the 3′UTR of CTCFL is linked to sedentary-light activity during sleep, indicating an influence on daily movement patterns through genetic variation."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATK GENE &quot;" target="&quot;TOTAL ENERGY EXPENDITURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Highly significant variants for total energy expenditure were identified in the MATK gene, suggesting a strong genetic association with overall metabolic rate."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MATK GENE &quot;" target="&quot;TOTAL ENERGY EXPENDITURE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variants in MATK are significantly associated with total energy expenditure, highlighting its role in overall metabolic pathways."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHRNA3 GENE &quot;" target="&quot;SLEEPING ENERGY EXPENDITURE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic associations detected for CHRNA3 linked to sleeping energy expenditure, indicating this gene's role in basal metabolism during sleep."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CHRNA3 GENE &quot;" target="&quot;SLEEPING ENERGY EXPENDITURE &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The CHRNA3 gene is linked to sleeping energy expenditure, indicating a genetic impact on basal metabolism during sleep."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEP DURATION &quot;" target="&quot;ARHGAP11A INTRONIC VARIANT &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The intronic variant in ARHGAP11A is associated with sleep duration, indicating a direct genetic influence on this physiological process."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPIRATORY QUOTIENT (RQ)&quot;" target="&quot;C21ORF34 SNP &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The SNP in C21orf34 influences the respiratory quotient during sleep, suggesting a significant impact of genetic variation on metabolic efficiency."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LIGHT ACTIVITY &quot;" target="&quot;RPL7P3 VARIANT &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genetic variation in RPL7P3 is associated with accelerometer-measured light activity, indicating its role in physical behavior patterns."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEDENTARY-LIGHT ACTIVITY &quot;" target="&quot;CTCFL VARIANT &quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CTCFL variant affects sedentary-light activity during sleep, reflecting the genetic influence on low-intensity movements."</data>
      <data key="d6">chunk-46227b557f62c59155b1b9cef71d0d17</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RNASE1, ASS1P11&quot;" target="&quot;URINARY NITROGEN EXCRETION, CREATININE EXCRETION&quot;">
      <data key="d4">7.5</data>
      <data key="d5">"Variants near RNASE1 and ASS1P11 genes are linked to urinary nitrogen excretion and creatinine excretion, respectively."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KLKB1, MPRIP&quot;" target="&quot;SERUM FREE IGF-1, SERUM IGFBP-3&quot;">
      <data key="d4">7.9</data>
      <data key="d5">"Variants within KLKB1 and MPRIP genes are associated with serum free IGF-1 and IGFBP-3 levels, respectively."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DARC, GREB1, DFNB31, CCR3, RASGEF1A, ABO&quot;" target="&quot;MCP-1, IL-6&quot;">
      <data key="d4">9.8</data>
      <data key="d5">"Coding variants in DARC, GREB1, and DFNB31; as well as an intronic SNP in CCR3 and RASGEF1A are associated with MCP-1 levels. Additionally, a variant within the ABO gene is strongly linked to IL-6."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AD LIBITUM ENERGY INTAKE AT DINNER, SLEEP DURATION, RESPIRATORY QUOTIENT (RQ) DURING SLEEP&quot;" target="&quot;TMEM229B, ARHGAP11A, C21ORF34&quot;">
      <data key="d4">7.8</data>
      <data key="d5">"An intronic SNP in TMEM229B is associated with energy intake at dinner. An intronic SNP in ARHGAP11A affects sleep duration and an SNP near C21orf34 influences respiratory quotient during sleep."</data>
      <data key="d6">chunk-6794be47bcde46ad4a07e0cc372ea3d2</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS3833080: P.GLY369_ASP370DEL9&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The genomic variant rs3833080 affects the amino acid sequence of the APOBR protein."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS180743: P.PRO428ALA&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"A non-synonymous SNP in APOBR that alters an amino acid, potentially affecting protein function."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;EXTREMELY OBESE CHILDREN AND ADOLESCENTS&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The study population of extremely obese children and adolescents were screened for variants in the APOBR gene."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;GENETIC VARIANT RISK ALLELES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Risk alleles within APOBR are associated with increased odds for obesity in individuals."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS151233, RS149271, RS180744, RS151174, RS40831, RS61738759, RS200751685, RS40833, AND RS142786317&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These are additional variants in APOBR that do not affect amino acid sequences but may influence gene expression or regulation."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;APOBR&quot;" target="&quot;RS180743 G-ALLELE AND RS3833080 DELETION ALLELE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These genetic variants were associated with obesity in case-control studies of extremely obese children and adolescents."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MUTATION TASTER, SIFT, POLYPHEN2, PANTHER, SNAP, PMUT, ENSEMBL, PROVEAN&quot;" target="&quot;GENOMIC VARIANT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These bioinformatics tools predict functional effects of genetic variations identified in the study."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;C.1036_1062DEL27&quot;" target="&quot;APOBR TRANSCRIPT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"A common deletion variant affecting a transcript, with no predicted function on protein structure."</data>
      <data key="d6">chunk-7ca64f92964b051cfb1c43f967f243a5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS142786317: C.*118_*119DELCA&quot;" target="&quot;SULT1A1&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The SULT1A1 gene contains the genomic variant rs142786317, which affects transcription factor binding sites and splicing enhancer/silencer elements."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A1&quot;" target="&quot;MET1VAL&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"This non-synonymous variant in SULT1A1 was not reproducibly identified across multiple samples, suggesting it may be a false positive or an artifact of sequencing."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A1&quot;" target="&quot;P.PRO200 = (RS3176926)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This synonymous variant in SULT1A1 is predicted to alter the binding domains for splicing regulators and transcription factor AML-1, potentially impacting gene expression."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.PRO19LEU (RS10797300)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Detected in SULT1A2, this variant shows potential functional modification based on prediction tools, indicating a possible impact on protein function."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.SER44ASN (RS145008170)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This conservative amino acid change in SULT1A2 near the binding pocket of xenobiotics is predicted to have a 'non-neutral' or 'deleterious' impact on function."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.TYR62PHE (RS4987024)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This non-conservative missense variant in SULT1A2 is predicted by various tools to have a higher probability of functional changes, though results are mixed."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.ALA164VAL (RS142241142)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The non-conservative exchange in SULT1A2 away from the binding pocket is predicted to have less significant functional impact compared to other variants."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SULT1A2&quot;" target="&quot;P.ASN235THR (RS1059491)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"This conservative SNP in SULT1A2 is predicted by PolyPhen2, SNAP and SIFT as likely to be functionally relevant, indicating probable alterations to the protein."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM&quot;" target="&quot;C.3536C&gt;G &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Detected in TUFM's 3' untranslated region, this variant is predicted to alter splicing regulator or transcription factor binding sites, impacting gene regulation."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM&quot;" target="&quot;RS7187776: C.-55T&gt;C, RS4788099: C.500−19T/C, RS8061877: C.248−18G&gt;A, AND RS61737565: C.922+29C&gt;G&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"A series of intronic variants in TUFM are predicted to lead to changes in transcription factor binding sites or splicing regulatory elements, potentially affecting gene expression."</data>
      <data key="d6">chunk-607feda7df4db8151b99560074c91eea</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TUFM&quot;" target="&quot;TRANSCRIPTION FACTOR BINDING SITE&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Disruption of transcription factor binding sites in TUFM may alter gene expression regulation."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS61737565: C.922+29C&gt;G&quot;" target="&quot;SRY, HFH 2, HMG-IY&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The rs61737565 variant affects the binding sites for transcription factors such as SRY, HFH 2, and HMG-IY."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SRY, HFH 2, HMG-IY&quot;" target="&quot;RS8061877&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Disruption of transcription factor binding sites by rs8061877 affects the interaction with proteins like SRY, HFH 2, and HMG-IY."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICE SITES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The g.28854194C/G variant affects splice enhancer and silencer sites impacting mRNA processing."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICE ENHANCER BINDING SITE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The g.28854194C/G variant alters splice enhancer binding sites affecting splicing patterns."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;G.28854194C/G&quot;" target="&quot;SPLICING SILENCER SITE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The g.28854194C/G variant changes splicing silencer sites impacting mRNA stability and translation."</data>
      <data key="d6">chunk-fde6653b9d9013ed054505cfe4cd1455</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANT&quot;" target="&quot;EPA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"No significant genotype-by-diet interactions were found for EPA, indicating that EPA levels are less influenced by genetic variants in the FADS1/2 gene cluster."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;IL1B&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The genomic variant in the IL1B gene is suggested to be associated with increased risk of ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER&quot;" target="&quot;PTGS1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Genomic variants in the PTGS1 gene are also suggested to influence ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL1B RS7596684&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This genomic variant is suggested to have an association with the risk of developing ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PTGS1 RS2282169&quot;" target="&quot;OVARIAN CANCER RISK&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"This genomic variant is suggested to be associated with the risk of developing ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;ALOX15&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No consistent associations were observed between variants of ALOX15 gene and the risk of developing ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;CCL2&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Variants in the CCL2 gene showed no significant association with ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;IL18&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"Results for the IL18 gene did not show significant associations with ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;OVARIAN CANCER RISK&quot;" target="&quot;IL6&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"No strong association was observed between variants in IL6 gene and ovarian cancer risk."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HISTOLOGICAL SUBTYPE OF OVARIAN CANCER&quot;" target="&quot;IL1B, PTGS1&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"There was no significant heterogeneity in the association between these genes and histological subtypes of ovarian cancer."</data>
      <data key="d6">chunk-b6ea16f7f7eb8bc6f36f2be03fe62403</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 RS1051266&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"There is less evidence for an association between SLC19A1 SNP and childhood ALL risk compared to NOS3 rs3918186."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 GENE&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The NOS3 gene is part of the folate metabolic pathway, and genetic variations within this gene are associated with childhood ALL risk."&lt;SEP&gt;"The NOS3 gene, as part of the folate metabolic pathway, is associated with increased risk for childhood ALL through SNP rs3918186."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 GENE&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Genetic variations in the NOS3 gene significantly increase the risk of developing childhood ALL."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 GENE&quot;" target="&quot;FOLATE METABOLIC PATHWAY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The SLC19A1 gene, part of the folate metabolic pathway, shows less evidence in data for association with childhood ALL risk compared to NOS3 rs3918186."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 GENE&quot;" target="&quot;CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"While associated with increased risk, evidence for SLC19A1 in contributing to childhood ALL is less compelling compared to NOS3."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLIC PATHWAY&quot;" target="&quot;MTHFD2 GENE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The MTHFD2 gene is part of the folate metabolic pathway and has SNPs associated with childhood ALL risk in initial screening."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLIC PATHWAY&quot;" target="&quot;BHMT2 GENE&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Like MTHFD2, BHMT2 is a gene within the folate metabolic pathway showing SNP associations but not proceeding to final analysis due to lower posterior probability."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FOLATE METABOLIC PATHWAY&quot;" target="&quot;POSTERIOR PROBABILITY OF INCLUSION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The posterior probability measure helps determine which SNPs from the folate metabolic pathway genes should proceed for further analysis based on initial screening data."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOS3 RS3918186 RISK FACTOR&quot;" target="&quot;BAYES FACTORS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The Bayes factor of 7.38 for NOS3 rs3918186 indicates strong evidence that this SNP is associated with childhood ALL risk."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLC19A1 RS1051266 RISK FACTOR&quot;" target="&quot;BAYES FACTORS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Bayes factor of SLC19A1 rs1051266 indicates less evidence compared to NOS3 rs3918186, showing a weaker association with childhood ALL risk."</data>
      <data key="d6">chunk-0ce38a2d49e01ec790464306e01de9b4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEALTHY EATING DIET GROUP AND MEDITERRANEAN DIET GROUP DIETARY PATTERNS&quot;" target="&quot;LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Dietary patterns significantly influenced long chain n-3 fatty acid concentrations in serum after dietary interventions."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LONG CHAIN N-3 FATTY ACIDS INTAKE AND CONCENTRATION&quot;" target="&quot;LINEAR REGRESSION ANALYSIS FOR FATTY ACID INTAKE AND BASELINE SERUM AA CONCENTRATION&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Fatty acid intake was a significant predictor of baseline serum long chain n-3 fatty acid concentration."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ARACHIDONIC ACID (AA)&quot;" target="&quot;BASELINE SERUM AA CONCENTRATION MEASUREMENT&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The baseline measurement of arachidonic acid concentration is critical for understanding its influence on health outcomes."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOTYPE DISTRIBUTION OF SNPS (SINGLE NUCLEOTIDE POLYMORPHISMS)&quot;" target="&quot;BMI DIFFERENCE BETWEEN MINOR ALLELE CARRIERS AND NON-CARRIERS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Significant BMI difference correlates with the presence of minor alleles in genotypes."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BASELINE AA CONCENTRATION MEASUREMENT IN SERUM AND COLON&quot;" target="&quot;FATTY ACID METABOLISM PATHWAY&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Baseline arachidonic acid levels serve as an important marker for metabolic pathways."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DIETARY INTAKE OF LONG CHAIN N-3 FATTY ACIDS AND BASELINE CONCENTRATION PREDICTION&quot;" target="&quot;LONG CHAIN N-3 PUFA DIETARY INTAKE INCREASE IN HEALTHY EATING GROUP&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Predictive analysis aligns with observed dietary intervention outcomes for long chain omega-3 intake."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AS A COVARIATE IN GENOTYPE ANALYSIS&quot;" target="&quot;SERUM AND COLON FATTY ACID CONCENTRÇÕES BY GENOTYPE GROUP&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Age retained as covariate for more accurate fatty acid concentration analysis based on genotype."</data>
      <data key="d6">chunk-8b9890cf10c4a751a1d0ec7e9843002d</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;POLYUNSATURATED FAT: SATURATED FAT RATIO&quot;" target="&quot;MEDITERRANEAN DIET&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The Mediterranean group had a slight increase in the polyunsaturated fat:saturated fat ratio, but this change was not statistically significant."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;COLON AA CONCENTRATIONS&quot;" target="&quot;HEALTHY EATING DIET&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"For individuals without minor alleles in FADS1/2 gene cluster, colon AA concentrations increased significantly under the Healthy Eating diet compared to the Mediterranean diet."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;MUFA&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The Mediterranean diet significantly increased MUFA levels, indicating its impact on fatty acid metabolism."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;N-3 PUFA&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both long-chain n-3 PUFA and MUFA significantly increased in the Mediterranean arm only, showing a dietary pattern's effect on omega-3 polyunsaturated fatty acids."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MEDITERRANEAN DIET&quot;" target="&quot;SERUM 18:2 N-6&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"The Mediterranean dietary pattern significantly decreased serum levels of 18:2 n-6."</data>
      <data key="d6">chunk-e1b4f4dac52e806f19c580640a50c729</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SNORING&quot;" target="&quot;PULSE RATE&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"An increase in pulse rate is observed to be causally influenced by snoring according to the generalized summary-data-based MR (GSMR) analysis.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEP APNOEA&quot;" target="&quot;EXCESSIVE DAYTIME SLEEPINESS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals suffering from sleep apnea commonly experience excessive daytime sleepiness as a result of poor quality nighttime sleep.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GWAS (GENOME-WIDE ASSOCIATION STUDY)&quot;" target="&quot;GENOMIC VARIANTS &quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These variants were identified through GWAS as having a significant impact on the genetic predisposition to snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANTS &quot;" target="&quot;SNP HERITABILITY (H2SNP)&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The heritability measure captures variance explained by genomic risk loci associated with snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOMIC VARIANTS &quot;" target="&quot;TOP 15 RISK LOCI &quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Specific genomic variants within these top risk loci are significant in influencing the genetic predisposition to snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;SCHIZOPHRENIA &quot;">
      <data key="d4">10.0</data>
      <data key="d5">"The negative genetic correlation indicates distinct underlying genetic factors between schizophrenia and the tendency to snore."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;AVERAGE SPO2 &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Despite being a measure of oxygen saturation, average SpO2 does not show a significant genetic correlation with habitual snoring compared to minimum SpO2 and Perc90."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;PERC90 (PERCENT OF SLEEP WITH OXYHEMOGLOBIN SATURATION UNDER 90%) &quot;">
      <data key="d4">6.0</data>
      <data key="d5">"This measure is significantly genetically correlated with habitual snoring, especially after adjusting for BMI."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;CORONARY ARTERY DISEASE &quot;">
      <data key="d4">7.0</data>
      <data key="d5">"A disease that shows a moderate genetic correlation with habitual snoring, indicating overlapping risk factors."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENETIC CORRELATIONS &quot;" target="&quot;FLUID INTELLIGENCE SCORE &quot;">
      <data key="d4">10.0</data>
      <data key="d5">"A negative genetic correlation suggests that the genetic factors influencing fluid intelligence and habitual snoring are distinct."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SELF-REPORTED SLEEP APNOEA &quot;" target="&quot;OXYGEN HEMOGLOBIN SATURATION (SPO2)&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"These measures, particularly minimum and percent under 90% SpO2, correlate genetically with sleep apnea and thereby with habitual snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HEART ATTACK &quot;" target="&quot;BMI ADJUSTMENT ANALYSIS &quot;">
      <data key="d4">8.0</data>
      <data key="d5">"After controlling for BMI in the GWAS analysis, heart attack is no longer genetically associated with snoring."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HYPERTENSION &quot;" target="&quot;BMI ADJUSTMENT ANALYSIS &quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Similar to heart attack, hypertension shows a loss of genetic correlation with habitual snoring upon adjustment for BMI."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;NOCTURNAL HYPOXIA MEASURES (MINIMUM SPO2, AVERAGE SPO2 AND PERC90)&quot;" target="&quot;GENETIC CORRELATION WITH SNORING&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"These measures correlate genetically with snoring after adjustment for BMI, indicating a strong genetic influence on the relationship between nocturnal hypoxia and snoring.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DLEU7 GENE ON CHROMOSOME 13&quot;" target="&quot;MSRB3 GENE ON CHROMOSOME 12&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both genes are identified in association studies for snoring, highlighting their potential role in the genetic architecture of this condition.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BCL11B GENE&quot;" target="&quot;ROBO2 GENE&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"These two genes share some associations with snoring and musculoskeletal traits, suggesting common underlying biological pathways or mechanisms.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SMG6 GENE&quot;" target="&quot;ANAPC4 GENE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"These genes are both linked to musculoskeletal traits such as height and heel bone mineral density, suggesting interconnected pathways related to body morphology and snoring.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;LMO4 GENE&quot;" target="&quot;RNA5SP471 GENE&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Both genes have been associated with sleep disorders like insomnia and narcolepsy, indicating a shared role in the regulation of sleep patterns.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MAJOR CORONARY HEART DISEASE&quot;" target="&quot;HEART ATTACK&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"The risk of heart attack is strongly linked with coronary heart disease, which can result from atherosclerosis in the coronary arteries.")</data>
      <data key="d6">chunk-13862d7ab74f5d4fa3f2261984d15d64</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS200391180&quot;" target="&quot;RECENT SNORING&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"This genomic variant identified in females significantly influences the likelihood of recent snoring."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SEX-STRATIFIED GWAS ANALYSIS&quot;" target="&quot;PGS (POLYGENIC SCORE)&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"The polygenic score derived from GWAS results can predict recent snoring based on genetic risk factors."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PGS (POLYGENIC SCORE)&quot;" target="&quot;TOP HITS IN GWAS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The top hits from GWAS analyses contribute significantly to the polygenic score which predicts recent snoring risk."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT SNORING&quot;" target="&quot;PROBABLE OSA&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"Severe cases of recent snoring may indicate probable obstructive sleep apnea, a serious health condition requiring medical attention."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT SNORING&quot;" target="&quot;SNORING SEVERITY&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The severity of snoring increases with the frequency and intensity of recent snoring episodes."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RECENT SNORING&quot;" target="&quot;CROSS-SEX GENETIC CORRELATION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"High genetic correlation between sexes indicates similar genetic predispositions towards snoring in both males and females."</data>
      <data key="d6">chunk-a34b927ed42ff0917960122b4d203f83</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SLEEP APNOEA &quot;" target="&quot;SNORING &quot;">
      <data key="d4">5.0</data>
      <data key="d5">"There is a significant genetic relationship between habitual snoring and self-reported sleep apnea, indicating overlapping risk factors."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ALCOHOL CONSUMPTION FREQUENCY &quot;" target="&quot;SMOKING FREQUENCY &quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Both lifestyle habits are positively correlated with the prevalence of snoring in their respective genders."</data>
      <data key="d6">chunk-9977706363cc368b3be503d07ed3ef62</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VITAMIN D STATUS&quot;" target="&quot;BMI PRE-PREGNANCY (KG/M2)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Pre-pregnancy BMI can influence maternal vitamin D status due to lifestyle factors including diet and exercise."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VDBP POLYMORPHISMS&quot;" target="&quot;NEONATAL VITAMIN D STATUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Genomic variants in VDBP can influence neonatal vitamin D status at birth."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMI PRE-PREGNANCY (KG/M2)&quot;" target="&quot;UVB EXPOSURE&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Pre-pregnancy BMI and UVB exposure both influence maternal vitamin D status during pregnancy."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;UVB EXPOSURE&quot;" target="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Exposure to UVB light is a critical environmental factor affecting the production of vitamin D in pregnant women."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GESTATION PERIOD (WEEKS)&quot;" target="&quot;MATERNAL HEIGHT (CM)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Maternal height may interact with the duration of gestation affecting prenatal care and neonatal outcomes."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC GENOTYPE (RS2298850)&quot;" target="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The CC genotype at rs2298850 is associated with higher maternal 25(OH)D concentrations, indicating a positive impact on vitamin D status."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CC GENOTYPE (RS4588)&quot;" target="&quot;MATERNAL VITAMIN D STATUS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The CC genotype at rs4588 also shows association with elevated maternal 25(OH)D during delivery, impacting neonatal health."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BIRTH BIOCHEMICAL DATA&quot;" target="&quot;MATERNAL HEIGHT (CM)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Maternal height may correlate with biochemical data taken at birth, impacting prenatal care and neonatal health outcomes."</data>
      <data key="d6">chunk-617cab4d8c10048a1335bf565693bf97</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;VEGF SERUM LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs3025020 genotype is positively correlated with higher serum VEGF levels, indicating its role in angiogenesis and possibly exacerbating PCOS-related metabolic disturbances."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;INSULIN RESISTANCE INDEX HOMA-IR&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs3025020 genotype is positively correlated with increased insulin resistance, suggesting its role in the pathogenesis of metabolic disturbances associated with PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;HIGH SENSITIVITY C-REACTIVE PROTEIN (HS-CRP)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele carrier of rs3025020 SNP is associated with higher levels of hs-CRP, indicating a pro-inflammatory effect."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS3025020 (-583T&gt;C)&quot;" target="&quot;BIOACTIVE TESTOSTERONE LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs3025020 genotype is positively correlated with increased bioactive testosterone levels, contributing to hyperandrogenism in PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;VEGF SERUM LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs2010963 genotype is inversely correlated with serum VEGF levels, indicating a protective role against PCOS metabolic disturbances."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;FREE TESTOSTERONE LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs2010963 genotype is inversely correlated with free testosterone levels, indicating a protective role against hyperandrogenism characteristic of PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;ERYTHROCYTE SEDIMENTATION RATE (ESR)&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The minor allele carrier of rs2010963 SNP is associated with lower levels of ESR, indicating an anti-inflammatory effect."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RS2010963 (-634C&gt;G)&quot;" target="&quot;BIOACTIVE TESTOSTERONE LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The presence of rs2010963 genotype is inversely correlated with bioactive testosterone levels, suggesting a protective effect against hyperandrogenism."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TOTAL TESTOSTERONE LEVELS&quot;" target="&quot;PCOS&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"While total testosterone levels are comparable between women with PCOS and controls, the bioactive forms of these hormones show differences that correlate with disease pathology."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;LH/FSH RATIO&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"The ratio of LH to FSH is elevated in women with PCOS compared to control subjects, indicating a key hormonal imbalance characteristic of this condition."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;SHBG LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Significantly lower SHBG levels are observed in women with PCOS compared to controls, contributing to increased free androgens."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PCOS&quot;" target="&quot;TSH LEVELS&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"While TSH levels are higher but within normal range in women with PCOS compared to controls, this may reflect a subtle thyroid dysfunction or metabolic alteration."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HS-CRP LEVELS&quot;" target="&quot;INFLAMMATION&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Increased hs-CRP levels are associated with pro-inflammatory processes in women carrying the minor allele of VEGFA SNP rs3025020, reflecting a higher inflammatory response."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ANTI-INFLAMMATORY EFFECT&quot;" target="&quot;ESR LEVELS&quot;">
      <data key="d4">1.0</data>
      <data key="d5">"Decreased ESR levels among carriers of the minor allele of VEGFA SNP rs2010963 suggest an anti-inflammatory effect, possibly protective against chronic inflammation in PCOS."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IL-10 LEVELS&quot;" target="&quot;VEGFA SNPS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No correlation between IL-10 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this anti-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VEGFA SNPS&quot;" target="&quot;IL-6 LEVELS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No correlation between IL-6 levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VEGFA SNPS&quot;" target="&quot;TNFΑ LEVELS&quot;">
      <data key="d4">0.0</data>
      <data key="d5">"No correlation between TNFα levels and either VEGFA SNP rs3025020 or rs2010963 indicates that this pro-inflammatory cytokine is not directly influenced by these genetic variants."</data>
      <data key="d6">chunk-2c178ae99eeffdddbea511cafbe4a7d5</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;VAL CARRIER GENOTYPE&quot;" target="&quot;RESPONSE BIAS&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"Individuals carrying the val variant showed higher response bias compared to iso homozygotes, indicating a genetic influence on behavioral responses."&lt;SEP&gt;"Individuals carrying the val variant showed higher response bias compared to iso homozygotes, indicating a relationship between this genotype and behavior."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISO HOMOZYGOTE GENOTYPE&quot;" target="&quot;RESPONSE BIAS&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals with the iso homozygote genotype exhibited lower response bias as compared to val carriers, suggesting a genetic influence on behavioral responses."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ISO HOMOZYGOTE GENOTYPE&quot;" target="&quot;SHOCK INTENSITY SELECTION&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Individuals with the iso homozygote genotype selected lower levels of shock intensity than val carriers, indicating differential stress sensitivity."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;ISO HOMOZYGOTES&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Individuals homozygous for the iso allele show less pronounced changes in response bias under stress conditions compared to val carriers, suggesting differential susceptibility to environmental stressors.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;CONDITION (STRESS VS NO-STRESS)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The manipulation of stress condition significantly affects response bias, with reduced bias towards rewarded stimuli observed under stress compared to no-stress conditions.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;SKIN CONDUCTANCE RESPONSES (SCR)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Changes in skin conductance responses are associated with variations in response bias during stress conditions; elevated SCRs correlate with altered cognitive biases under stress, yet do not fully explain genotype effects on response bias.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;CRHR1 SNPS (RS12938031, RS10445364, RS4076452)&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The presence of CRHR1 SNPs does not significantly alter the effect of MR genotype on stress-induced response bias reductions but slightly modifies variance explanation.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;RESPONSE BIAS&quot;" target="&quot;MR GENOTYPE (COMT GENE VARIANTS)&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Differences in MR genotype, particularly the val allele compared to iso homozygotes, uniquely explain changes in response bias during stress conditions after controlling for other influencing factors like discriminability and SCR.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;STAI SCORES&quot;" target="&quot;TIME × CONDITION × GENOTYPE INTERACTION&quot;">
      <data key="d4">0.5</data>
      <data key="d5">"There was a trend showing that STAI scores increased over time and condition differently across genotypes, suggesting genetic modulation of stress response."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DISCRIMINABILITY&quot;" target="&quot;SHOCK INTENSITY&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Although there were significant main effects for discriminability and block number, no differences emerged between genotype groups in any block regarding the impact of shock intensity on discriminability.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CRHR1 GENE&quot;" target="&quot;STRESS-INDUCED REWARD LEARNING DEFICITS&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Polymorphisms in the CRHR1 gene are linked to variations in reward learning deficits induced by stress, indicating a genetic basis for differential susceptibility to stress effects on cognitive processes.")</data>
      <data key="d6">chunk-5e709975097a773fb3d31e265d76a71b</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CONDITION × TIME × GENOTYPE TREND&quot;" target="&quot;PANAS NA&quot;">
      <data key="d4">0.6</data>
      <data key="d5">"The PANAS negative affect scale showed an interaction effect with trends indicating differential changes in emotional distress over time for different genotypes."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;SC RESPONSES&quot;" target="&quot;TIME × GENOTYPE INTERACTION&quot;">
      <data key="d4">0.7</data>
      <data key="d5">"There was a trending effect suggesting that skin conductance responses varied over time differently based on genotype, hinting at genetic modulation of physiological arousal."</data>
      <data key="d6">chunk-4b4f7d54511e2d8bbf5af6073d25b647</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMP4 GENE&quot;" target="&quot;NUMBER OF TEETH TRAIT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants in BMP4 play a role in the number of permanent teeth, though less pronounced than with 'age at first tooth' trait."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CACNB2 GENE&quot;" target="&quot;DENTAL DEVELOPMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"Variants in CACNB2 are found to be linked to variations in age at first tooth, suggesting a role in the timing of tooth development."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CDON GENE&quot;" target="&quot;TOOTH MORPHOGENESIS&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"SNP rs4937076 near CDON gene is associated with phenotypes related to dental morphogenesis."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AJUBA/C14ORF93 GENE&quot;" target="&quot;DENTAL PHENOTYPES&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"The SNP rs997154 near AJUBA gene is associated with phenotypic variation in dental development traits."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;TEX14/RAD51C GENE&quot;" target="&quot;TOOTH COUNT&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"The SNP rs412000 near TEX14/RAD51C is associated with variation in the count of teeth at one year."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;FAM155E–EDA&quot;" target="&quot;CRANIOFACIAL DEVELOPMENT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genomic variant FAM155E-EDA is involved in craniofacial development measures."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;BMP4&quot;" target="&quot;TOOTH ERUPTION&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Bone Morphogenetic Protein 4 (BMP4) influences the timing of tooth eruption and number of primary teeth."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGF2BP1&quot;" target="&quot;TOOTH ERUPTION&quot;">
      <data key="d4">6.0</data>
      <data key="d5">"Insulin-like Growth Factor 2 mRNA Binding Protein 1 (IGF2BP1) influences tooth eruption timing."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;MSRB3&quot;" target="&quot;DENTAL PHENOTYPE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Methionine Sulfoxide Reductase B3 (MSRB3) contributes significantly to dental phenotype development."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADK&quot;" target="&quot;NOSE WIDTH&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"Adenosine Kinase (ADK) variants are associated with measures of nose width in craniofacial studies."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AJUBA&quot;" target="&quot;HEIGHT AND CRANIOFACIAL PHENOTYPES&quot;">
      <data key="d4">8.0</data>
      <data key="d5">"LIM Domain Containing 7 Protein (AJUBA) is involved in mid-brow height increase, possibly linked to height."</data>
      <data key="d6">chunk-29b3ac5f9dbe166f36559a272d7bcba1</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 GENE&quot;" target="&quot;PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"The pathway analysis for 'age at first tooth' highlights pathways that include genes like HMGA2 and BMP4 as being significant, indicating their importance in dental health."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 GENE&quot;" target="&quot;AGE AT FIRST TOOTH TRAIT&quot;">
      <data key="d4">4.0</data>
      <data key="d5">"Genetic variants in HMGA2 significantly influence when an individual develops their first tooth."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR AGE AT FIRST TOOTH SCORE (PMETA = 0.0012)&quot;" target="&quot;HEIGHT TRAIT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genetic variants associated with age at first tooth show a moderate association with height, suggesting an underlying biological link between these traits."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE SIGNIFICANT SNPS FOR NUMBER OF TEETH SCORE (PMETA = 9.8 × 10−4)&quot;" target="&quot;HEIGHT TRAIT&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The genetic variants associated with the number of teeth also show a moderate association with height, similarly suggesting an underlying biological link between these traits."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;PATHWAY ANALYSIS RESULTS (AGE AT FIRST TOOTH)&quot;" target="&quot;ALLIGATOR SOFTWARE&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"The ALLIGATOR software is used to conduct pathway analysis for 'age at first tooth', revealing significant biological pathways involved."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;CALU/OPN1SW GENE&quot;" target="&quot;ORAL HEALTH&quot;">
      <data key="d4">5.0</data>
      <data key="d5">"Variation in this region affects oral health parameters like age of first tooth and number of teeth."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DENTAL PHENOTYPES&quot;" target="&quot;MSRB3 GENE&quot;">
      <data key="d4">11.0</data>
      <data key="d5">"The SNP rs1956529 in MSRB3 region is associated with phenotypic variation related to dental traits."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ADK GENE&quot;" target="&quot;ORAL DEVELOPMENT&quot;">
      <data key="d4">7.0</data>
      <data key="d5">"SNP rs7924176 near ADK gene shows association with oral developmental traits such as tooth number."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DENTAL TRAITS&quot;" target="&quot;DLEU7 GENE&quot;">
      <data key="d4">9.0</data>
      <data key="d5">"Variation around DLEU7 gene is linked to phenotypes like age at first tooth and number of teeth."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;KCNJ2 GENE&quot;" target="&quot;TOOTH DEVELOPMENT&quot;">
      <data key="d4">10.0</data>
      <data key="d5">"Genetic variations near KCNJ2 are reported to impact dental development including the timing of first tooth appearance."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;IGF2BP1 GENE&quot;" target="&quot;ORAL DEVELOPMENT TRAITS&quot;">
      <data key="d4">12.0</data>
      <data key="d5">"Variations near IGF2BP1 gene influence oral developmental traits such as tooth number and age of eruption."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;ORAL DEVELOPMENT TRAITS&quot;" target="&quot;LINC01278 GENE&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"Variants around LINC01278 gene are linked to oral developmental traits such as the timing of first tooth eruption."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;DENTAL MORPHOGENESIS&quot;" target="&quot;EDA GENE&quot;">
      <data key="d4">13.0</data>
      <data key="d5">"SNPs in EDA region are associated with phenotypic variations in dental morphology and development."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;HMGA2 REGION&quot;" target="&quot;TOOTH COUNT VARIABILITY&quot;">
      <data key="d4">14.0</data>
      <data key="d5">"The SNP rs17101923 in HMGA2 region shows significant association with variability in the number of teeth at one year."</data>
      <data key="d6">chunk-50e07db177a6a08799261934e8e71ac4</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;AGE AT FIRST TOOTH TRAIT&quot;" target="&quot;GENOME-WIDE ASSOCIATION STUDY (GWAS)&quot;">
      <data key="d4">3.0</data>
      <data key="d5">"The GWAS investigates genetic variants associated with when an individual first develops teeth."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
    <edge source="&quot;GENOME-WIDE ASSOCIATION STUDY (GWAS)&quot;" target="&quot;NUMBER OF TEETH TRAIT&quot;">
      <data key="d4">2.0</data>
      <data key="d5">"The GWAS also explores genetic factors influencing the number of permanent teeth in adults, though less significant pathways were found compared to 'age at first tooth'."</data>
      <data key="d6">chunk-c63d60b991cd7442f690dcc364af47dd</data>
      <data key="d7">1</data>
    </edge>
  </graph>
</graphml>
